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People are often unreasonable, illogical and self-centred; 
Forgive them anyway. 
If you are kind, people may accuse you of selfish, ulterior motives; 
Be kind anyway. 
If you are successful, you will win some false friends, and have some true enemies; 
Succeed anyway. 
If you are honest and frank, people may cheat you; 
Be honest and frank anyway. 
What you spend years building, someone could destroy overnight; 
Build anyway. 
If you find serenity and happiness, some may be jealous; 
Be happy anyway. 
The good you do today, people will often forget tomorrow; 
Do good anyway. 
Give the world the best you have, and it may never be enough; 
Give the world your best anyway. 
You see, in the final analysis, it is between you and God. 
It was never between you and them anyway. 
Mother Theresa 
This thesis is dedicated to the loving memory of 
my grandmother 




CHARLES FELIX MARGOT 
1918 -1997 
May their souls and the souls of all the faithfully departed, 
through the mercy of God, rest in peace. 
Amen 
Abstract 
This PhD thesis describes a phytochemical investigation of seven medicinal plants, 
namely, Ledebouria ovatifolia (Hyacinthaceae), Eucomis pole-evansii 
(Hyacinthaceae ), 
(Hyacinthaceae ), 
Lachenalia rub ida (Hyacinthaceae), Drimia capitata 
Papaver aculeatum (Papaveraceae), Spilanthes mauritiana 
(Asteraceae) and Tachiadenus longiflorus (Gentianaceae). 
The southern African Hyacinthaceae is a large, chemically and morphologically 
diverse group of plants. Plants of the genus Ledebouria are used extensively by 
traditional healers in Kwazulu-Natal, particularly in enemas and as purgatives for both 
humans and cattle. Investigations of Ledebouria ovatifolia led to the isolation of three 
compounds, a novel norlignan, a class, which has never before been found in this 
family, and two eucosterol-type compounds. Chemical investigations of Eucomis 
pole-evansii and Lachenalia rub ida have revealed the presence of two 
homoisoflavonoids of the 3-benzyl-4-chromanone type, a novel 3-benzylidene-4-
chromanone type homoisoflavonoid as well as a novel 3-benzylchromone. 
Investigations of Drimia capitata have yielded a novel bufadienolide and its glycoside 
Plants of the family Papaveraceae have been of great interest chemically, as they 
contain alkaloids such as morphine and codeine. Morphine is an intense analgesic 
used to treat chronic pain, while codeine is milder and is found in cough syrups and 
headache remedies. The species Papaver aculeatum is thought to be a premature 
member of the Papaveraceae and it was thought that it might contain precursors to 
these alkaloids. This plant yielded an alkaloid, (+ )-N-acetylanonaine. 
In South Africa, the African plant Spilanthes mauritiana (Asteraceae), is used 
medicinally by the Zulus as an oral local analgesic for the relief of toothache. Other 
medicinal usage of this plant includes healing broken limbs, stomach-ache, diarrhoea, 
bladder complaints and headaches. This plant yielded one known and one novel 
isobutylamide. The known isobutylamide, spilanthol, has been attributed with 
larvicidal and other insecticidal properties. 
Members of the family Gentianaceae commonly accumulate bitter substances called 
iridoids. The species Tachiadenus longiflorus yielded the known triterpenoid, 
oleanolic acid; two known coumarins, scopoletin and scoparone; and what appears to 
be an iridoid derivative. Syntheses of aesculetin, scoparone and isoscopoletin were 
also performed for comparison purposes. 
The final chapter in this thesis is an attempt to synthesise the norlignan isolated from 
Ledebouria ovatifolia. This procedure involves firstly the synthesis of the appropriate 
chalcone, secondly the formation of the appropriate Grignard reagent and its 
attachment to the chalcone, thirdly reduction of the vinyl ketone to form the vinyl 
alcohol and finally dehydration to form the norlignan. This unfortunately did not 
occur, however a novel cyc1isation product was formed and was identified as (E)-3-
vinyl-l-( 4 '-hydroxypheny 1)-3",4 "-dimethoxyindene. 
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1.1 The Importance of Medicinal Plants 
Until relatively recently, the primary source of all the medicines in the world was 
plants, and they are continuing to provide mankind with new remedies). Plant-based 
traditional medicine systems play a vital role in health care, and the World Health 
Organisation (WHO) estimates that approximately eighty percent of the world's 
inhabitants are dependant on traditional medicines for their primary health care2• In 
the remaining twenty percent of the population, plant products also play an important 
role in health care, as an analysis of prescribed drugs indicated that approximately 
twenty-five percent contained plant extracts or active principles derived from higher 
plants2• Currently approximately one hundred and nineteen chemical substances 
isolated from ninety plant species are considered as important drugs and are used in 
one or more countries2• Seventy-four percent of these one hundred and nineteen drugs 
were discovered as a result of chemical investigations directed at isolating the active 
substances from traditional medicinal plants2• 
Natural products and their derivatives are extensively used in clinical drugs with 
quinine, morphine, codeine, aspirin and reserpine being a few well-known examples). 
The development of anti-cancer drugs such as paclitaxel, from Taxus brevifolia, and 
vincristine, from Catharanthus roseus, has been a significant breakthrough for 
pharmaceutical companies), however new analogues are currently being isolated and 
synthesised. In South Africa, many of the medicines used are still derived from plant 
sources, which can be bought informally from traditional healers, or commerciallyl. 
Many South African plants, including Aloe ferox (Cape aloe), Agathosma betulina 
(buchu) and Harpagophytum procumbens (devil's claw) are known and used 
worldwidel. 
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The bark of the quinine tree, Cinchona pubescens (Rubiaceae), yields the alkaloid, 
quinine (Figure 1.1) which, before the recent development of more effective synthetic 
drugs such as quinacrine, chloroquine and primaquine, provided the only treatment for 
malaria 1,3 . 
quinine 
Figure 1.1. The structure of quinine. 
However, with the increase in resistant parasites, it was necessary to search for other 
agents, both synthetic and natural product based2. From the extract of a traditional 
Chinese herbal remedy plant, Artemisia annua (Wormwood) (Compo sitae/ 
Asteraceae), the active agent artemisinin, a sesquiterpene endoperoxide, was isolated. 
This plant had been used for centuries in China in the treatment of fevers and as an 
antimalariaI2.4. Artemisinin has been shown to be responsible for the antimalarial 
properties of this plant, as it is an effective blood schizontocide in humans infected 
with malaria and it shows virtually no toxicity4. Artemisinin can be reduced to the 
lactol (hemiacetal) dihydroartemisinin, which has been used for the semi-synthesis of 
a range of analogues of which the acetal, artemether, has been shown to be a very 
promising antimalarial agent4. When compared to artemisinin, these analogues show 
increased activity and also a reduction in the probability of a re-infection4. 
Dihydroartemisinin rapidly clears the blood of malarial parasites, however, it does not 
have a prophylactic effect4. Investigations have also led to the identification of 
artemether, which is now in widespread use throughout the world as a potent 
treatment for malaria
2
• Chemically, these analogues are unlike any other class of 
current antimalarial agent and may become a significant group of drugs in the battle 
2 
against this life-threatening disease4. The structures of artemisinin, artemether and 
dihydroartemisinin are shown in figure 1.2. 
o 
artemisinin artemether dihydroartemisinin 
Figure 1.2. The structures of artemisinin, artemether and dihydroartemisinin2. 
Atropine (Figure 1.3), the racemic form of hyoscyamine5, and other tropane alkaloids 
are isolated from Atropa belladonna l (Solanaceae). These compounds are used in eye 
drops, injected to treat Parkinson's disease and used in skin patches to treat motion 
sickness l . Atropine produces an increased heart rate, dilated pupils, dry skin and 




Figure 1.3. The structure of atropine5. 
Morphine and codeine are obtained from the unripe fruit capsules of the opium poppy, 
Papaver somniferum (Papaveraceae). Crude 'opium', the air-dried latex from P. 
somniferum, contains about twenty five percent of its weight as opium alkaloids, with 
3 
morphine and codeine being the major components2• Morphine is a powerful 
analgesic and narcotic and continues to be one of the most vital analgesics for the 
relief of severe pain, usually in terminal patients. It also induces a state of euphoria 
and mental detachment, together with nausea and vomiting5• Codeine, the 3-0-methyl 
ether of morphine, is the opium alkaloid that is most widely used5• It is a milder 
analgesic and is found in cough syrups and headache remedies l . Most of the 
prescribed codeine is manufactured by semi-synthesis from morphine due to the very 
small amounts of this compound found in opium5. From morphine, the addictive drug, 
heroin, is also produced7. Figure 1.4 shows the structures of morphine, codeine and 
heroin. 
morphine (R 1=R2=H) 
codeine (R1=H, R 2=CH 3) 
heroin (R1=R 2=COCH3) 
Figure 1.4. The structures of morphine, codeine and heroin. 
A very well known and most used drug in pain relief is aspirin (Figure 1.5). It is the 
acetyl derivative of salicylic acid and is used to lower fever, relieve pain, reduce 
inflammation and thin the blood8. Aspirin was originally derived from salicin (Figure 




Figure 1.5. The structures of salicin and aspirin. 
Reserpine (Figure 1.6) is an alkaloid isolated from the root of the snakeroot plant, 
Rauwolfia serpentina (Apocynaceae), a small evergreen climbing shrub native to the 
Indian subcontinent9. The plant was used for centuries to treat insanity as well as 
physical illnesses such as fevers and snakebites9. Reserpine has been reported to cause 
many toxic side effects including nightmares, Parkinsonism, gastrointestinal 
disturbances and severe depressions,9. Reserpine has also been suggested to playa role 
in the promotion of breast cancers, however, it is widely used as an antihypertensive 




Figure 1.6. The structure of reserpine. 
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The treatment of cancer is poorly defined in terms of folklore and traditional 
medicine, thus the claims that plants have a long history of effective use in the 
treatment of cancer, can be viewed with some scepticism
2
. The Madagascan 
periwinkle, Catharanthus roseus (Apocynaceae), due to its folklore usage as a tea for 
diabetics, was originally investigated for potential hypoglycaemic activity2.5. 
Although the blood sugar levels of rabbits were not affected by the plant extracts, the 
test animals became susceptible to bacterial infection due to low white blood cell 
levels5. Thus anticancer activity was suggested, which initiated the exhaustive 
investigation of the constituents5. Chemical investigations yielded a mixture of 
alkaloids, two of which, vinblastine and vincristine2.1O, shown in figure 1.7, were 
introduced into cancer chemotherapy and have proved to be vital in the fight against 
cancer. Vinblastine and vincristine show very little structural difference, however, 
there is a significant difference in the spectrum of human cancers that respond to these 
two drugs5. Vinblastine is used to treat Hodgkin's disease (a cancer affecting the 
lymph glands, spleen and liver), advanced breast cancer and advanced testicular 
carcinoma5.1O• Vincristine has superior antitumor activity compared to vinblastine but 
is more neurotoxic5. A high rate of remission of childhood leukaemia has been shown 
in treatment using this drug5. Some other cancer conditions, including lymphomas, 
small cell lung cancer, and cervical and breast cancers also respond positively to this 
drug5. These alkaloid drugs need to be injected, and are both currently used in 
combination with other drugs in cancer chemotherapl. 
vinblastine vincristine 
Figure 1.7. The structures of vinblastine and vincristine2. 
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Selective chemical modifications of vinblastine and vincristine have led to two semi-
synthetic derivatives, vinorelbine and vindesine, shown in figure 1.8, being introduced 
for the treatment of cancer2,S,1O. Recently, the use of vinorelbine has been approved in 
the United States, while vindesine is still undergoing clinical trials2. Vindesine has 
been used in the treatment of acute lymphoid leukaemia in childrens. Vinorelbine is 
orally active and has a broader anticancer activity, however, with fewer neurotoxic 
side-effects than either vinblastine or vincristines. 
vinorelbine vindesine 
Figure 1.8. The structures of vinorelbine and vindesine2. 
A very effective treatment for breast and ovarian cancer is the drug paclitaxel, which 
is sold as Taxoll,S. It is a diterpenoid derivative found in the bark of Taxus brevifalia 
(Taxaceae), commonly known as the Pacific Yew1,S,1l. Several Native American 
tribes have used parts of this plant for non-cancerous treatments2, while the leaves of 
Taxus baccata, the common yew, are used in the traditional Asiatic Indian medicine 
system, with a single reported use in the treatment of cancer2. The problem with 
paclitaxel is the difficulty in obtaining the drug. The amount of paclitaxel in the yew 
bark is very low and the tree is very slow growing, and only yields enough paclitaxel 
to treat one patient. Although paclitaxel has been produced by total synthesis, this is 
not commercially viable. Docetaxel (sold as Taxotere), is a side chain analogue of 
paclitaxel, which has also been produced by semi-synthesis from lO-deacetylbaccatin 
1114. Docetaxel has improved water solubility compared with paclitaxel and is being 
7 
used clinically against ovarian and breast cancers4. The structures of paclitaxel and 
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Figure 1.9. The structures of paclitaxel and docetaxel. 
Plants provided an important source of raw materials for medicines in the early part of 
the 20
th 
century; however, later, synthetic analogues were produced to replace many 
of these plant-derived medicines 12. Recently, plants have once again become a 
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significant source of new medicines due to problems with drug resistant micro-
organisms, the side effects from modem drugs as well as diseases which emerge 
where no medicines are available12• The vast medicinal knowledge of indigenous 
people is captivating researchers around the world. The major discoveries listed in this 
chapter, show the importance of plants in providing new target molecules for drug 
development. 
Southern Africa is an important centre of plant diversity in the world, producing a 
large number of plant species (approximately thirty thousand higher plants in South 
Africa and three thousand in Botswana), many of which are endemic to the area13. 
One of the world's richest floral regions boasting over six thousand endemic species is 
the Cape Floristic Regionl4. A wide variety of plant types, which have adapted to the 
different habitats, is a result of the great variation in climatic types from the sub-
tropical eastern coast to the semi-desert vegetation of much of the region, to the 
Mediterranean climate of the Western Cape l3 . The indigenous people of southern 
Africa have a long history of traditional plant usage for medicinal purposes l3 . The 
southern African medicinal plant trade is a vital part of the economy with over seven 
hundred plant species reported as being traded in the region 15. The factors of the large 
numbers, uniqueness and variety of the plants, commercial and social importance, and 
ethno-botanical information available make natural products research an important 
area of research for the region 13. 
In this work, the chemical investigation of seven African medicinal plants, namely, 
Ledebouria ovatifolia (Hyacinthaceae), Eucomis pole-evansii (Hyacinthaceae), 
Lachenalia rubida (Hyacinthaceae), Drimia capitata (Hyacinthaceae), Papaver 
aculeatum (Papaveraceae), Spilanthes mauritiana (Asteraceae) and Tachiadenus 
longiflorus (Gentianaceae), has been undertaken to find compounds with biological 
activity. Three main classes of compounds were isolated, namely, homoisoflavonoids, 
triterpenoids and coumarins and therefore the biosynthesis of these three classes will 
be discussed in detail. 
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1.2 Introduction to Homoisoflavonoids 
Homoisoflavonoids, also referred to as homoisoflavanones, are a group of naturally 
occurring compounds isolated predominantly from the Hyacinthoideae subfamily of 
the Hyacinthaceae (Liliaceae sensu lato) family16-20. Bohler and Tamm first isolated 
this class of compounds in 1967 from Eucomis bicolor and many others have 
. f E . 21 -24 S ·ll 25-27 subsequently been isolated from other specIes 0 ucomlS , Cl a , 
l h . . 20 D·· . 28 M ·17 d Led b . 29 Ve t elmza , rzmzopsls, uscarz an e ourza . 
o 
Figure 1.10. The numbering system of a typical homoisoflavonoid. 
Homoisoflavonoids (Figure 1.10) belong to a homogeneous group of naturally 
occurring oxygen heterocycles3o. However, the term "homoisoflavonoid" is a 
misnomer since these compounds are not biogenetically related to isoflavonoids and 
do not undergo the 2,3-aryl rearrangement of the C6-C3-C6 group that typically occurs 
in the biosynthesis of isoflavonoids31.32. In addition, homoisoflavonoids have a 
sixteen-carbon skeleton as opposed to the fifteen-carbon atoms characteristic of the 
isoflavonoid skeleton. Thus, although this term is often used when making reference 
to these compounds, the systematic name 3-benzyl-4-chromanones is more correct. 
Characteristically, homoisoflavonoids have an additional benzylic carbon atom 
situated between the Band C-rings, leading to a sixteen-carbon skeleton. This 
skeleton bears either a chromane, chromone or chromanone group, which has a benzyl 
or benzylidene group situated at the 3-position19. Homoisoflavonoids vary from one 
another by the substitution patterns on the A and B-rings. Common substituents are 
hydroxy, methoxy, acetoxy and in some cases even methyl and aldehyde groups. 
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Homoisoflavonoids are generally classified into three basic types30; 3-benzyl-4-
chromanones (Figure 1.11), 3-benzyl-3-hydroxy-4-chromanones (Figure 1.12) and 3-
benzylidene-4-chromanones (Figure 1.13). The latter are characterised by the 




Figure 1.11. The structure of a 3-benzyl-4-chromanone homoisoflavonoid. 
o 
3-benzyl-3-hydroxy-4-chromanone 








Figure 1.13. The structure of 3-benzylidene-4-chromanone homoisoflavonoids. 
In addition to these three basic structural types, numerous homoisoflavonoids 
containing a fourth ring have been isolated19,33. These unusual compounds include 
scillascillin, which has a unique 3-spiro-cyclobutene system, brazilin and dracaenone 
(Figure 1.14). Brazilin and dracaenone have been isolated from the non-
Hyacinthaceae species, Caesalpinia spp (Caesalpinaceae) and Dracaena loureiri 
(Dracaenaceae) respectively. The C-4 carbonyl group is lost in brazilin and rather a 
cyclopentene ring is observed, while in dracaenone, a cyclohexene ring is observed. 
scillas cillin dracaenone 
brazilin 
Figure 1.14. The structures of scillascillin, brazilin and dracaenone. 
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1.2.1 The Biosynthesis of Homoisoflavonoids 
Aromatic compounds derived from plants can be formed by one of two biosynthetic 
pathways, namely, the shikimate pathway (originating from carbohydrates) or the 
. . . f I d I I A ' t ) 34-36 polyketide pathway (ongmatmg rom acety an rna ony coenzyme um s . 
Homoisoflavonoids are of mixed origin and the biosynthesis involves both of the 
pathways, with ring B being shikimate-derived and ring A polyketide-derived
32
• This 





Figure 1.15. The origin of the A and Brings. 
An important stage in the biosynthesis of homoisoflavonoids is the formation of a 
chalcone as chalcones are known to be the direct precursors of homoisoflavonoids. 
This is achieved in the following way: shikimate derived L-phenylalanine is converted 
to cinnamic acid in a deamination reaction catalysed by the enzyme L-phenylalanine 
ammonia lyase37. This involves the elimination of ammonia in an anti-periplanar 
fashion to yield trans-cinnamic acid. Hydroxylation of the cinnamic acid then occurs, 
mediated by the mono-oxygenase enzyme, cinnamate-4-hydroxylase, which results in 
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Scheme 1.1. The formation of 4-coumaric acid38. 
This reaction mechanism involves a hydrogen shift called the NIH shift (Scheme 1.2). 
This shift was first discovered at the National Institute of Health in Bethesda, hence 
the phenomenon's name, and was established using tritium labelling experiments36. 
This mechanism involves the replacement of the proton in the para position with a 
hydroxy group and the proton's subsequent migration to the meta position. 
[0] 
COOH 7 COOH COOH 
7 COOH 7 COOH 
Scheme 1.2. The mechanism of the NIH shift39. 
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The 4-cournaric acid formed is converted to the CoA ester, 4-hydroxycinnamoyl-
CoA, by the enzyme 4-coumarate:CoA ligase. The 4-hydroxycinnamoyl-CoA 
molecule then combines with three malonyl CoA derived acetate units to give the 
polyketide ester. This resultant ester then cyc1ises via a Claisen type condensation to 
yield the tetrahydroxychalcone. This reaction is catalysed by the enzyme chalcone 
synthase36-38 (Scheme 1.3). 
4-coumarate:Co 
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A common methylating agent in living systems is methionine, probably as S-
adenosylmethionine, which provides the tetrahydroxychalcone with an additional 
methyl group forming 4,4',6'-trihydroxy-i-methoxychalcone (Scheme 1.4). This 
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2',4' ,6',4-tetrahydroxychalcone 4',6',4-trihydroxy-2'-methoxychalcone 
Scheme 1.4. The formation of 2'-methoxy-4',6',4-trihydroxychalcone. 
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Dewick, who proposed the biosynthetic scheme for the conversion of cha1cones to 
homoisoflavonoids32, suggests that the methoxy group, derived from L-methionine, in 
the precursor i -methoxycha1cone is oxidised, and subsequent cyclisation results in 
the three basic types of homoisoflavonoids (Scheme 1.5). The 3-benzyl-4-chromanone 
types are produced by the addition of a hydride ion, while the loss of a proton leads to 
the formation of the 3-benzylidene-4-chromanone types. 3-Benzyl-3-hydroxy-4-
chromanones are either formed by the addition of water to a 3-benzylidene-4-
chromanone type homoisoflavonoid or by the oxidation of the C-3 position of a 3-
benzyl-4-chromanone type homoisoflavonoid. 
HO 
• oxidation of 
7 6 2' methoxyl group 
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Scheme 1.5. The proposed biosynthetic routes to the homoisoflavonoids32. 
The formation of scillascillin, brazilin and dracaenone-type compounds can be 
explained by more complex mechanisms. Dewick32, Bhandari37 and co-workers have 
proposed some of these mechanisms. Scillascillin and brazilin are thought to form 
16 
from activated 3-benzyl-3-hydroxy-4-chromanone precursors, which cyclise to form a 
cyclobutene ring in scillascillin32 (Scheme 1.6) and a cyclopentene ring in the case of 







Scheme 1.6. The proposed formation of scillascillin32• 
HO 
3-benzyl-3-hydroxy-4-chromanone 





Dracaenone-type compounds, on the other hand, are thought to be derived from 3-
benzy1chroman-type compounds, which cyclise via para-para phenolic oxidative 
coupling to yield a tetracyclic intermediate4o. Dienone-phenol rearrangement of this 





Scheme 1.8. The biosynthesis of dracaenone-type compounds40• 
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1.2.2 The Biological Activities of Homoisoflavonoids 
Homoisoflavonoids have many diverse biological activities and considerable research 
is still necessary in order to appreciate them fully. Within the plant, these compounds 
are concentrated in the waxy layers between the storage leaves of the bulbs
33 
and this 
specific distribution has prompted the investigation of their biological significance. 
From previous studies these compound have been shown to possess anti-mutagenic, 
. . fl . b . I d I· . 3340-42 h· h ld I· antI-m ammatory, antI- actena an ana geslc properties ' , w IC cou exp am 
their widespread ethnobotanical usage by traditional healers. 
An investigation of the roots of Hoffmanseggia intricata41 (Fabaceae) showed two 
homoisoflavonoids which had antimutagenic and antitoxic properties. These 
compounds, identified as intricatin (8-hydroxy-7 -methoxy-3-( 4' -methoxybenzyl)-4-
chromanone) and intricatinol (7 ,8-dihydroxy-3-( 4' -methoxybenzyl)-4-chromanone), 
both shown in figure 1.16, displayed varying toxicity inhibition of 2-amino-
anthracene, acetylaminofluorine and ethylmethanesulphonate towards Salmonella 
typhimurium41 • Intricatinol, the dihydroxy analogue, was found to be broadly active 
and it was postulated that the presence of a dihydroxy group in ring A could lead to 
increased potency of the homoisoflavonoid41 • Investigations of a crude extract from 
the bulbs of Muscari comosum42 (Hyacinthaceae), revealed extensive anti-
inflammatory properties with the inhibition of croton oil-induced dermatitis in the 
mouse ear. The inhibitory effect of this administration was comparable to the potent 
anti-inflammatory drug, indomethacin42• In general, phenolic compounds are known 




Figure 1.16. The structures of intricatin and intricatinol. 
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1.3 Introduction to Triterpenoids 
The terpenes are amongst the most widespread groups of natural products and are 
derived from a common biosynthetic pathway based on mevalonate as parent. 
Terpenes are typically found in higher plants, lower animals (coelenterates, molluscs 
and arthropods), fungi, algae and lichens4• Members of this class also form the basis 
of mammalian sex hormones, pheromones and plant hormones. 
Despite being structurally diverse, terpenoids are composed of a single unifying 
feature, the Cs isoprene unit. In 1953 Ruzicka
43 proposed the "Biogenetic Isoprene 
Rule" which stated that all terpenoids are formed by the head-to-tail linkage of 
isoprene units. This rule was later improved and extended to include different types of 
terpenoids derived from a single parent compound unique to that class i.e. geraniol 
(C lO), farnesol (CIS), geranylgeraniol (C20), and squalene (C30) (Figure 1.17), 




Figure 1.17. Some examples of the structures of terpenoids. 
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Terpenoids are grouped according to the number of isoprene units they contain i.e. 
hemiterpenoids, Cs; monoterpenoids, CIQ; sesquiterpenoids, CIS; diterpenoids, C20; 
triterpenoids, C30; and carotenoids, C40 (Scheme 1.9). 
MEVALONIC ACID 
j 
DIMETHYLALL YL DIPHOSPHATE - HEMITERPENOIDS, C5 
j 
GERANYL DIPHOSPHATE • MONOTERPENOIDS, CIO 
j 




STEROIDS TRITERPENOIDS, C30 
GERANYLGERANYL DIPHOSPHATE - DITERPENOIDS, C20 
j ~AROTENOIDS, C40 
POL YlSOPRENES 
Scheme 1.9. Terpenoid groups derived from mevalonic acid44• 
However, isoprene itself is not the biogenetic precursor of terpenoids and is only 
rarely found in nature45. The biochemically active isoprene units are the diphosphate 
esters, dimethylallyl diphosphate (DMAPP) and isopentenyl diphosphate (IPP)4 
(Figure 1.18) 
~opp ~opp 
dimethylallyl diphosphate isopentenyl diphosphate 
Figure 1.18. The biochemically active isoprene units. 
21 
1.3.1 The Biosynthesis of Triterpenoids 
The triterpenoids form a very diverse group of naturally occurring compounds, which 
are widely distributed throughout the Plant Kingdom. The starting material for the 
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Scheme 1.10. The formation of hydroxymethylgluteryl CoA 4. 
CH2CSCoA 
Two molecules of acetyl CoA combine in a Claisen condensation to form acetoacetyl 
CoA. A third molecule of acetyl CoA is incorporated via a stereospecific aldol 
addition
4 
to form (3S)-3-hydroxy-3-methylgluteryl CoA (HMG-CoA), these reactions 
being catalysed by acetyl CoA acetyltransferase and HMG-CoA synthase, 
respectively. Acetoacetyl CoA is more acidic than the third acetyl CoA molecule and 
thus serves as the nuc1eophile. NADPH then reduces the thio ester, HMG-CoA via the 
hemithioacetal to the aldehyde, (3R)-mevaldic acid, which is in tum reduced by 
NADPH to (3R)-mevalonic acid in higher plants (Scheme 1.11), the enzyme 
catalysing this reaction being hydroxymethylgluteryl CoA reductase46• The 
22 
conversion of HMO-CoA into mevalonic acid is irreversible, and hence, mevalonic 
. .,. 45 
acid has no metabolic future except In terpene lormatlOn . 
NADPH NADP+ 
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Mevalonic acid is the primary precursor of all the terpenoids biosynthesised by plants. 
The catalytic phosphorylation of mevalonate to form (3R)-phosphomevalonic acid 
(Scheme 1.12) occurs via the enzyme mevalonate kinase and is ATP dependent. Only 
the R form is utilised by organisms for producing terpenes, as the S form is 
metabolicall y inert 43. 
OH 
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CH3 
(3R)-phosphomevalonic acid 
Scheme 1.12. The phosphorylation of mevalonic acid4,46. 
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This phosphorylation is a primary point at which control of terpenoid biosynthesis 
operates, as mevalonic acid kinase activity has been found to be inhibited by such 
products of the acetate-mevalonate pathway as gerany1, farnesy1, gerany1gerany1 and 
phytyl diphosphates44 (Figure 1.19). 






Figure 1.19. The inhibiting products of the acetate mevalonate pathway. 
The conversion of (3R)-phosphomevalonic acid into (3R)-diphosphomevalonic acid 
(Scheme 1.13) is cata1ysed by phosphomeva1onate kinase. A concerted 
decarboxylation-dehydration of (3R)-diphosphomevalonic acid gives isopentenyl 
diphosphate, the biogenic isoprene unit, and is cata1ysed by the enzyme 
diphosphomeva1onate decarboxylase, a highly stereospecific enzyme involved in the 
trans elimination of the carboxyl and hydroxyl groupS44. 
The interconversion of isopentenyl diphosphate (IPP) and dimethyl allyl diphosphate 
(DMAPP) is an equilibrium reaction catalysed by the enzyme isopentenyl-
diphosphate-i1-isomerase. Although the isomerisation is reversible, the equilibrium 
24 
lies heavily on the side of DMAPp4, This generates a reactive electrophilic DMAPP 
and a nucleophilic IPP, due to the terminal double bond, 
OR 
HOOe, ~ ~ 
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isopentenyl diphosphate 
Scheme 1.13, The formation and isomerisation of isopentenyl diphosphate4,46, 
Isopentenyl diphosphate condenses with dimethyl allyl diphosphate, via the enzyme 
prenyl transferase to yield geranyl diphosphate, which, in tum, condenses with 
isopentenyl diphosphate to form famesyl diphosphate (Scheme 1.14), Up till this point 
























Scheme 1.14. The formation offamesyl diphosphate46. 
oPP 
The NADPH-dependant enzyme famesyl transferase, bound to membranes of the 
endoplasmic reticulum, joins two molecules of famesyl diphosphate, tail-to-tail, to 
give presqualene diphosphate (Scheme 1.15), which then undergoes diphosphate 
elimination and rearrangement to yield squalene46 . This reaction is catalysed by 
squalene synthase and is NADPH dependent44. 
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farnesyl diphosphate 
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squalene 
Scheme 1.15. The formation of squalene4. 
27 
Cyc1isation of squalene occurs via the intermediate squalene-2,3-oxide, catalysed by 
squalene mono-oxygenase, which forms from a reaction involving 0 2 and NADPH 
cofactors4,44,47 (Scheme 1.16). 
O2 + HP + 
NADPHt NADP+ 
l(" A • 
moo om yg"" " l) squalene R 
o squalene-2,3-epoxide 
Scheme 1.16. The formation of the squalene-2,3-epoxide intermediate 46. 
One of the simplest cyc1isations of squalene-2,3-epoxide, that forming the dammarene 
derivative, dammarenediol, via the dammarenyl cation, is shown in scheme 1.17. 






Scheme 1.17. The cyc1isation of squalene-2,3-epoxide 4. 
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The pentacyc1ic triterpenoids, such as lupeol and ~-amyrin are biosynthesised from a 
tetracyc1ic precursor of the dammarene type by a rearrangement resulting in the 
expansion of ring D and the formation of ring E4 (Scheme 1.18). 
HO 
dammarenyl cation baccharenyl cation 
HO HO 
lupeol lupenyl cation 
~-amyrin oleanyl cation 
Scheme 1.18. The rearrangement of the dammarenyl cation4• 
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In animals, squalene-2,3-epoxide, via the protosteryl cation intermediate, can cyc1ise 
to form the lanosterol family of tetracyc1ic triterpenoids (Scheme 1.19). Lanosterol is 


















Cycloartenol, a cyclisation product of squalene in plants, is similarly formed via 
squalene-epoxide4,44,45 (Scheme 1.19). Cycloartenol contains a cyclopropane ring 
generated by inclusion of the methyl group at C-lO. The hydrogen at C-9 migrates to 
C-8 and the carbocation so formed is quenched by cyclopropane formation and loss of 
one of the methyl protons. 
Through its conversion to 24-methylenecycloartenol or cholesterol, cycloartenol is the 
precursor of a wide range of compounds collectively termed the phytosterols, which 
contain varying numbers of carbon atoms. Lanosterol, however, is not implicated in 
the biogenesis of phytosterols47• However for many of the plant sterols the 
cyclopropane ring of cycloartane has to be re-opened. Manipulation of the cycloartane 
skeleton results in the formation of the eucosterol class of compounds (Scheme 1.20). 
Eucosterol is a spirocyclic nortriterpenoid, which has a basic lanosterol triterpemoid 
skeleton where the side chain has been modified to produce a hemiketal4• This 
he mike tal is converted to an ether by reduction. Variations in these compounds are 
due to different degrees of oxygenation in the aglycone and differing combinations of 












I. Nucleophilic addition to 
carbonyl group 
2. Decarboxylation of C-26 
OH 
Reduction at C-23 
~ 
Scheme 1.20. The proposed formation of eucostero148 . 
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1
1. Reduction of side chain 
2. Oxidation ofC-26 
eucosterol 
COOH 
Bufadienolides are cardiac glycosides which are characterised by a steroidal aglycone 
coupled to a sugar group. They are characterised by having a ~-substituted, doubly 
unsaturated, six-membered lactone ring (pentadienolide) at C-174. Bufadienolides are 
derived from the addition of an oxaloacetyl-CoA molecule to a pregnanolone
4
, such as 


















Scheme 1.21. The biosynthesis of a bufadienolide from a pregnanolone precursor4. 
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The large number of bufadienolides that have been isolated is primarily due to the 
extensive variation in the oxygenation pattern of the aglycone, and the variation in the 
sugars attached at the C-3 position. Generally, tertiary methyl groups are present at C-
10 and C-13, however, occasionally an aldehyde group replaces the methyl group at 
C-104. In most cases a ~-hydroxyl group is present at C-14, while a ~4-double bond is 
also common 4. 
Most natural triterpenoids and steroids are oxygenated at C-3, the original epoxide 
oxygen from squalene-2,3-oxide, usually as alcohols but some as ketones. 
Triterpenoids are distinguished from each other by unsaturations, additional hydroxyl 
groups, and frequently carbonyl groupS49. 
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1.3.2 The Biological Activities of Triterpenoids 
In plants, the pentacyclic triterpenoids often exist as glycosides, the resulting 
compounds are termed saponins. Saponins, even at low concentrations, produce 
frothing in aqueous solutions because they have soap-like properties. Saponins are 
known to be highly toxic to cold-blooded animals and are lethal if injected as they 
haemolyse the red blood corpuscles. Medicinally these compounds are used as anti-
inflammatory agents, antibiotics, fungicides, and, most importantly, molluscicides44• 
A large range of cholestane glycosides have been isolated from poisonous 
Ornithogalum thyrsoides and 0. saundersiae species5o. These steroidal compounds 
have been reported to exhibit potent cytostatic activities both in vitro (animal and 
human cell lines) and in vivo (mouse leukaemia)51-53. Many species of Urginea have 
been identified as toxic causing cardio activity and gastro-intestinal irritation, and are 
of agricultural concem54. Links have been established between hyacinthaceous plants 
and deaths caused by homicidal agents and traditional medicine preparations. 
The mechanism of action of bufadienolides and the cumulative toxicity of plants 
containing them have been extensively reviewed by Kellerman et al. 55. Digitalis-like 
compounds have been detected in low quantities in mammalian tissue4. The 
compound 19-norbufalin is found in the human eye lenses and at higher 
concentrations if a cataract is present. The bufadienolides are believed to regulate 
ATPase activit/. 
Previously, plants containing cardiotonic glycosides were used as arrowhead poisons. 
Nowadays, they are used as heart drugs4. Although these drugs strengthen a weak 
heart, the toxic dose is extremely close to the therapeutic dose, so the optimal dosage 
control must be exercised4. Extracts of Digitalis are used in the successful treatment 
of dropsy, which is an excessive accumulation of fluid in the body tissues4. The 
extract was found to alleviate this condition by improving the blood supply to the 
kidneys, thereby removing the excess fluid4. 
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1.4 Introduction to Coumarins 
Coumarins are one of the most important biologically active classes of compounds of 
plant origin. They are made up of a benzene ring fused with a pyrone ring in a linear 
manner and are 8-lactones, or more specifically a-benzopyrones
56
. 
Coumarins can be placed into one of five groups, namely, group A (coumarins with 
substitution mainly on the benzene ring), group B (coumarins showing substitution 
only on the pyrone ring), group C (furanocoumarins), group D (3,4-benzocoumarins) 
and group E (pyranocoumarins)56. 
1.4.1 Group A Coumarins 
This category consists of coumarin itself as well as umbelliferone. Other members of 
this group include coumarin methyl ethers or isoprenoid substituted benzene rings, 
especially at the 8-position56. An example of a coumarin belonging to group A is 
aurapten, a constituent of grapefruit peel and of the root barks of Feronia elephantum 




7 I 2 





Figure 1.20. The structures of coumarin, umbelliferone and aurapten56. 
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1.4.2 Group B Coumarins 
The first pheny1coumarin to be isolated from a natural source was dalbergin, isolated 
from the heartwood of Dalbergia sissoo, which also occurs with its methyl ether
56
. 
This coumarin has the phenyl group attached at the 4-position. The structure of 
dalbergin is shown in figure 1.21. 
o 
dalbergin 
Figure 1.21. The structure of dalbergin56. 
1.4.3 Group C Coumarins 
In furocoumarins, it is more common for rings to fuse in a linear fashion than in one 
of the angular modes, however, both linear and angular fusion occurs in some 
plants56. Furocoumarins have isoprenoid derived residues attached to either oxygen or 
carbon. The isopropyldihydrofuran ring possibly arises from the cyclisation of 
isoprenoid residues onto neighbouring hydroxyl groups in substituted coumarins56• 
Angelicin, which is a constituent of Angelica archangelica and Psoralea corylifolia, 
is an example of a group C coumarin where the rings are fused in an angular 
fashion56• Psoralen has a linear type of structure and was first isolated from the seeds 




Figure 1.22. The structures of angelicin and psoralen56. 
1.4.4 Group D Coumarins 
In the group D coumarins, a benzene ring is fused at the 3,4-position. The fungus 
Alternaria tenuis56 produces the only known fungal 3,4-benzocoumarin, altemariol, as 
well as its methyl ether. This fungus is weakly parasitic on certain plants but is mainly 





Figure 1.23. The structure of altemariol56. 
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1.4.5 Group E Coumarins 
The pyran ring system, found in pyranocoumarins, is formed when an isoprenoid unit 
is attached to a carbon and oxygen atom on the coumarin nucleus
57
. This group of 
coumarins can be either linear or angular57. An example of this type of coumarin is 
xanthyletin (Figure 1.24), which is extracted from the bark of Xanthaxylum 
americanum, the fruits of Luvanga scandens, the bark of Citrus acida and the 
heartwood of Chlaraxylan swietenia57 • 
o 
xanthyletin 
Figure 1.24. The structure of xanthyletin. 
1.4.6 The Biosynthesis of Coumarins 
The biosynthesis of coumarins (Scheme 1.22) involves the hydroxylation of cinnarnic 
acid artha to the side-chain, a reaction catalysed by phenolase38,58,59. 
The artha-hydroxy group undergoes glucosylation resulting in isomerisation of trans-
cinnamic acid derivatives to the less stable cis-form. In the case of a single isolated 
double bond, cis/trans isomerisation would be unfavourable, however, cinnamic acid 
has a fully conjugated double bond system, which allows this process to occur quite 
readily38. Subsequent hydrolysis of the sugar group, via enzymatic cleavage of the 
glycoside, leads to spontaneous cyclisation and lactone formation, resulting in the 
final coumarin product. Both cis/trans isomerisation and lactonisation are enzyme 
mediated and light is not necessary for coumarin biosynthesis38. 
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R 1 = R2 =R, cinnamic acid 
Rl = OR, R2 = R, p-coumaric acid 
Rl = OR, R2 = OCR3, ferulic acid 
R2 ~ 
~ ~OOH Rl~O( 
I 
glucose 
cis-cinnamic acid derivative 






trans-cinnamic acid derivative 
Rl = R2 =R, coumarin 
Rl = OR, R2 = R, umbelliferone 
RI = OR, R2 = OCR3, scopoletin 
Scheme 1.22. The biosynthesis of coumarins58. 
Most naturally occurring coumarins contain an oxygen substituent at the 7-position, 
introduced by para-hydroxylation followed by ortho-hydroxylation of cinnarnic acid. 
Umbelliferone is regarded as the parent compound of the 7-oxycoumarins. Prior to 
isomerisation and ring closure, several hydroxy groups may be introduced and 
methylated, such as ferulic acid giving scopoletin. Ferulic acid in tobacco tissue 
cultures converts to scopoletin while the subsequent formation of a glucoside is 
absent. However, in the intact plant, scopoletin accumulates as the glucoside 




Scheme 1.23. The formation of scopolin38. 
Daphnin in Daphne adam of the family Thymelaeaceae and cichoriin in chicory 
(Cicharium intybus, Compositae) are biosynthesised from p-coumaric acid and not 
caffeic acid (Figure 1.25), the second hydroxy group being introduced after ring 




Figure 1.25. The structure of caffeic acid. 
Chicory contains an enzyme that catalyses the transglucosylation of cichoriin to 
aesculin, with aesculetin being an intermediate. A similar enzyme in Daphne catalyses 
the transglucosylation of daphnin to daphnetin-8-glucoside. In both cases, the 










glucose--o ~ 0 0 HO ~ 0 0 
cichoriin aesculetin 
1 
glucose-oXXl "?' ""::::: 
I 
HO ~ 0 0 
aesculin 
Scheme 1.24. The biosynthesis of daphnin, cichoriin, aesculetin and aesculin58. 
Coumarin itself was isolated initially from tonka beans (Coumaraouna odorata) and 
then from various melilot species, e.g. Melilotus officinalis and from Asperula 
odorata. It has a pleasant odour and is likened to that of newly mown hay. Evidence 
shows that plants contain the glucosides of trans- and cis-o-coumaric acid, and that 
coumarin is only produced through damage during the harvesting process resulting in 
enzymatic hydrolysis and lactonisation38 . Melilotic acid glucoside is the bound form 
of coumarin in sweet clover. In mature plants, biosynthesis of the glucoside occurs via 
reduction of coumarin (Scheme 1.25), followed by ring cleavage, and finally 
glucosylation. In shoots, however, melilotic acid glucoside is formed directly from 0-
coumaric acid glucoside. 
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~ mature plants 
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young sh~ts ~COOH 
~o-glUCOSe 
o-coumaric acid glucoside melilotic acid glucoside 
Scheme 1.25. The biosynthesis of melilotic acid glucoside in sweet clover58. 
Fermenting sweet clover produces 4-hydroxycoumarin, which can react with 




~o-gIUCOSe .. ~OHCOOH ~OOH UOH~ 






Scheme 1.26. The proposed formation of dicoumarol in spoilt hay38.58. 
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Characteristically, coumarms fluoresce (usually blue) in ultraviolet light. Those 
derived from umbelliferone fluoresce with a blue colour when irradiated with visible 
light, while, if the coumarin has a free 7-hydroxy group, a green fluorescence is seen 
in alkaline solution56. 
1.4.7 The Biological Activities of Coumarins 
Coumarins have been shown to have an extensive range of biological activities, and 
coumarin itself is highly toxic to mammals. Certain umbelliferone derivatives act as 
sunburn preventatives56. This they achieve by being able to absorb a wide range of 
ultraviolet frequencies, dissipate the energy as fluorescence, and finally to modify the 
erythermal response to ultraviolet light56. Umbelliferone (page 36) has been found 
active against undulant fever, the infection by Brucella malitensis and B. abortus56 . 




Figure 1.26. The structure of mammein. 
Dicoumarol possesses blood anticoagulant properties, which causes intestinal 
bleeding in livestock4,56, resulting in death. However, dicoumarol and synthetic 
analogues can be used therapeutically as anticoagulants, by inhibiting the synthesis of 
certain proteins concerned with the blood-clotting mechanisms. Hence, these 
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compounds have found clinical use in the prevention of thrombosis and to aid the 
dissolution of blood clots56 , Vitamin K, an example of which is shown in figure 1.27, 
is a blood-clotting promoter, and dicoumarol, being an analogue of the vitamin, acts 
as a competitive inhibitor of the enzymes concerned in the synthesis of blood-clotting 
proteins58 , Novobiocin (Figure 1.27), a metabolite of Streptomyces niveus, has been 
found to exhibit antibiotic properties56, and chartreusin (Figure 1.27), found in 

















Figure 1,27, The structures of vitamin K2(30)' chartreusin and novobiocin, 
Furocoumarins are highly toxic to fish, but show little toxicity towards other 
animals56, For this reason plant extracts have been added to streams to paralyse the 
fish and hence they can be easily caught without their edibility being affected56, 
Generally, furocoumarins appear to photosensitise the skin and produce a poisonous 
character in plants56, Psoralen (Page 38) has been used for the treatment of alopecia56, 
while the seeds of Psoralea corylifolia are used in the Hindu Ayurvedic system of 
medicine as laxatives and diuretics as well as in the treatment of leucoderma and 
lepros/6, Psoralen and its derivatives show photodynamic activity and hence may be 
taken orally to promote sun tanning of the skin58 , 
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CHAPTER 2 
Extractives from the Hyacinthaceae 
2.1 Introduction to the Hyacinthaceae 
The species Ledebouria ovatifolia, Eucomis pole-evansii, Lachenalia rub ida and 
Drimia capitata all belong to the family Hyacinthaceae (Liliaceaea sensu lato). Based 
on chemotaxonomical, morphological, cytological and molecular data, members of 
the Hyacinthaceae can be divided up into five sub-families. The Hyacinthoideae, 
Urgineoideae and Ornithogaloideae occur in southern Africa l , while the 
Clorogaloideae and Oziroeoideae are restricted to Northern America and Andean 
South America respectivel/. Ledebouria ovatifolia, Eucomis pole-evansii and 
Lachenalia rubida belong to the sub-family Hyacinthoideae, while Drimia capitata 
belongs to the Urgineoideae sub-family. 
Since early times, the generic names, Hyacinthus, Ornithogalum and Scilla have been 
used and represent the most important genera of the Hyacinthaceae. In his Genera 
Planatarum (1754), Linne based his characterisations of these three genera mainly on 
their floral characteristics3. Consequently, some species belonging to the 
Hyacinthaceae were incorrectly classified and distributed into these three genera 
resulting in highly unnatural classifications3. 
The Hyacinthaceae is a diverse family consisting of approximately seventy genera 
and about one thousand species3, with large numbers of species in southern Africa 
(approximately twenty-seven genera and four hundred species) and the 
Mediterranean
4
. The geographic distribution of the Hyacinthaceae is shown in green 
in figure 2.1. 
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Figure 2.1 . The geographic distribution of the Hyacinthaceae3. 
The Hyacinthaceae are mostly perennial bulbous plants with subterraneous or epigeal 
bulbs3. The bulbs grow in grassland or woodlands between trees and bushes. The 
bulbs themselves have characteristic fleshy scales that produce copious adhesive, 
elastic threads when separated. The leaves are occasionally grazed but the threads in 
the bulbs generally prevent them from being eaten by porcupines and Chacma 
baboons. The inflorescence is a raceme bearing one to hundreds of flowers, which are 
visited mainly by insects, but in some genera, also birds3. Many genera of the 
Hyacinthaceae are used in the horticultural trade and also in traditional medicine4. 
Charybdis maritima, the sea onion, of the subfamily Urgineoideae, has been used 
medicinally and its use was first described in 1554 BC in the Ebers Papyrus of the 
Middle Empire of Egypt as a cure for dropsy3. Bufadienolides are cardiac active 
substances isolated from this species as well as from Urginea indicd. In South Africa, 
several species of Hyacinthaceae including Ledebour;a cooper;, L. ;nguinata, L. 
ovatifolia and L. revoluta, as well as several members of the Urgineoideae are 
poisonous to grazing animals. The toxic compound, scilliroside (a bufalienolide), 
found in certain Hyacinthaceae species, is also used to poison rats3. Hyacinthaceae are 
rarely used for human consumption as food. However, in Greece, the bulbs of 
Muscari comosum (Hyacinthoideae) are eaten pickled, and in France, flowers of 
Loncomelos pyrenaicus (Omithogaloideae) are eaten as a vegetable3. In Africa, the 
bulbs of Ledebouria apertiflora and L. revoluta of the subfamily Hyacinthoideae, are 
eaten by the Bushmen3. 
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A relatively small portion of the southern African Hyacinthaceae has been 
investigated phytochemically. The compounds that have been isolated can be 
classified into four groups, namely, homoisoflavonoids, steroidal type compounds, 
bufadienolides and miscellaneous compounds. 
2.2 Extractives from Ledebouria ovatifolia 
Ledebouria (subfamily: Hyacinthoideae, family: Hyacinthaceae) was formerly 
included in the genus Scilla, but has now been independently classified5. The three 
genera that were previously thought to be closely related, Scilla, Schizocarphus and 
Ledebouria, were grouped according to their morphology, cytology, anatomy and 
chromatographl. Based on their physical characteristics, it was evident that there was 
a much closer affinity between Scilla and Schizocarphus than between either of these 
groups and Ledebouria6 . Based on these findings, Jessop6 suggested that Ledebouria 
be accepted as a generically distinct genus. Ledebouria ovatifolia has been classified 
previously as Scilla ovatifolia, Scilla lanceaefoli, Scilla guttata, Scilla climatocarpha, 
Scilla cicatricosa, Scilla albomarginata, Scilla elevans and Scilla collina5,6 . 
Figure 2.2. Photographs of Ledebouria ovatifolia (photographed by Dr. Neil Crouch). 
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Members of the genus Ledebouria are extensively used by traditional healers in 
Kwazulu-Natal in enemas and as purgatives for both humans and cattle5•7• Ledebouria 
ovatifolia bulbs, shown in figure 2.2, are used by the Zulu in enemas for gastro-
enteritis and in medicines taken for influenza and backache5•7. It has been reported 
that the plants are rubbed on pubescent female breasts to make them grow5•7. In the 
Transkei, the bulbs are used as purgatives for adults and children over the age of five 
months8. 
Toxicity levels of L. ovatifolia are quite high, as 1.5 kg of fresh bulbs is fatal to sheep 
within a few hours9. Post-mortem findings include, among other effects, general 
cyanosis, severe hyperaemia and oedema of the lungs, congestion and regressive 
changes of the liver and kidneys9. However, two rabbits recovered after being given 
109 of the bulb and 20 g of the leaf and flower of this plant9. Tests conducted at 
Onderstepoort Research Station proved that this species is toxic to both sheep and 
rabbits at levels of 2 g per kilogram of live mass. 
Other species of Ledebouria are also used by traditional healers. The Sotho people use 
L. revoluta for the treatment of lumbago and as a cha,rm to drive away lightning5. 
They also used L. cooperi as a soothing medication for women in their fourth month 
of pregnancy and to inebriate boys during circumcision rites5• Certain species of 
Scilla and Eucomis including S. natalensis, S. nervosa, E. autumnalis, E. bicolour and 
E. comosa are extensively used by traditional healers as purgatives and in enemas5, 
which makes our chemical investigations interesting as these three genera have been 
reported to be a rich source of homoisoflavonoids. 
Species of Ledebouria are perennial, deciduous and usually solitary bulbous herbs. 
The bulbs are found below the ground and are oblong in shape with fleshy scales4• 
There are approximately forty-six species extending across Africa to the southern tip 
of India with about thirty-eight species being indigenous to southern Africa4. 




• Further investigations of this plant have also yielded the novel 
chalcone, ovatifolin 11. This plant was chemically investigated for a second time as the 
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plant in this study was the Highveld form which was collected from the Blyde Nature 
Reserve, while the first investigation was performed on Ledebouria ovatifolia that 
was purchased from the Warwick Triangle market in Durban, Kwazulu-Natal. The 
structures of the compounds isolated by Pohl et al. are shown in figure 2.3. 
HO o OH 
OH 0 











Figure 2.3. Compounds previously isolated from Ledebouria ovatifolia. 10, II 
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2.2.1 Results and Discussion 
The dichloromethane extract of Ledebouria ovatifolia (Bak) Jessop yielded three 
compounds (compounds I-III). The extract from the L. ovatifolia (Highveld form) 
collection yielded different compounds compared to the L. ovatifolia collected from 
the Warwick Triangle. This confirms that the environment that a plant grows in plays 
an important role in the type of compounds that plant produces. No compounds were 




Figure 2.4. The structures of compounds I-III. 
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2.2.1.1 Structural Elucidation of Compound I 
(-)-(Z)-I-(4'-hydroxyphenyl)-3~-(5"-hydroxy-3",4"-dimethoxyphenyl) 
-1,4-pentadiene 
(Spectra 1a-i, pages 208-216) 
The first compound isolated from Ledebouria ovatifolia was isolated as a yellow gum 
and was identified as the novel noriignan, (-)-(Z)-1-(4'-hydroxyphenyl)-3~-(5"­
hydroxy-3",4"-dimethoxyphenyl)-1,4-pentadiene (Figure 2.5). This is the first time 
that a noriignan has been isolated from the Hyacinthaceae family*. 
( -)-(Z)-I-( 4' -hydroxyphenyl)-3-( 5" -hydroxy -3",4" -dimethoxyphenyl)-
1,4-pentadiene 
Figure 2.5. The structure of compound I. 
The high resolution mass spectrum showed a parent ion peak at mJz 312.13690, which 
was consistent with the molecular formula of C19H2004 (C19H200 4 requires 
312.13616). A double bond equivalence often was deduced. 
The infra-red spectrum showed a broad band at 3412 cm-1 due to the O-H stretching 
vibrations and two sharp peaks at 2923 cm-1 and 2847 cm-1 due to the asymmetric and 
• A colleague in the group has simultaneously isolated two norlignans, Z-1,3-bis(4-hydroxyphenyl)-1,4-
pentadiene from Drimiopsis burkei and E-1 ,3-bis( 4-hydroxyphenyl)-1 ,4-pentadiene from Drimiopsis 
maculata. 
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symmetric C-H stretching respectively. The CH2 and CH3 bending vibrations were 
observed at 1355 em-I, 1230 cm-I and 1105 em-I. 
The IH NMR spectrum showed a pair of two-proton doublets at 8 7.16 and 8 6.78 
(J = 8.6 Hz) assigned to H-2'/6' and H-3'/5' respectively, which indicated a para-
substituted aromatic ring. The HMBC spectrum showed a correlation between the 
H-3'/5' proton resonance and the fully substituted C-4' carbon resonance at 8 154.6. 
The methine carbon signal assigned to C-3'/5' was observed at 8 115.1. The methine 
carbon peak ascribed to C-2'/6'(8 130.0) showed correlations in the HMBC spectrum 
with H-l(8 6.52) and H-3'/5'. 
The H-l one-proton signal (8 6.52, d, J = 11.7 Hz) in the IH NMR spectrum occurred 
as a doublet, with one peak of the doublet being hidden under the H-6" resonance. In 
the COSY spectrum, the H-l signal was seen to be coupled to a one-proton double 
doublet resonance appearing at 85.66 (J = 10.1, 11.7 Hz), which was assigned to H-2. 
A coupling constant of 11.7 Hz between H -1 and H -2 suggests that the substitution 
pattern is cis across the double bond. The cis configuration was further proved by the 
fact that H-l showed correlations in the NOESY spectrum to H-2'/6' as well as to H-2. 
The H-3 proton signal at 8 4.42 (lH, dd, J = 6.2, 10.0 Hz) showed correlations in the 
NOESY spectrum with H-2'/6', H-2" and H-6". A model showed that these 
correlations were only possible for the cis isomer. The methine carbon resonances at 
8 129.0, 8 131.2 and 8 47.6 were ascribed to C-l, C-2 and C-3 respectively. In the 
COSY spectrum, the H-2 proton resonance was seen to be coupled to the H-l and H-3 
protons, while the one-proton multiplet at 8 5.99, due to H-4, was seen to be coupled 
to 2H-5 and H-3. The pair of double doublet resonances due to H-5 (8 5.18 and 
8 5.17) only showed coupling in the COSY spectrum with the H -4 signal. The C-4 
methine carbon signal occurred at 8 140.2 while the C-5 methylene carbon resonance 
occurred at 8 115.4. 
Two meta coupled protons were present on the B ring, and their resonances occurred 
at 86.31 (IH, d, H-2", J = 1.8 Hz) and 8 6.50 (lH, d, H-6", J = 1.8 Hz). Both the H-2" 
and H-6" resonances showed correlations in the NOESY spectrum with H-3. The 
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corresponding methine carbon resonances occurred at 8 103.5 and 8 107.2 
respectively. In the HMBC spectrum the C-2" signal showed only a correlation with 
H-6", while the C-6" resonance showed only a correlation in the HMBC spectrum 
with H-2". 
In the IH NMR spectrum, two sharp singlets were observed at 83.80 and 83.85, each 
integrating to three protons, which indicated the presence of two methoxy groups. The 
methoxy group, which had a methyl carbon resonance at 8 55.8, was positioned at 
C-3" (8 152.3, C) as it showed a correlation in the NOESY spectrum with H-2". The 
second methoxy group protons showed no correlations in the NOESY spectrum. This 
methoxy group would have to be positioned on C-4" (8 134.0, C) as if it were placed 
at position C-5", we would see a correlation in the NOESY spectrum with H-6" and 
we do not. Furthermore, if the second methoxy group was placed at C-5", the ring 
would be symmetrical, which it is not. The two hydroxy groups were attached to the 
fully substituted carbon whose resonances occurred at 8 149.2 (C-5'') and 8 154.6 
(C-4 '). 
This compound was found to be a new norlignan identified as (:. )-(Z)-I-( 4 '-
hydroxyphenyl)-3~-(5"-hydroxy-3 ",4"-dimethoxyphenyl)-1 ,4-pentadiene. When tested 
for anti-inflammatory activity, compound I, at a concentration of 10 J-lg/cm3 showed 
72.7% inhibition of prostaglandin synthesis using the microsomal cell screen, 42.2% 
inhibition using the Cox-l screen and 23.4% inhibition using the Cox-2 screen (page 
72). 
The NMR data for compound I is tabulated in table 2.1 and the HMBC and NOESY 
correlations are depicted in figure 2.6 and figure 2.7 respectively. 
59 
Figure 2.6. The HMBC (C -7 H) correlations for compound I. 
Figure 2.7. The NOESY correlations for compound I. 
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Table 2.1. NMR data and correlations for compound I (CDCh) 
Carbon IH NMR data 13C NMRdata COSY HMBC NOESY 
Number (400 MHz) (100 MHz) correlations correlations correlations 
C7H 
1 
6.52 (lH, d, 
129.0 (CH) H-2 H-2'/-6 ' H-2, H-2'/6' 
1=11.7 Hz) 
2 
5.66 (lH, dd, 1=10.1, 
131.2 (CH) H-1, H-3 H-3 H-1, H-3, H-6" 
11.7 Hz) 
3 
4.42 (lH, dd, 1=6.2, 
47.6 (CH) H-2, H-4 
2H-5, H-2, H-2' /6', H-2", 
10.0 Hz) H-2" , H-6" H-6" 
4 5.99 OH, m) 140.2 (CH) H-3,2H-5 H-2, H-3 H-5 
Sa 




5.17 (lH, dd, 1=1.5, 
H-4 H-4 
17.2Hz) 
l' - 129.7 (C) - H-3'/S' -
2' 7.16 (lH, d, 1=8.6Hz) 130.0 (CH) H-3'/5 ' 
H-1, H-3 ' 5', 
H-1, H-3, H-3'/5' 
H-2'/6' 
3' 6.78 (lH, d, 1=8.6Hz) 115.1 (CH) H-2'/6' H-3'/S' H-2'/6' 
4' - 154.6 (C) - H-2' /6' , H-3' /5' -
5' 6.78 OH, d, 1=8.6Hz) 115.1 (CH) H-2'/6' H-3'/5' H-2'/6' 
6' 7.16 (lH, d, 1=8.6Hz) 130.0 (CH) H-3'/5' H-1, H-2' /6'(w), H-1, H-3, H-3'/5' 
H-3'/5' 
1" - 139.7 (CH) - H-2, H-3 -
2" 6.31(lH, d, 1=1.8Hz) 103.5 (CH) H-6", OCH3 at H-6" H-3, OCH3 at C-3" H-3" 
3" - 152.3 (C) - H-2" , 
OCH, at C-3" 
-
4" - 134.0 (C) - H-2", H-6", 
OCH3 at C-4" 
-
5" - 149.2 (C) - H-6" -
6" 6.50 (lH, d, 1= 1. 8Hz) 107.2 (CH) H-2" H-2" H-2, H-3 
OCH3 at 3.80 (3H, s) 55.8 (CH3) H-2" H-2" C-3" -
OCH3 at 3.85 (3H, s) 60.9 (CH3) C-4" - - -
61 
2.2.1.2 Structural Elucidation of Compound II 
(23S)-17 a,23-epoxy -3~,29-dihydroxy -27 -norlanost-8-ene-15,24-dione 
(Spectra 2a-p, pages 217-232) 
The second compound isolated from Ledebouria ovatifolia was isolated as white 
needle-like crystals and was identified as the known compound, (23S)-17a,23-epoxy-
3~, 29-dihydroxy-27-norlanost-8-ene-15,24-dione, commonly known as eucosterol 
(Figure 2.8). Eucosterol has been previously isolated from Eucomis bicolour, 




Figure 2.8. The structure of compound II. 
The mass spectrum revealed compound II to have a molar mass of 472.3189 g morl, 
which corresponded to a molecular formula of C29~OS (C29H440 S requires 
472.3189) and a double bond equivalence of eight. 
The infra-red spectrum of compound II showed the presence of an absorption at 
3488 cm-
I 
which was due to the O-H stretching vibrations. Absorptions were also 
observed at 2943 cm-
I 
and 2878 em-I, which could be assigned to the C-H symmetric 
and asymmetric stretchings respectively. The C=O stretching vibrations were evident 
at 1740 em-land 1731 em-I, while the CH2 and CH3 bending vibrations could be seen 
at 1463 cm-
I 
and 1381 em-I. The absorption at 1038 cm-I was due to C-O stretchings. 
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The IH NMR spectrum showed the presence of four singlet methyl proton resonances 
at 80.89,80.87,8 1.19 and 8 1.32, each integrating to three protons. By comparison 
of NMR data for compound II with the literature datal2 for eucosterol, these 
resonances were ascribed to 3H-18, 3H-19, 3H-28 and 3H-30 respectively and this 
was subsequently confirmed by means of the HMBC spectrum. A methyl proton 
doublet integrating to three protons was observed at 8 1.07 (J = 6.8 Hz) and was 
assigned to 3H-21. This resonance was seen to be coupled in the COSY spectrum to 
H-20 (8 2.19, m). The methyl proton resonance at 8 1.01 (t, J = 7.2 Hz), ascribed to 
3H-26, was seen to be coupled in the COSY spectrum to 2H-25 (8 2.44, q, 
J= 7.2 Hz). 
The doublet methyl proton resonance assigned to 3H-21 was seen to be correlated in 
the NOESY spectrum to a triplet methine proton resonance at 8 4.62. This was 
assigned to H-23 as it was seen to be coupled in the COSY spectrum to 2H-22 (8 1.87, 
m). The corresponding carbon resonances were observed at 8 81.5 (C-23) and 8 36.6 
(C-22), using the HSQC spectrum. The C-21 methyl group was assigned an a 
configuration as this resonance showed a correlation in the NOESY spectrum to 
3H-18. A model was constructed and from the model it was evident that if C-20 and 
3H-18 were ~ in orientation, then a correlation would be seen in the NOESY spectrum 
between 3H-21 and 3H-18, confirming that 3H-21 is a in orientation. Due to the 
3H-21 resonance being correlated to H-23 in the NOESY spectrum, it can be 
concluded that H-23 is also of the a orientation. 
In the i3e NMR spectrum, twenty-nine carbon resonances were observed, which 
indicated a nortriterpenoid-type skeleton. The two fully substituted resonances at 
8 215.7 and 8 212.6 were due to the two carbonyl group carbons at C-15 and C-24 
respectively. These two carbon resonances could be differentiated as C-15 showed an 
HMBC correlation to 2H-16 (8 2.71 and 8 2.16) and 3H-30, while H-24 was seen to 
be correlated in the NOESY spectrum with 2H-22, H-23, 3H-26 and 3H-30. The i3C 
NMR spectrum also showed the presence of two carbon resonances at 8 135.8 (C) and 
8 132.6 (C), which indicated the presence of a double bond. This double bond was 
found to be situated between C-8 and C-9. This was confirmed by the HMBC 
spectrum, which showed correlations of the peak at 8 132.6 (C-8) with H-6~ (8 1.77), 
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H-6a (8 1.32) and 3H-30 (8 1.32), while the carbon resonance at 8 135.8 (C-9) 
showed correlations in the HMBC spectrum with H-5 (8 1.11), H-12~ (8 1.53) and 
3H-19 (80.87). 
The oxygenated methylene carbon resonance (8 64.2) was assigned to C-29 as it 
showed correlations in the HMBC spectrum to H-5 and 3H-28. The methine carbon 
resonance ascribed to C-3 (8 80.3) also showed a correlation in the HMBC spectrum 
to 2H-29 (8 4.16 and 8 3.29, 2 x d, J = 11.0 Hz). The COSY spectrum showed 
coupling between the two H-29 resonances, as did the NOESY spectrum. The 3H-28 
resonance was assigned the alpha configuration as it was seen to correlated in the 
NOESY spectrum with H-3. The 2H-29 resonance was thus assigned the beta 
configuration which was confirmed by the NOESY spectrum as H-29B was seen to be 
correlated with 3H-19. 
The molecular formula of compound II was found to be C29H440 S and hence a double 
bond equivalence of eight was deduced. This confirmed the 17,23-ether linkage, as it 
fitted in with the extra ring needed by the double bond equivalence calculation. This 
compound was also acetylated in order to confirm the presence of the 17,23-ether. No 
acetylation at C-17 and C-23 was observed indicating that these two oxygenated 
carbon atoms did not have hydroxy groups attached but rather formed part of an ether 
ring system. The only acetylations that did occur were at C-3 and C-29. 
The NMR data of compound II was compared to the literature data12 of eucosterol and 
the l3C NMR values correlated well, but certain values were slightly different due to 
this compound being run in CDCh and the literature data being run in CsDsN. 
However, due to the HMBC correlations, it was possible to make conclusive 
assignments and hence correct the literature data for those assignments that were 
uncertain to Ziegler et al. 12• The NMR data and correlations for compound II are 
listed in table 2.2. 
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Table 2.2. NMR data and correlations for compound II (CDCh) and literature 
data for eucosterol (CsDsN)12 
13CNMR UCNMR 
IHNMR 13CNMR HMBC NOESY 
literature data for 
Carbon data 
COSY correlations data for acetylated data correlations correlations Number (400 MHz) (100 MHz) C7H eucosterol
12 eucosterol 
(22.63 MHz) (100 MHz) 
H-l~, H-3, 






113 1.16 (IH, m) H-la, H-2a H-la 
2a 1.76 (lH, m) 27.9 (CH2) 
H1~, H-3 H-3 28.9 (CH2) 29.7 -
213 1.76 OH, m) H-la, H-3 -
3 3.38 (IH, m) 80.3 (CH) H-2~, H-2a 2H-l,2H-29 
H-la, H-5, 
79.9 (CH) 80.0 
H-2a,3H-28 
4 42.4 (C) 
2H-l, H-5, 
- 43.1 (C) 40.9 - - 3H-28, 2H-29 
5 1.11 (lH, m) 50.4 (CH) 2H-6 
2H-l,2H-6, 
H-3 51.1 50.9 
3H-19,3H-28 
6a 1.32 OH, m) H-6~, H-7~ 
H-Ia, H-6~, 




613 1.77 (lH, m) H-7a 
H-6a 
7a 2.28 OH, m) 2H-6, H-7~ 
H-la, H-6a, 
H-5,2H-6 H-7~, 3H-30 32.3 (CH2) 26.8 
713 2.57 (lH, m) 
26.4 (CH2) H-6a, H-7a H-7a,3H-19 
8 - 132.6 (C) - 2H-6,3H-30 - 133.1 (C) 133.2 
9 - 135.8 (C) - H-5, H-12~, - 136.6 (C) 135.4 3H-19 
10 - 37.0 (C) - H-5,2H-6, 37.6 37.2 2H-ll,3H-19 -
11a 2.07 (lH, m) H-ll~, H-12a H-ll~ 
1.99 OH, m) 
20.3 (CH2) H-lla, H-12~ 
2H-12 H-lla, H-12~, 18.8 (CH2) 20.4 
1113 3H-19 
12a 2.28 (lH, m) H-lla, H-12~ H-12~ 
1213 1.53 (lH, m) 
22.7 (CH2) 
H-ll~, H-12a 
3H-18 H-ll~, H-12a, 23.4t 22.7 
3H-19,3H-26 
13 - 47.3 (C) - 2H-12,2H-16, 47.7 (C) 47.3 2H-18,3H-30 -
14 - 57.7 (C) - 2H-12,2H-16, 57.9 (C) 57.7 3H-18,3H-30 -
15 - 215.7 (C) - 2H-16,3H-30 - 215.1 (C) 215.5 




1613 2.16 (lH, m) H-16a H-16a,3H-19, 
2H-22, 3H-26 
H-16a, 
17 - 90.9 (C) - 3H-18, - 91.2 (C) 90.9 
3H-21,2H-22 
18 0.89 (3H, s) 19.7 (CH3) - 2H-12 3H-21 19.9 19.1 
19 0.87 (3H, s) 20.2 (CH3) - H-5 
H-7~, H-ll~, 
H-12~, H-16~, 20.4t 20.3 
H-29B 
20 2.19 OH, m) 43.2 (CH) 3H-21, H-22 H-16~, H-16a,2H-22 43.4 (CH) 43.3 3H-21,2H-22 
21 
1.07 (3H, d, 
17.0 (CH3) H-20 2H-22 
3H-18,2H-22, 
1=6.8Hz) H-23 17.2 17.1 
22 1.87 (2H, m) 36.6 (CH2) H-20, H-23 
2H-16, H-20, 
3H-21 3H-21, H-23, 27.2 36.6 
2H-25, 3H-26 
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23 4.62 (lH, t) 81.5 (CH) 2H-22 2H-22 81.8 (CH) 81.6 
24 212.6 (C) 
2H-22, 2H-25, - 211.7 (C) 212.1 - - 3H-36 
25 
2.44 (2H, q, 
32.2 (CH2) 3H-26 3H-26 
2H-22, H-23, 
36.9 32.3 
J-7.2Hz) 3H-26, 3H-30 
26 
1.01 (3H, t, 
7.2 (CH3) 2H-25 2H-25 
H-12~, H-22, 
7.6 (CH3) 7.3 J-7.2Hz) 2H-25 





3.29 (lH, d, 
H-29B 3H-28, H-29B 
J=I1.0Hz) 
64.2 (CH2) H-5,3H-28 64.3 (CH2) 65.3 
29B 
4.16 (lH, d, 
H-29A 3H-19, H-29A 
J=I1.0Hz) 
30 1.32 (3H, s) 23.6 (CH3) 
H-7a, H-16a, 
24.1 23.7 - -
2H-25 
!;;H3CO - - - - - - 21.2' at C-29 
CHJ£O 
- - - - - - 171.1" at C-29 
!;;H3CO 
- - - - - - 21.1 ' at C-3 
CH3!;;O - - - - - - 170.6--at C-3 
t, :j: literature values are reported to be interchangeable, however, from the NMR data 
of compound II the correct assignments could be made. 
*,** values are interchangeable 
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2.2.1.3 Structural Elucidation of Compound III 
(23S)-17 a,23-epoxy-3B,28,29-trihydroxy-27 -norlanost-8-en-24-one 
(Spectra 3a-i, pages 233-241) 
The third compound to be isolated from Ledebouria ovatifolia was isolated as an 
orange gum and was found to be a derivative of the eucosterol-type nortriterpenoids 
identified as (23S)-17 a,23-epoxy-3B,28,29-trihydroxy-27 -norlanost -8-en-24-one 
(Figure 2.9). This compound has been isolated previously from Muscari comosum13 




Figure 2.9. The structure of compound III. 
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The mass spectrum showed a molecular ion peak at mlz 474.33398 g mor l , which 
corresponded to a molecular formula of C29H4605 (C29H4605 requires 474.33453). A 
double bond equivalence of seven was deduced from this molecular formula. 
In the infra-red spectrum, peaks were observed at 3437 cm- l (O-H stretching), 
2929 cm-
l 
(aliphatic C-H stretching), 2853 cm- l (C-H stretching) and 1731 cm- l (C=O 
stretching). 
The IH NMR spectrum showed the presence of five methyl group proton resonances, 
two of which, 3H-21 and 3H-26, were not easily recognised as they were 
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superimposed at 8 1.04. This was confirmed by the HSQC spectrum which clearly 
showed the two methyl carbon resonances ascribed to C-21 (8 17.1) and C-26 (87.4) 
correlating to the signal at 8 1.04. These methyl group proton resonances were 
assigned by comparison to eucosterol. In the HMBC spectrum, the resonances due to 
C-17 (8 97.0) and C-24 (8 213.6) showed correlations to the proton signal at 8 1.04, 
further proving the presence of the 3H-21 and 3H-26 proton resonances at 8 1.04. The 
C-17 resonance showed a correlation in the HMBC spectrum to the proton singlet at 
8 0.86 and this signal was therefore assigned to 3H-18. In the same way, the proton 
singlet at 8 0.92 was assigned to the resonance at C-19 as it showed a correlation in 
the HMBC spectrum with C-9. The HMBC spectrum also showed a correlation of the 
carbon resonance due to C-8 with the remaining three-proton methyl group singlet 
resonance at 8 1.19. This proton signal was ascribed to the 3H-30 methyl protons. 
Thus when this compound was compared with eucosterol, it was evident that this 
compound was one methyl group deficient, which suggested that the methyl groups at 
C-4 had been modified. 
In further comparing this compound with eucosterol, it was observed in the l3C NMR 
spectrum of this compound that only one carbonyl group was present indicating that 
the C-15 ketone was absent. Furthermore, only five methyl group proton resonances 
could be seen in the IH NMR spectrum and, in addition, the presence of an additional 
hydroxy methyl group, whose resonances was observed at 83.75 (d, J = 11.2 Hz) and 
84.13 (d, J = 11.2 Hz) was observed. This group was placed at C-4 because the C-3 
(8 77.6) resonance showed correlations in the HMBC spectrum with the methylene 
group protons. Thus this resonance was assigned 2H-28. The HMBC spectrum also 
showed correlation of the methine carbon resonance due to C-3 with the 2H-29 
(83.73 and 8 4.33,2 x d, J = 11.5 Hz) proton signals as in eucosterol. 
All the correlations found in the COSY, NOESY and HMBC spectra are tabulated in 
table 2.3. By comparison with literature l3, this compound was found to be the known 
compound (23S)-17 a,23-epoxy-3 ~,28,29-trihydroxy-27 -norlanost -8-en-24-one. Table 
2.3 shows the NMR data and correlations for compound III as well as the literature 
NMR values for this compound. 
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Table 2.3. NMR data and correlations for compound III (CDCh) and literature 
data for (23S)-17 a,23-epoxy -3 ~,28,29-trihydroxy -27 -norlanost-8-en-
24-one (CDCh)13 
Carbon IHNMR IJCNMR COSY HMBC NOESY TIC NMR data for 
Number data data correlations correlations correlations (23S)-17 a,23-epoxy-
(400 MHz) (100 MHz) C7H 3~,28,29-trihydroxy-
27 -norlanost-8-en-24-
one13 
1 1.72 (2H, m) 35.2 (CH2) - 3H-19 3H-19 35.3 
2 1.76 (2H, m) 27.3 (CH2) H-3 2H-1 3H-19 27.5 
3 3.72 (lH, m) 77.6 (CH) H-2 2H-28, 2H-29 2H-28 77.86 
4 - 45.8 (C) - H-5 - 45.96 




6 l.46 (2H, m) 18.6 (CH2) H-5 - 3H-19 18.72 
7 1.98 (2H, m) 26.1 (CH2) - - H-5 26.24 
8 - 133.9 (C) - 3H-30 - 134.14 
9 - 135.2 (C) - 3H-19 - 134.48 
10 - 36.7 (C) - H-5,3H-19 - 36.50 




1113 l.94 (lH, m) 
-
2H-12 2H-12,3H-19 






12~ 2.18 (lH, m) 2H-ll 3H-18,3H-21 
13 - 48.5 (C) - 3H-18,3H-30 - 48.69 
14 - 50.4 (C) - 3H-18,3H-30 - 50.55 






1513 1.32 (lH, m) 2H-16 H-16~ 
16a 2.15 (lH, m) 2H-15 -
39.6 (CH2) - H-15~, 39.70 
16~ l.60 (lH, m) 2H-15 3H-18, H-20, 
3H-21 
17 - 97.0 (C) - 3H-18, 97.18 3H-21,2H-22 -
H-12~, 
18 0.86 (3H, s) 19.4 (CH3) - 3H-21 H-16~, H-20, 19.51 
3H-21 
19 0.92 (3H, s) 19.1 (CH3) - -
2H-1,2H-6, 
19.23 2H-7, H-29B 
20 2.14 (lH, m) 43.5 (CH) 3H-21 3H-21 H-16~, 3H-18 43.63 
21 1.04 (3H, d) 17.1 (CH3) H-20 2H-22 
H-12~, 
l7.18 3H-18, H-23 
22 l.78 (2H, m) 36.7 (CH2) H-23 3H-21 3H-21, H-23 36.77 
4.64 (lH, dd, 
3H-21,2H-22, 23 1 =7.3,10.4 81.4 (CH) H-22 - 81.52 
Hz) 2H-25 
24 - 213.6 (C) - 3H-26 - 213.63 
25 
2.53 (2H, q, 
32.2 (CH2) 3H-26 3H-26 H-23,3H-26 1=7.33 Hz) 32.30 
26 l.04 (3H, t) 7.4 (CH3) 2H-25 2H-25 H-25 7.39 
28A 
3.75 (lH, d, 
H-28B 1=11.2 Hz) H-28B 
4.13 (lH, d, 
70.9 (CH2) H-5, H-29A 7l.27 
28B 
1=1l.2 Hz) H-28A -
29A 
3.75 (lH, d, 
H-29B 3H-19, H-29B 1=11.5 Hz) 
63.6 (CH2) 
H-3, H-5, 
4.33 (lH, d, 3H-28 63.81 29B 
1=11.5 Hz) H-29A -
30 1.19 (3H, s) 25.8 (CH3) - 3H-18 H-15a, H-16~ 25.91 
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2.2.2 Foreword to Experimental Sections 
Nuclear Magnetic Resonance (NMR) Spectroscopy 
All the NMR spectra were recorded using a 300 MHz Varian Gemini NMR 
spectrometer or a Varian Unity Inova 400 MHz NMR spectrometer. The spectra were 
obtained using the solvents deuterated chloroform (CDCl)) and deuterated methanol 
(CD30D). For the NMR data, chemical shifts are expressed in 0 (ppm) from 
tetramethylsilane as an internal standard and coupling constants (1) are given in hertz 
(Hz). The spectra were referenced against the central line of the deuteriochloroform 
signal at Oc 77.0, the CHCl) singlet at OH 7.24, the deuteriomethanol signal at Oc 49.0 
or the CHD20D signal at OH 3.34. 
Infra red (IR) Spectroscopy 
The infrared spectra were recorded using a Nicolet Impact 400 D spectrometer. In all 
cases the dissolved sample was dropped onto a NaCI disc and the spectrometer was 
calibrated against air. 
Ultra violet (UV) Spectroscopy 
UV absorption spectra were obtained on a Varian DMS 300 UV-visible 
spectrophotometer using dichloromethane as a solvent. The NaOAc and AICl) used 
for the bathochromic shift tests were prepared by dissolving 0.5 g of each salt 
(anhydrous) in 100 cm3 redistilled methanol. 
Mass Spectrometry (MS) 
Gas chromatography/mass spectrometry was performed using a Finnigan 1020 
GCIMS spectrometer using both injection and solid probe methods. High resolution 
mass spectra (HRMS) were recorded on a Kratos 9/50 HRMS instrument by Dr. P. 
Boshoff at Cape Technikon. 
High resolution mass spectra were also run by Mr John Hill at Kent Mass 
Spectrometry in London on a VG (now Waters) 70-SE magnetic sector by direct 
insertion probe using an accelerating voltage of 8KV and a mass range of 3000. 
Electron impact (EI) used an ionising potential of 70 e V, 100 J.!A trap current and a 
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source temperature of 200°C, while Fast Atom Bombardment (FAB) was performed 
using a Ceasium ion gun, Matrix:MNOBA. 
Low resolution mass spectra (LRMS) were recorded by Dr L Fourie at the 
Potchefstroom University, who performed EI analyses on a Micromass 
Autospec-TOF. The samples were run in EI mode at 70e V. 
Melting Point Determination 
A Kofler micro-hot stage melting point apparatus was used to record the melting 
points of all the crystalline compounds isolated in this work. All values are 
uncorrected. 
Optical Rotation (OR) 
All the optical rotations, except those for compounds VI, VIII, X, XXI and XXII were 
recorded at room temperature in chloroform on an Optical Activity Ltd AA-5 
automatic polarimeter together with a series A2 stainless steel (4 x 200 mm) 
unjacketed flow tube. The optical rotation for compounds VI, VIII, X, XXI and XXII 
were recorded at room temperature in chloroform or methanol on a Perkin Elmer 
polarimeter (Model 341). 
Column Chromatography 
Glass columns ranging from 1 em to 4 em in diameter were used in the separation 
procedure. Merck 9385 silica gel was used as the solid phase and elution was allowed 
to proceed via gravity. Solvents used included hexane, dichloromethane, ethyl acetate 
and methanol in varying proportions depending on the polarity of compounds being 
isolated. 
Thin Layer Chromatography (TLC) 
The progress of column chromatography was monitored using thin layer 
chromatographic plates. Aluminium backed plates (Merck Art 5554) coated with 
silica gel (0.2 mm thick) and containing a fluorescent indicator (F254) were used. The 
plates were developed using anisaldehyde spray reagent consisting of anisaldehyde, 
cone. H2S04 and methanol in a ratio of 1 :2:97, followed by heating of the plates. 
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Anti-inflammatory and anti-bacterial Screening 
Biological activity screening of compounds I, IV, V, XIV, XVII, XVIII, XIX and XX, 
was performed by Karen du Toit at the University of Natal, Pietermaritzburg. The 
anti-inflammatory activity screening involved the use of microsomal cells and the 
enzymes, Cox-l and Cox-2. Cox-l and Cox-2 are the cyclooxygenase enzymes that, 
in the arachidonic acid cascade, are involved in the formation of prostaglandins. The 
percentage inhibition is measured against indomethacin as a positive control. The 
indomethacin's activity ranged between 70-80% in the microsomal cells and 60-70% 
in the Cox-l assay. The anti-bacterial activity testing was performed on compound 
IV. This activity is measured as the minimum inhibitory concentration (MIC), which 
is the lowest concentration at which the bacterium, Staphylococcus aureus is 
inhibited. The concentration of sample used in the anti-inflammatory screening was 
10 Ilg/cm3 of solvent, and was the same for all samples submitted. 
2.2.3 Experimental 
The bulbs (2168 g) of Ledebouria ovatifolia (Highveld form) were collected from the 
Blyde Nature Reserve by Dr. Neil Crouch. A voucher specimen (N. Crouch 854) is 
retained at the Natal Herbarium. The bulbs were chopped into small pieces and 
extracted with dichloromethane and methanol using continuous agitation for 
approximately 48 hours. The excess solvents were removed using the rotor evaporator 
resulting in the dichloromethane (I5.81g) and methanol (115.89 g) crude extracts. The 
methanol extract was partitioned with ethyl acetate resulting in an ethyl acetate crude 
extract of 5.49 g. 
Isolation of compounds I-III 
The dichloromethane and ethyl acetate extracts were chromatographed using silica gel 
(Merck 9385) as the stationary phase on a crude column (3 cm in diameter) in order to 
separate the compounds. 
The mobile phase used for the dichloromethane extract was a dichloromethane : 
methanol step gradient [100 % dichloromethane (fractions 1-20), 1% methanol in 
dichloromethane (fractions 21-45), 2% methanol in dichloromethane (fractions 46-
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60), 5% methanol in dichloromethane (fractions 61-80), 10% methanol in 
dichloromethane (fractions 81-100), 20% methanol in dichloromethane (fractions 
100-120), 100% methanol (fractions 121-130)]. Fractions of 40 cm3 each were 
collected in each step. Elution using a 5% methanol in 95% dichloromethane solvent 
system afforded compounds I and II. Compound I was purified using the same mobile 
phase on a column (2 cm in diameter) with silica gel as the stationary phase, while 
compound II eluted pure from the crude column. Elution with 10 % methanol in 
dichloromethane yielded compound III, which was purified using the same mobile 
phase on a column (1 cm in diameter). 
The ethyl acetate extract contained the same compounds isolated from the 
dichloromethane extract, while the methanol extract contained a large amount of 
sugar. 
Acetylation of compound II 
Approximately 10 mg of the compound was placed in a stoppered round-bottomed 
flask with pyridine (1 cm3) and acetic anhydride (1 cm3). The contents of the flask 
were allowed to react at room temperature for 24 hours. Thereafter, methanol (3 x 10 
cm
3
) was added to remove the excess acetic anhydride, and the pyridine was removed 
by the addition of toluene (3 x 10 cm\ The final traces of toluene were removed by 
further addition of methanol (3 x 10 cm\ All solvents were removed on a rotor 
evaporator. 
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2.2.3.1 Physical data for Compound I 
Name: (-)-(Z)-1-( 4 '-hydroxyphenyl)-3~-(5"-hydroxy-3 ",4"-dimethoxyphenyl)-l ,4-
pentadiene 
Physical appearance: yellow gum 
Yield: 129.1 mg 
Mass: HRMS [M+] at mlz 312.13690, Cl9H2004 requires 312.13616 
EIMS: mlz (reI. int.): 312 (100.00), 297 (13.37), 295 (9.32), 281(17.23), 265 
(7.33), 218 (5.14), 205 09.12), 204 (10.39), 203 (7.88), 181 (6.21), 179 
(5.32), 173 (17.16), 167 (9.58), 165 (5.58), 159 (5.60), 158 (18.56), 157 
01.24), 145 (7.58), 133 (5.15), 115 (8.82), 107 (40.96), 91 (6.55), 77 (6.28), 
71 (6.54),69 (5 .51), 57 (8.06), 55 (6.11) 
Infra-red: v ~~l em-I: 3412,2923,2847, 1355, 1230, 1105 
Optical Rotation: [a]D = -161.9° (c = 0.278 g/lOO cm3; CHCh) 
IH and 13e NMR Data: Refer to table 2.1 (page 61) 
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2.2.3.2 Physical data for Compound II 
Name: (23S)-17 a,23-epoxy-3~, 29-dihydroxy-27 -norlanost -8-ene-15 ,24-dione 
Synonyms: eucosterol 
Physical appearance: white needle-like crystals 
Yield: 293.6 mg 
Melting Point: 234-236°C, Literature = 235-2360 C 12 
Mass: LRMS [M+] at mlz 472.3189, C29H440S requires 472.3189 
ElMS: mlz (reI. int.): 472 (32.15), 454 (10.72), 439 (7.70), 415 (15.07), 414 
(21.58), 397 (14.79), 379 (8.68), 343 (11.37), 303 (24.78), 257 (10.88), 239 
(11.01), 181 (18.69), 171 (14.91), 159 (15.02), 157 (14.12), 155 (97.53), 137 
(16.28), 135 (19.60), 133 (17.18), 129 (14.95), 125 (24.45), 123 (27.48), 121 
(24.57), 113 (15.94), 111 (30.90), 109 (45.34), 99 (30.61), 97 (36.28), 83 
(70.39),69 (100.00), 57 (43.94), 55 (70.52),43 (94.42) 
Infra-red: V~a:;l cm-1 : 3488,2943,2878,1740,1731,1289,1038 
Optical Rotation: [a]D = +23.0° (c = 0.217 g/ 100cm3; CHCl)), 
Literature [a] ~ = +20.4 ± 2° (c = 1.00, CHCl))12 
IH and 13e NMR Data: Refer to table 2.2 (pages 65 and 66) 
2.2.3.3 Physical data for Compound III 
Name: (23S)-17a,23-epoxy-3~,28,29-trihydroxy-27 -norlanost-8-en-24-one 
Physical appearance: orange gum 
Yield: 21.7mg 
Mass: [M+] at mlz 474.33398, C29H460S requires 474.33453 
ElMS: mlz (reI. int.): 474 (51), 459 (27),456 (8), 417 (25), 57 (100) 
Infra-red: V~a:;l cm-1: 3437,2929,2853,1731 
Optical Rotation: [a]D = -22.7° (c = 0.088 gllOO cm3; CHCl)), 
Literature [a]D = -27.0° (c = 0.5)13 
IH and 13e NMR Data: Refer to table 2.3 (page 69) 
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2.3 Extractives from Eucomis poie-evansii 
Plants of the genus Eucomis (subfamily: Hyacinthoideae, family: Hyacinthaceae) are 
perennial bulbous herbs, which can either grow solitary or gregariously. The bulb is 
large and oblong in shape with the outer scales being dark and membranous4. 
Approximately eleven species are found in the area ranging from South Africa to 
Zimbabwe and Malawi. Eucomis species are widespread but are absent from drier 
areas, thus they are mainly found in grasslands, forests, swamps and along 
riverbanks4. These plants are used in traditional medicine and also make beautiful 
garden plants due to their unusual shape. The common name 'pineapple lily' is derived 
from the raceme, which resembles a pineapple4. 
Figure 2.10. Photograph of Eucomis pole-evans;; (photographed by Dr. Neil Crouch). 
2.3.1 Results and Discussion 
The dichloromethane extract of Eucomis pole-evans;; N.E.Br. yielded two 
homoisoflavonoids, compound IV being a 3-benzyl-4-chromanone type 
homoisoflavonoid and compound V being a 3-benzylidene-4-chromanone type 
homoisoflavonoid. This extract also yielded the same nortriterpenoid, eucosterol, that 
was previously isolated from Ledebouria ovatifolia. The methanol extract was 
investigated, however it contained the same compounds that were found in the 
dichloromethane extract as well as a large amount of sugar. 
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HO HO OH 
H HO H 
OH 0 H 
compound IV compound V 
Figure 2.11. The structures of compounds IV and V. 
2.3.1.1 Structural Elucidation of Compound IV 
(-)-[R]-S,7-dihydroxy-3-(4'-hydroxybenzyl)-8-methoxy-4-chromanone 
(Spectra 4a-p, pages 242-257) 
The first compound to be isolated from E. pole-evansii was isolated as yellow crystals 
and was identified as (-)-[R]-5,7-dihydroxy-3-(4'-hydroxybenzyl)-8-methoxy-4-
chromanone, commonly known as 3,9-dihydropunctatin. This compound was 





( -)-[R ]-5, 7 -dihydroxy -3-( 4'-hydroxybenzyl)-8-methoxy -4-chromanone 
Figure 2.12. The structure of compound IV. 
The mass spectrum revealed compound IV to have a molar mass of 
316.09469 g mor
I






(C I7H I60 6 requires 316.09469) and a double bond equivalence often. 
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The infra-red spectrum of compound IV showed an absorption at 3390 cm-I due to the 
stretching vibrations of the hydroxy group. Absorptions were also evident at 
2918 cm-I (C-H asymmetric stretching) and 2847 cm-I (C-H symmetric stretching). 
The C=O stretching vibration was observed at 1637 cm-I and is shifted considerably 
as ~-hydroxy ketones have a chelation effect which causes a shift in the carbonyl 
frequency 17. This absorption arises from a carbonyl group which has had its double 








This resonance effect is described as conjugate chelationl7 and explains the low 
frequency absorption stretch of compound IV. 
The absorption at 1518 cm-I in the infra-red spectrum was due to the aromatic C=C 
stretching. The CH2 and CH3 bending vibrations were observed at 1452 cm-I, 
1268 cm-I and 1165 cm-I, while the absorption at 1018 cm-I was due to the C-O 
stretching. 
The NMR data for compound IV indicated that it was a homoisoflavanone of the 
3-benzyl-4-chromanone type. The definitive IH NMR resonances were the two pairs 
of double doublets at 8 4.35 (lH, J = 4.1,11.3 Hz), 84.18 (lH, J = 7.2,11.3 Hz) and 
8 3.17 (lH, J = 4.1, 13.8), 8 2.69 (IH, J = 10.1, 13.8) and the multiplet at 8 2.82 
(lH), which are typical of the two ABX systems for the 2H-2, 2H-9 and H-3 protons 
respectively I 8. 
In the IH NMR spectrum a pair of doublets, each integrating to two protons, was 
observed at 8 7.08 (J = 8.3 Hz) and 8 6.78 (J = 8.3 Hz). These signals were assigned 
to the respective H-2'/6' and H-3'/5' protons of the B-ring and the corresponding 
methine carbons were found at 8 130.3 (C-2'/6j and 8 115.6 (C-3'/5j. In the COSY 
spectrum, coupling was observed between the H-2'/6' proton resonance and the 
H-3' /5' proton resonance. A coupling constant of 8.3 Hz is indicative of a para 
substituted aromatic ring, thus the C-4' (8 154.4) position must be substituted. The 
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H-2'/6' resonance exhibited correlations in the NOESY spectrum with H-3'/5', 2H-9 
and H-3, and its corresponding methine carbon showed a correlation in the HMBC 
spectrum with 2H-9. The methylene carbon resonance ascribed to C-9 was observed 
at 8 31.9 and showed correlations in the HMBC spectrum with the 2H-2 and H-2'/6' 
resonances. 
The mass spectrum of homoisoflavonoids is used to identify the substitution pattern 
on the B ring. In general, an intense peak at mlz 121 is indicative of an A-4 and retro 
Diels Alder (RDA) fragmentation pattern and this corresponds to a 
methoxybenzyllmethoxytropylium ion19• However, a base peak at mlz 107 IS 
indicative of a hydroxybenzyl/hydroxytropylium ion19• In compound IV a peak at mlz 

















Scheme 2.1. The MS fragmentation pattern for compound IV. 




mlz 107 mlz 107 
In the l3C NMR spectrum of homoisoflavonoids, the C-5, C-6 and C-8 chemical shifts 
are generally used to confirm the A-ring substitution pattern. The C-5 resonance 
usually occurs at 8 165.8 when there is a 5,7-dihydroxy substitution pattern20. 
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However, the presence of a methoxy substituent at C-6 results in C-5 resonating about 
9.0 ppm upfield from the norm20. Furthermore when C-6 or C-8 is unsubstituted, these 
resonances are observed at 8 97.1-97.3 and 8 95.8-96.0 respectively if C-7 carries a 
hydroxy group. When C-7 carries a methoxy group, these resonances are at a higher 
field2o. 
The only position that was protonated on the A ring was the C-6 position (8 95.9, 
CH), which corresponded to the singlet signal in the 1 H NMR spectrum at 8 6.11. The 
C-5 and C-4a resonances showed correlations in the HMBC spectrum to H-6 and the 
hydroxyl group proton at C-5, while the C-8 resonance showed correlations in the 
HMBC spectrum to H-6, the hydroxyl group proton at C-7 and methoxy group 
protons at C-8. The C-7 resonance could be assigned as this resonance showed a 
correlation in the HMBC spectrum to H-6 and the hydroxyl group proton at C-7, 
while the C-8a resonance was seen to be correlated in the HMBC spectrum with 2H-2. 
The sharp singlet at 8 3.38, integrating to three protons, was due to the presence of 
protons of a methoxy group. The corresponding methyl carbon resonance appeared at 
861.5. In the HMBC spectrum the 3H-methoxy group protons showed a correlation to 
C-8, indicating that the methoxy group occurred at C-8. 
The ultra violet (UV) spectra are useful in determining the substitution pattern on the 
A ring of homoisoflavonoids when the compounds are analysed using NaOAc and 
AICh. The original UV spectra usually give absorption maxima between 295-310 nm. 
However, when NaOAc or AICh solutions are added, this causes a shift in the 
maxima in certain instances. For example, when a bathochromic shift is observed with 
NaOAc, this indicates the presence of a hydroxy group at the C-7 position l6, 21 , while 
a bathochromic shift with AICh, indicates the presence of a hydroxy group at the C-5 
.. 16 21 Th b f h'f' . posItIon ' . e a sence 0 a SIt Imphes a methoxy group is present at the 
respective positions. 
In this compound, a bathochromic shift (+36 nm) was observed with NaOAc 
confirming that a hydroxy group occurred at C-7. The H-7 hydroxy group proton 
resonance occurred as a singlet at 8 6.39 and showed a correlation in the HMBC 
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spectrum to C-6. The 'H NMR spectrum showed a singlet resonance at 8 11.95 due to 
the hydroxy group protons, which indicated the presence of a hydroxy group at C-5. 
Further evidence of a hydroxy group at C-5 was revealed by a positive bathochromic 
shift (+ 19 nm) in the UV spectrum with AICl). This was confirmed by the presence of 
the C-4 carbonyl resonance at 8 197.7. The carbonyl carbon resonance is de shielded 
due to chelating effects with the hydroxy group and this causes it to be shifted 
down field in the l3C NMR spectrum to almost 8 200.020. In the event of a methoxy 
group being present at C-5, the carbonyl carbon would resonate much further upfield 
of 8 200.0. In the HMBC spectrum the fully substituted C-4 carbon resonance showed 
correlations with 2H-9, 2H-2 and H-3(w). 
Five fully substituted carbon resonances were observed for carbons of the A ring and 
were assigned to the signals at 8 157.7 (C-5), 8 102.4 (C-4a), 8 127.6 (C-8), 8 160.2 
(C-7) and 8 153.0 (C-8a). The absolute stereochemistry at C-3 has been determined by 
Professor D. Ferreira at the University of Mississippi, USA, for a series of 
homoisoflavanones of this type from the group using circular dichroism. In all cases 
the absolute stereochemistry at C-3 was shown to be R, implying that H-3 must be u. 
It is assumed that the stereochemistry would be the same for compound IV. 
By comparison with the literature data16, compound IV was identified as the known 
homoisoflavanoid, (-)-[R]-5, 7 -dihydroxy-3-( 4 '-hydroxybenzyl)-8-methoxy-4-
chromanone. Compound IV, at a concentration of 10 )lg/cm3, showed a 28.2% 
inhibition of prostaglandin synthesis using the microsomal cell screen and a 2.5% 
inhibition using the Cox-2 screen (page 72). This compound also showed an anti-
bacterial activity at a MIC value of 0.98mM. This minimum inhibitory concentration 
(MIC) is the lowest concentration at which the bacterium, Staphylococcus aureus is 
inhibited. 
The data for compound IV, as well as the literature data is given in Table 2.4. The l3C 
NMR data for compound IV did not correlate well with that of literature and this may 
be due to these compounds being run in different solvents. However, using HMBC 
correlations it was possible to make conclusive assignments for compound IV. The 
HMBC and NOESY correlations for compound IV are shown in figure 2.13 and 
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figure 2.14 respectively. 
In order to confirm the structure, compound IV was acetylated. In the IH NMR 
spectrum, three singlet peaks, each integrating to three protons, were observed at 
82.36,82.32, and 8 2.28 which were assigned to the acetate groups at C-S (8 14S.6, 
C), C-7 (8 148.6, C) and C-4' (8 149.S, C) respectively. In the NOESY spectrum, the 
acetate group at C-S was seen to be correlated with the proton peak ascribed to H-6, 
the acetate group at C-7 showed a correlation with the proton signal due to the 
methoxy group at C-8 (8 138.8, C) and the acetate group at C-4' was seen to be 
correlated with the proton resonance assigned to H-3'/S'. Thus the positions of the 
hydroxy groups in compound IV were confirmed. The NMR data and correlations for 
the acetylated compound IV are shown in table 2.S. 
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Figure 2.13. The HMBC (C -7 H) correlations for compound IV. 
Figure 2.14. The NOESY correlations for compound IV. 
82 
Table 2.4. NMR data and correlations for compound IV (CDCh) and literature 
data for 3,9-dihydropunctatin (CD30D)16 
Carbon IHNMRdata 13CNMR COSY HMBC NOESY -Uc NMR literature 
Number (400 MHz) data correlations correlations correlations data 




4.35 (lH, dd, H-2B, H-3 H-2B, H-3 
J=4.1, 11.3 Hz) 69.4 (CH2) 2H-9 70.5 
2B 
4.18 (lH, dd, H-2A, H-3 
H-2A, H-3, 
J=7.2, 11.3 Hz) H-9B, H-2'/6' 
H-2A, H-2B, 
H-2A, H-2B, 
3 2.82 OH, m) 46.8 (CH) H-9A, H-9B 
H-2A,2H-9 H-9A, H-9B 48.0 
H-2'/6' 





4a - 102.4 (C) -
H-6, 102.8 
OH at C-5 
-
S - 157.7 (C) - H-6, 161.0 t OH at C-5 -
6 6.11 (IH, s) 95.9 (CH) -
OH at C-5, 
OH at C-5 97.2 
OH atC-7 
7 - 160.2 (C) - H-6, 161.6 t OH at C-7 -
H-6, 
8 - 127.6 (C) - OH atC-7, - 130.1 I 
OCH3 at C-8 
8a - 153.0 (C) - 2H-2 - 155.6 
9A 
3.17 (lH, dd, 
H-3, H-9B, 
H-3, H-9B, 
J=4.1, 13.8 Hz) 
31.9 (CH2) 2H-2, H-2'/6' 
H-2'/6' 
2.69 (lH, dd, H-2B, H-3, 
33.1 
9B H-3, H-9A 
J=4.1, 13.8 Hz) H-9A, H-2'/6' 
I' - 129.8 (C) - H-3, H-3'/5' - 129.8 1 
2' 
7.08 (lH, d, J=8.3 H-2B, H-3, 
Hz) 
130.3 (CH) H-3'/5' 2H-9, H-2'/6' H-9A, H-9B, 131.1 
H-3'/5' 
3' 
6.78 (lH, d, I-8.3 
115.6 (CH) H-2'/6' H-3'/5' Hz) H-2'/6' 116.4 
4' - 154.4 (C) - H-2'/6', H-3'/5' - 157.1 t 
5' 6.78 OH, d, J 8.3 115.6 (CH) H-2'/6' H-3'/5 Hz) H-2'/6' 116.4 
6' 7.08 (lH, d, J=8.3 130.3 (CH) 
H-2B, H-3, 
Hz) H-3'/5' 2H-9, H-2'/6' H-9A, H-9B, 131.1 
H-3'/5' 
OCH3 at 3.83 (3H, s) 61.5 (CH3) 
2H-2(w),OH 
C-S - - 61.5 atC-7(w) 
OHat C-S 11.95 (lH, s) - - - H-6 -
OH at C-7 6.39 (lH, s) - - - OCH3 at 
C-8(w) -




[R ]-5, 7 -diacetoxy-8-methoxy-3-( 4' -acetoxybenzyl)-4-chromanone 
Figure 2.15. The structure of acetylated compound IV. 
Table 2.5. NMR data and correlations for the acetylated compound IV (CDCh) 
Carbon IHNMRdata 13CNMRdata COSY HMBC correlations NOESY 
Number (400 MHz) (100 MHz) correlations C~H correlations 
2A 
4.43 (lH, dd, J=4.4, H-2B, H-3 
H-2B, H-3, 
11 .S Hz) 69.S (CH2) H-9A, H-9B 
H-2'/6'(w) 
2B 
4.23 (lH, dd, J=8.8, 
H-2A, H-3 
H-2A, H-3, H-9B, 
I1.S Hz) H-2'/6'(w) 
3 2.84 (lH, m) 47.8 (CH) 
H-2A, H-2B, H-2A, H-2B, H-
H-9A, H-9B 
-
9A, H-9B, H-2'/6' 
4 - 190.9 (C) - H-2A, H-2B -
4a - 112.S (C) - H-6 -
5 - 14S.6T (C) - H-6 -
6 6.4S (lH, s) 110.9 (CH) - - 3H-OAc at C-S 
7 - 148.6t (C) - H-6 -
8 - 138.8 (C) - H-6, OCH3 at C-8 -
8a - IS6.4 (C) - H-2A, H-2B -
9A 
3.24 (lH, dd, J'-4.3, 
H-3, H-9B H-3, H-9B, H-2'/6' 14.2 Hz) 
2.63 (lH, dd, 
31.S (CH2) H-2A, H-2'/6' 
H-2B(w), H-3, 9B H-3, H-9A J=1O.6, 14.1 Hz) H-9A, H-2'/6' 
l' - 13S.4 (C) - H-9A, H-9B, H-3'IS ' -
2' 7.19 (lH, d, J-8.4 130.0 (CH) H-3'IS' H-9A, H-9B, H-2'/6' 2H-2(w), H-3, H-Hz) 9A, H-9B, H-3'IS' 
3' 7.02 (lH, d, J-8.6 121.9 (CH) H-2'/6 ' H-3'IS' H-2'/6', 3H-OAc at Hz) C-4' 
4' - 149.5 (C) - H-2'/6', H-3'IS' -
5' 
7.02 (lH, d, J-8 .6 
121.9 (CH) H-2'/6' H-3 'IS' H-2'/6', 3H-OAc at Hz) C-4' 
6' 7.19 (IH, d, J-8.4 130.0 (CH) H-3'IS' H-9A, H-9B, H-2'/6' 2H-2(w), H-3, H-Hz) 9A, H-9B, H-3'IS' 
OCH3 at C-8 3.81 (s) 61.0 (CH3) - - 3H-OAc at C-7 
!;:H3COZ at 
2.36 (s) 21.0 (CH3) C-5 - - H-6 
!;:H3COZ at 2.32 (s) 20.7 (CH3) C-7 - - OCH3 at C-8 
!;:H3COZ at 
2.28 (s) 21.1 (CH3) C-4' - - H-3'IS' 
CHJ!::Oz at 
169.S (C) 3H-OAc at C-S C-5 - - -
CHJ!::Oz at 
167.9 (C) C-7 - - 3H-OAc at C-7 -
CH3!;;Oz at 169.5 (C) C-4' - - 3H-OAc at C-4' -
r Values may be mterchangable 
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2.3.1.2 Structural Elucidation of Compound V 
(E)-S,6,7-trihydroxy-3-(4'-hydroxybenzylidene)-8-methoxy-4-
chromanone 
(Spectra 5a-i, pages 258-266) 
The second compound to be isolated from Eucomis pole-evansii was isolated as 
yellow crystals and was identified as the novel compound (E)-5,6,7-trihydroxy-3-(4'-
hydroxy benzylidene )-8-methoxy-4-chromanone (compound V). 
HO 
HO 
(E)-5,6,7 -trihydroxy -3-( 4' -hydroxy benzylidene )-8-methoxy -4-chromanone 
Figure 2.16. The structure of compound V. 
The mass spectrum indicated a molar mass of 330 g mor l , which corresponded to a 
molecular formula of C17H I40 7 (C17H I40 7 requires 330) and a double bond 
equivalence of eleven. Further fragments were observed at mlz 298 (M+ - CH30H) 
and mlz 107. The latter indicated the presence of a hydroxytropylium ion. 
The infra-red spectrum of compound V showed an absorption at 3381 cm· l , which 
was due to the O-H stretching vibration. Absorption peaks were also observed at 
2917 cm- l and 2846 em-I, which were due to the C-H asymmetric and symmetric 
stretching respectively. The C=O stretching vibration was observed at 1634 em-I, 
while the aromatic C=C stretching was observed at 1514 em-I. The CH2 and CH3 
bending absorptions were observed at 1378 em-I, 1307 cm- l and 1170 em-I, and the 
absorption peak at 1034 cm- l was due to the C-O stretching. 
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The appearance of the resonances at 8 5.32 (2H, s, 2H-2) and 8 7.72 (lH, s, H-9) in 
the lH NMR spectrum, as well as the appearance of an a,~-unsaturated carbonyl 
carbon resonance at 8 185.3 (C-4, C) in the l3C NMR spectrum, indicated the 
presence of a 3-benzylidene (i.e. a 3(9)-unsaturated) system22. In the COSY spectrum, 
the 2H-2 resonance was seen to be weakly coupled to H-9. 
The lH NMR spectrum showed a pair of doublet proton resonances, each integrating 
to two protons, at 8 7.14 (J = 8.4 Hz) and 8 6.83 (J = 8.4 Hz), which were assigned to 
H-2'/6' and H-3'/5' respectively. The corresponding methine carbon resonances were 
observed at 8 132.3 and 8 115.8. The C-2' 16' carbon resonance showed a correlation 
in the HMBC spectrum to H-9, and C-9 (8 137.7), in tum, showed a correlation in the 
HMBC spectrum to 2H-2. The C-4 carbon resonance was seen to be correlated in the 
HMBC spectrum with 2H-2 and H-9. In the NOESY spectrum the proton resonance 
assigned to H-2' 16' showed a correlation to H-3' 15', H-9 and 2H-2. The fact that a 
correlation was not observed in the NOESY spectrum between H-9 and 2H-2, 
indicated that this compound must be the (E)-isomer. Also, the chemical shifts for C-2 
(8 67.7) of this 3-benzylidene-4-chromanone agreed with the value for eucomin22, 
thus confirmed the same E configuration to be assigned to this derivative22 . 
Furthermore, an E-orientation of the double bond was indicated by the position of the 
H-2 and H-9 proton signals at 85.32 and 8 7.72 respectivell3• 
The A ring substitution pattern was deduced by UV absorption, whereby positive 
bathochromic shifts were observed with the addition of both NaOAc (+30 nm) and 
AICh (+50 nm). This indicated that hydroxy groups were present at C-5 and C-7. The 
1 H NMR spectrum also showed the presence of a singlet resonance integrating to 
three protons at 8 3.72, which indicated a methoxy group. This was placed at C-8 
(8 127.8) as it showed a NOESY correlation to 2H-2. A model was built in order to 
confIrm that this NOESY correlation was possible. 
From the NMR data this compound was identified as the novel 3-benzylidene-4-
chromanone, E-5 ,6,7 -trihydroxy-3-( 4'-hydroxybenzy lidene )-8-methoxy-4-chroman-
one. Compound V, at a concentration of 10 /-tg/cm3, showed a 29.7% inhibition of 
prostaglandin synthesis using the microsomal cell screen (page 72). The HMBC and 
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NOESY correlations are depicted in figures 2.17 and 2.18 respectively, while all the 
NMR data for this compound is given in table 2.6. 
Figure 2.17. The HMBC (C ~ H) correlations for compound V. 
Figure 2.18. The NOESY correlations for compound V. 
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Table 2.6. NMR data and correlations for compound V (CDCh) 
Carbon IHNMRdata 13CNMRdata COSY HMBC NOESY 
Number (400 MHz) (100 MHz) correlations correlations correlations 
C-7H 
H-9 H-9 
H-2'/6', OCH3 at 2 5.32 (2H, s) 67.7 (CH2) C-8 
3 - 126,4 (C) - 2H-2, H-9 -
4 - 185.3 (C) - 2H-2, H-9 -
4a - * - * -
5 - * - * -
6 - 102.6 (C) - OH atC-7 -
7 - * - * -
127.8 (C) 
OH at C-7, OCH3 -8 - - at C-8 
8a - 153.0 (C) - 2H-2 -
9 7.72 (lH, s) 137.7 (CH) 2H-2 2H-2, H-2'/6' H-2'/6' 
l' - 125.6 (C) - H-3'/5' -
2' 7.14 (lH, d, 132.3 (CH) H-3'/5' H-9, H-2'/6' 2H-2, H-9, H-3 '/5' J 8,4 Hz) 
3' 6.83 (lH, d, 115.8 (CH) H-2 '/6' H-3'/5' H-2 '/6 ' J-8,4 Hz) 
4' - 158.8 (C) - H-2'/6', H-3'/5' -
5' 6.83 (lH, d, 115.8 (CH) H-2'/6' H-3'/5' H-2'/6' J-8,4 Hz) 
6' 7.14 (IH, d, 132.3 (CH) H-3'/5' H-9, H-2'/6' 2H-2, H-9, H-3'/5' J-8,4 Hz) 
OCH3at 3.72 (3H, s) 61.2 (CH3) - - 2H-2 C-8 
OH at C-7 6.01 (lH, s) - - - -
* Carbon resonances and HMBC correlations not able to be determined from spectra 
2.3.2 Experimental 
Eucomis pole-evansii bulbs (2950 g) were collected from Mac Mac Pools, 
Mpumalanga by Dr. Neil Crouch. A voucher specimen (N. Crouch 856) is retained at 
the Natal Herbarium for verification purposes. The bulbs were chopped and extracted 
with dichloromethane and methanol for approximately 48 hours at room temperature 
using continuous agitation. The extracts were concentrated using a rotor evaporator 
resulting in the dichloromethane (34.05 g) and methanol (141.58 g) crude extracts. 
Column chromatography using silica gel (Merck 9385) was used for separation of the 
compounds. 
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Isolation of compounds IVand V 
The dichloromethane extract was chromatographed using silica gel (Merck 9385) as 
the stationary phase and a column of 3 cm in diameter. 
The mobile phase used for the dichloromethane extract was a dichloromethane : 
methanol step gradient [100% dichloromethane (fractions 1-40), 1% methanol in 
dichloromethane (fractions 41-80), 3% methanol in dichloromethane (fractions 81-
100), 5% methanol in dichloromethane (fractions 101-120), 10% methanol in 
dichloromethane (fractions 121-145). 20% methanol in dichloromethane (fractions 
146-160), 100% methanol (fractions 161-180)]. Fractions of 40 cm3 each were 
collected in each step. 
Both compounds IV and V were eluted from the column using 2% methanol in 98% 
dichloromethane and were purified on a second column (1 cm in diameter) using a 
100% dichloromethane solvent system. These compounds were distinguished from 
each other as compound IV exhibited a red coloured spot on thin layer 
chromatographic plates, while compound V was seen as an orange coloured spot, 
when the plate was sprayed with anisaldehyde spray reagent. 
The methanol extract was investigated, however, it contained the same compounds 
that were isolated from the dichloromethane extract as well as a large amount of 
sugar. 
Acetylation of compound IV 
Approximately 10 mg of the compound was placed in a stoppered round-bottomed 
flask with pyridine (1 cm3) and acetic anhydride (1 cm\ The contents of the flask 
were allowed to react at room temperature for 24 hours. Thereafter, methanol (3 x 10 
cm3) was added to remove the excess acetic anhydride, and the pyridine was removed 
by the addition of toluene (3 x 10 cm\ The final traces of toluene were removed by 
further addition of methanol (3 x 10 cm3). All solvents were removed on a rotor 
evaporator. 
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2.3.2.1 Physical data for Compound IV 
Name: (-)-[R]-5,7-dihydroxy-3-( 4'-hydroxybenzyl)-8-methoxy-4-ehromanone 
Synonyms: 3,9-dihydropunetatin 
Physical appearance: yellow crystals 
Yield: 19.8 mg 
Melting Point: 196-200°C, Literature = 205-206°C (CHCl)-hexane)16 
Mass: LRMS [M+] at mlz 316.09469, C17HI60 6 requires 316.09469 
ElMS: mlz (reI. int.): 316 (71.10), 301 (1.39), 299 (2.05), 210 (45.33), 209 
(15.82), 195 (21.06), 183 (7.56), 167 (10.40), 139 (7.82), 107 (100.00), 77 
(11.86),69 (8.01), 55 (7.30) 
Infra-red: v ~:;l em-I: 3390, 2918, 2847, 1637, 1518, 1452, 1268, 1165, 1165, 1018 
Ultra violet: A~-::H nm (log E): 296 (4.20), 343 (3.28) 
With NaOAe: 332 
With AICl) : 315 
Optical Rotation: [a]D = -27.8° (e = 0.09 g/lOO em3; CHCl)), 
Literature [a] ;4 = -37° (e = 0.3, MeOH)16 
IH Be and NMR Data: Refer to table 2.4 (page 83) 
2.3.2.2 Physical data for Compound V 
Name: (E)-5,6, 7 -trihydroxy-3-( 4'-hydroxybenzylidene )-8-methoxy-4-ehromanone 
Physical appearance: yellow amorphous 
Yield: 11.2 mg 
Mass: LRMS [M+] at mlz 330, C17HJ40 7 requires 330 
EIMS:mlz: 330,316,298,167, 107, 71 , 57,55, 44,28 
Infra-red: v ~:;l em-I: 3381 , 2917,2846, 1634, 1514, 1378, 1307, 1170, 1034 
Ultra violet: A~-::H nm (log E): 354 (3.73) 
With NaOAe: 384 
With AICl) : 404 
IH dB an e NMR Data: Refer to table 2.6 (page 88) 
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2.4 Extractives from Lachenalia rubida 
Plants belonging to the genus Lachenalia Jacq., (subfamily: Hyacinthoideae, family: 
Hyacinthaceae) are perennial bulbous herbs. The bulb varies in size and has either a 
hard or soft outer covering of dry, membranous scales, which occasionally form a 
neck4. There are approximately one hundred and ten species extending across 
southern Africa. Lachenalia is the largest genus of the Hyacinthaceae in southern 
Africa with several species only known from a single locality4. This work is the first 
time a plant from this genus is being investigated chemically. Plants of this genus 
occur in a wide range of habitats and are cultivated as ornamentals. There is no 
evidence of Lachenalia plants being used by traditional healers, however, they also 
seem to be a rich source of homoisoflavonoids. 
Figure 2.19. Photograph of Lachenalia rubida (photographed by Dr. Neil Crouch). 
2.4.1 Results and Discussion 
The dichloromethane extract of Lachenalia rubida yielded two compounds, the first 
(compound VI), being a 3-benzyl-4-chromanone type homoisoflavanone and the 
second (compound Vll), a novel 3-benzyl-4-chromone type homoisoflavone. The 
latter is a 3-benzylidene-4-chromanone with the double bond having been shifted 
from the 3,9-position to the 2,3-position. 
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H H H H 
compound VI compound VII 
Figure 2.20. The structures of compounds VI and VII. 
2.4.1.1 Structural Elucidation of Compound VI 
(-)-[R]-S-hydroxy-3-( 4-hydroxybenzyl)-7 -methoxy-4-chromanone 
(Spectra 6a-k, pages 267-277) 
OH 
H 
The first compound isolated from Lachenalia rubida was identified as the 
homoisofiavanone, (-)-[R]-5-hydroxy-3-( 4-hydroxybenzyl)-7 -methoxy-4-
chromanone. This compound has been reported by Adinolfi et aZ?O, however, it is not 
clear from the paper whether this compound was isolated as a natural compound or if 
it resulted from a methylation reaction. 
H H 
(-)-[R]-S-hydroxy-3-( 4-hydroxybenzyl)-7 -methoxy-4-chromanone 
Figure 2.21. The structure of compound VI. 
The mass spectrum indicated compound VI to have a molecular mass of 300 g mor l , 
which corresponded to a molecular formula of C17HI60 S (C17H I60 S requires 300) and 
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a double bond equivalence of ten. Further fragmentation was seen at mlz 193 and mlz 
107. The latter indicated the presence of a hydroxytropylium ion. 
The infra-red spectrum showed absorptions at 3407 cm- l (O-H stretching), 2918 cm-
l 
(C-H asymmetric stretching), 2849 cm- l (C-H symmetric stretching) and 1640 cm-
l 
(C=O stretching). The absorption at 1513 cm- l was due to the aromatic C=C 
stretching, while the CH2 and CH3 bending absorptions could be seen at 1443 cm-
1
, 
1374 cm- l and 1156 cm- l . 
On first inspection of the IH NMR spectrum, it was evident that this compound was a 
3-benzyl-4-chromanone type homoisoflavonoid, having a hydroxy group attached at 
position 5 and protonated at the C-6 and C-8 positions. Evidence of the hydroxy group 
attached to C-5 is given in the IH NMR spectrum by the singlet peak at 8 12.09 due to 
the hydrogen bonded hydroxy group proton and in the l3C NMR spectrum by the 
downfield position of the carbonyl resonance at C-4 (8 197.9). This signal at 8 12.09, 
showed a correlation in the NOESY spectrum with H-6 (8 6.04, d, J = 2.4 Hz) and 
correlations in the HMBC spectrum to C-5 (8 164.5, C), C-4a (8 102.6, C) and C-6 
(895.0, CH). Further evidence supporting the presence of a hydroxy group at C-5 was 
revealed by a positive bathochromic shift (+20 nm) in the UV spectrum with AICh. 
The I H NMR spectrum showed the presence of one methoxy group proton resonance 
at 8 3.79 (s), which was seen in the NOESY spectrum to be correlated with both the 
H-6 and H-8 (8 5.95, d, J = 2.1 Hz) proton resonances. The methoxy group was 
therefore placed at C-7 (8 167.8, C). This was confirmed by the HMBC spectrum, 
which showed a correlation between C-7 and the methoxy group proton resonance. 
No bathochromic shift was observed with NaOAc, indicating that a methoxy group 
occurred at C-7, an observation, which was also corroborated by the appearance of 
resonances due to H-6 and H-8 downfield of 6.0 ppm20. The HMBC spectrum also 
showed correlations of the proton resonance assigned to H-6 with C-5, C-4a and C-7. 
The B ring showed a para substitution pattern, indicated by a pair of doublet proton 
resonances at 8 7.08 (J = 8.5 Hz, H-2'/6') and 8 6.78 (J = 8.3 Hz, H-3'/5'). These 
doublet resonances are seen to be coupled to each other in both the COSY and 
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NOESY spectra. The methine carbon signal at 8 130.0, assigned to C-2' /6', showed 
correlations in the HMBC spectrum with H-3' /5', H-9A (8 3.15, dd, J = 4.2, 13.6 Hz) 
and H-9B (82.68, dd, J = 10.5, 13.6 Hz), while the fully substituted carbon resonance 
at 8 154.4 (C-4') showed correlations in the HMBC spectrum with H-2' /6' and 
H-3' /5'. In the NOESY spectrum the H-2' /6' peak showed correlations with the 
proton signals assigned to H-3'/5', H-3 and 2H-9. 
In the C ring, the proton resonance due to H-2A (8 4.26, dd, J = 4.2, 11.4 Hz) was 
seen to be coupled in the COSY spectrum with H-2B (84.09, dd, J = 7.0, 11.4 Hz) 
and the H-3 (82.78, m) proton peak. The proton resonance attributed to H-3 showed 
coupling in the COSY spectrum with the 2H-9 and 2H-2 proton signals and was seen 
to be coupled in the NOESY spectrum to 2H-2, 2H-9 and H-2' /6'. In the HMBC 
spectrum the methylene carbon resonance at 8 32.0 (C-9) showed correlations with 
H-2' /6' and 2H-2. 
The absolute stereochemistry at C-3 has been determined by Professor D. Ferreira at 
the University of Mississippi, USA, for a series of homoisoflavanones of this type 
from the group using circular dichroism. In all cases the absolute stereochemistry at 
C-3 was shown to be R, implying that H-3 must be u. It is assumed that the 
stereochemistry would be the same for compound VI. 
From the use of NMR spectroscopy and other spectral data, this compound was found 
to be the homoisoflavonoid, (-)-[R]-5-hydroxy-3-( 4-hydroxybenzyl)-7 -methoxy-4-
chromanone. The NMR data for compound VI is given in table 2.7 and is compared to 
the literature data20 for this compound. The values do not correlate exactly as they are 
run in different solvents. The HMBC and NOESY correlations for this compound are 
shown in figures 2.22 and 2.23 respectively. 
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Figure 2.22. The HMBC (C -7 H) correlations for compound VI. 
Figure 2.23. The NOESY correlations for compound VI. 
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Table 2.7. NMR data and correlations for compound VI (CDCh) and literature 
data for 5-hydroxy-3-( 4-hydroxybenzyl)-7 -methoxy-4-chromanone 
(CD30D)20 
13CNMR 
literature data for 
















4.26 OH, dd, H-2B, H-3 H-2B, H-3 
1=4.2, 11.4 Hz) 
68.9 (CH2) H-9A, H-9B 70.4 
2B 
4.09 (IH, dd, 
H-2A, H-3 H-2A, H-3 
1=7.0, 11.4 Hz) 
H-2A, H-2B, 
H-2A, H-2B, 
3 2.78 (lH, m) 46.8 (CH) H-9A, H-9B 
H-9A, H-9B H-9A, H-9B, 48.4 
H-2'/6' 
H-2A, H-2B, 
4 - 197.9 (C) - H-9A(w), OH at - 200.2 
C-5 
4a - 102.6 (C) - H-6 - 103.0 
5 - 164.5 (C) - H-6(w), OH at 165.6 C-5 -
6 
6.04 (IH, d, 
95 .0 (CH) H-8 
H-8(w), OH at 
OCH3 at C-7 95.8 1=2.4 Hz) C-5 
7 - 167.8 (C) -




5.95 (lH, d, 
93.9 (CH) H-6 OCH3 at C-7 94.6 1=2.1 Hz) 
-
8a - 162.8 (C) - H-2A, H-2B - 164.6 
9A 
3.15 (lH, dd, 
H-3, H-9B 
H-3, H-9B, 
1=4.2, 13.6 Hz) 
H-2A, H-2B, 
H-2 ' /6' 
2.68 (lH, dd, 32.0 (CH2) 32.9 
9B 1=10.5, 13.6 H-3, H-9A 
H-2' /6' H-3, H-9A, 
Hz) H-2' 16' 
l' - 130.0 (C) - H-2' 16', H-3 ' 15' - 130.2 
2' 
7.08 (lH, d, 
130.3 (CH) H-3'/5' 
H-9A, H-9B, H-3, H-9A, H-
1=8.5 Hz) H-3'/5' 9B, H-3 ' /5' 
131.2 
3' 
6.78 (IH, d, 
115.6 (CH) H-2' 16' H-3 ' /5' H-2'/6' J=8.3 Hz) 116.5 
4' - 154.4 (C) - H-2'/6', H-3'/5 ' - 157.3 
5' 6.78 OH, d, 115.6 (CH) H-2'/6' H-3'/5' 1=8.3 Hz) H-2'/6' 116.5 
6' 7.08 (IH, d, 130.3 (CH) H-3'/5' H-9A, H-9B, H-3, H-9A, 1=8.5 Hz) H-3 ' /5' H-9B, H-3'/5' 131.2 
OCH3 at 3.79 (3H, s) 55.7 (CH3) C-7 - - H-6, H-8 56.2 
OH at CoS 12.09 OH, s) - - H-6 -
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2.4.1.2 Structural Elucidation of Compound VII 
S-hydroxy-3-( 4-hydroxybenzyl)-7 -methoxychromone 
(Spectra 7a-i, pages 278-286) 
The second compound to be isolated from Lachenalia rubida was identified as the 
novel homoisoflavone, 5-hydroxy-3-( 4-hydroxybenzyl)-7 -methoxychromone. These 
types of homoisoflavones have been reported from Ophiopogon japonicui
4 




5-hydroxy-3-( 4-hydroxybenzyl)-7 -methoxychromone 
Figure 2.24. The structure of compound VII. 
The mass spectrum revealed compound VII to have a molar mass of 298 g mor l , 
which corresponded to a molecular formula of C17HI40S (C17HI40 S requires 298) and 
a double bond equivalence of eleven. The peak at mlz 107 indicated the presence of a 
hydroxytropylium ion which implied that a hydroxyl group was situated on ring B. 
In the infra-red spectrum, the O-H stretching vibration was observed at 3396 em-I. 
The absorptions at 2914 em-I and 2845 cm-I were due to the C-H asymmetric and 
symmetric stretching vibrations respectively. The C=O stretching could be seen at 
1651 em-I, while the aromatic C=C stretching vibration was observed at 1512 em-I. 
The CH2 and CH3 bending vibrations were seen at 1442 em-I, 1303 em-I and 
1164 em-I. 
Compound VII was contaminated with a slight impurity, the peaks of which have 
been cancelled out in the relevant spectra. The IH NMR spectrum showed the 
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presence of a pair of doublet resonances at 8 7.12 (2H, J = 8.3 Hz) and 8 6.77 (2H, J = 
8.3 Hz), which were indicative of a para disubstituted aromatic ring B system and 
were assigned to H-2'/6' and H-3'/5' respectively. The corresponding methine carbon 
resonances were observed at 8 130.1 (C-2' 16') and 8 115.5 (C-3' 15') in the l3C NMR 
spectrum. The C-2'/6' resonance was seen to correlate in the HMBC spectrum with 
the singlet two-proton resonance at 83.67, ascribed to 2H-9. This 2H-9 peak was seen 
to be correlated in the NOESY spectrum with H-2' 16', which further confirmed the 
peak assignment. The C-9 methylene carbon resonance observed at 8 29.7, showed 
HMBC correlations to the H-2' 16' resonance and the singlet olefinic proton resonance 
at 8 7.45 (IH). Due to this peak showing correlations in both the COSY and NOESY 
spectra to 2H-9, this peak was assigned to H-2. 
According to Kirkiacharian et al. 22, the chemical shift for the C-2 methine carbon 
resonance in 3-benzy1chromones should occur at approximately 8 152.5. Thus, the 
presence of the 2,3-double bond was confirmed by the resonance at 8 153.3 ascribed 
to C-2. Further confirmation was given by the fully substituted carbon resonance at 
8 123.2, which was assigned to C-3 as it showed HMBC correlations to H-2 and 2H-
9. The presence of the endo double bond shifts the C-3 absorption upfield by 6.4 ppm 
compared with their exo isomers, the 3-benzylidene-4-chromanones. 3-Benzylidene-
4-chromanones can isomerise to 3-benzy1chromones by migration of the exocyclic 
double bond into the pyrone ring. This chemical transformation requires drastic 
conditions and is irreversible22 . 
From the IH NMR spectrum, it is evident that the A ring is protonated at the standard 
C-6 (8 98.0) and C-8 (8 92.3) positions, by the presence of two doublet proton 
resonances, each integrating to one proton, at 8 6.32 (H-6, J = 2.2 Hz) and 8 6.31 
(H-8, J = 2.2 Hz). The H-6 and H-8 proton superimposed resonances showed a 
correlation in the NOESY spectrum to the methoxy group proton resonance at 83.82 
(3H, s) indicating that a methoxy group is positioned at C-7 (8 165.4, C). This was 
confirmed in the UV absorption spectrum where no bathochromic shift was observed 
with NaOAc, further proving that a methoxy group occurred at C-7. This observation 
was also corroborated by the appearance of resonances due to H-6 and H-8 downfield 
of 6.0 ppm
20
. The presence of a hydroxy group at C-5 (8 162.2, C) was indicated by 
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the singlet hydroxy group proton resonance at 8 12.66 (1H). Further evidence 
supporting the presence of a hydroxy group at C-5 was revealed by a positive 
bathochromic shift (+21 nm) in the UV spectrum with AICh. 
From the NMR data, this compound was identified as the novel 3-benzy1chromone, 
5-hydroxy-3-(4-hydroxybenzyl)-7-methoxychromone. The HMBC and NOESY 
correlations are shown in figures 2.25 and figure 2.26, while all the NMR data and 
correlations for compound VII are listed in table 2.8. 
H 
Figure 2.25. The HMBC (C -7 H) correlations for compound VII. 
Figure 2.26. The NOESY correlations for compound VII. 
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Table 2.8. NMR data and correlations for compound VII (CDCh) 
Carbon lHNMRdata 13C NMR data COSY 
HMBC NOESY ' 
correlations 
Number (400 MHz) (100 MHz) correlations C7H 
correlations 
2 7.4S (lH, s) lS3.3 (CH) 2H-9 2H-9 
2H-9, 
H-2'/6'(w) 
3 - 123.2 (C) - H-2,2H-9 -
4 - 181.6 (C) - H-2, 2H-9 -
4a 106.0 (C) 
H-6, H-8, - - OH at C-S -
S - 162.2 (C) - H-6, OH at C-S -
6 
6.32 (lH, d, 
98.0 (CH) - H-8, OH at C-S OCH3 at C-7 1=2.2 Hz) 
7 - 16S.4 (C) - H-6, H-8, OCH, at C-7 -
S 
6.31 (lH, d, 
92.3 (CH) H-6 OCH3 at C-7 1=2.2 Hz) -
Sa - lS8.1 (C) - H-8 -
9 3.67 (2H, s) 29.7 (CH2) H-2 H-2, H-2'/6' H-2, H-2'/6' 
l' - 130.4 (C) - H-2'/6', 
H-3'/5' 
-
2' 7.12 (lH, d, 130.1 (CH) H-3'/S ' 2H-9, H-2'/6' 2H-9, H-3'/5' 1=8.3 Hz) 
3' 6.77 (lH, d, 11S.S (CH) H-2'/6' H-3'/S' H-2'/6' 1=8.3 Hz) 
4' - lS4.3 (C) - H-2'/6', 
H-3'/S' -
S' 
6.77 (lH, d, 
11S.S (CH) H-2'/6 ' H-3'/S' H-2'/6 ' 1=8.3 Hz) 
6' 7.12 (lH, d, 130.1 (CH) H-3'/S' 2H-9, H-2'/6' 2H-9, H-3'/5' 1=8.3 Hz) 
OCH] at C-7 3.82 (3H, s) SS.8 (CH3) - - H-6, H-8 
OH at CoS 12.66 (lH, s) - - - -
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2.4.2 Experimental 
Lachenalia rubida bulbs (1666 g) were collected from Bloubergstrand by Graham 
Duncan. A voucher specimen is held in the Compton Herbarium and the voucher 
specimen number is G.D. Duncan 442. The dried bulbs were chopped and extracted 
with dichloromethane and methanol at room temperature for 48 hours using 
continuous agitation. The extracts were evaporated down using a rotor evaporator, 
which afforded the dichloromethane (4.92 g) and methanol (39.55 g) extracts. 
Isolation of compounds VI and VII 
The dichloromethane extract was chromatographed using silica gel (Merck 9385) as 
the stationary phase in a column of 3 cm in diameter. 
The mobile phase used for the dichloromethane extract was a hexane : 
dichloromethane : methanol step gradient [20% dichloromethane in hexane (fractions 
1-15), 40% dichloromethane in hexane (fractions 16-30), 80% dichloromethane in 
hexane (fractions 31-65), 100% dichloromethane (fractions 66-80), 1% methanol in 
dichloromethane (fractions 81-99), 5% methanol in dichloromethane (fractions 100-
110), 10% methanol in dichloromethane (fractions 111-119), 100% methanol 
(fractions 120-130)]. Fraction sizes of 40 cm3 were collected in each step. 
Both compounds VI and VII eluted from the column using 1 % methanol in 99% 
dichloromethane and were purified firstly on a 1 cm in diameter column and then on a 
Pasteur pipette column using a 100% dichloromethane solvent system. The 
compounds were distinguished from one another by the colour of the spot on the thin 
layer chromatographic plate when sprayed with anisaldehyde spray reagent. 
Compound VI exhibited a red spot, while compound VII was seen as an orange spot. 
The methanol extract was separated using column chromatography, however only 
sugar was isolated from this column. 
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2.4.2.1 Physical data for Compound VI 
Name: (-)-5-hydroxy-3-( 4-hydroxybenzyl)-7 -methoxy-4-ehromanone 
Physical appearance: amorphous 
Yield: 12.3 mg 
Mass: LRMS [M+] at mlz 300, C17HI605 requires 300 
EIMS:mlz: 300, 194, 193, 167, 107,28 
Infra-red: v ~~;l em-I: 3407,2918,2849, 1640, 1513, 1443, 1374, 1156 
Ultra violet: A~e::H nm (log E): 290 (4.04) 
With NaOAe : 290 
With AICh : 310 
Optical Rotation: [a]D = -7.1° (e = 0.028 g/100 em3; CHCh), 
IH and 13e NMR Data: Refer to table 2.7 (page 96) 
2.4.2.2 Physical data for Compound VII 
Name: 5-hydroxy-3-( 4-hydroxybenzyl)-7 -methoxy-ehromone 
Physical appearance: amorphous 
Yield: 7.1 mg 
Mass: LRMS [M+] at mlz 298, C17HI40 5 requires 298 
EIMS:mlz:298, 167, 107,77,28 
Infra-red: v ~~l em-I: 3396,2914,2845, 1651, 1512, 1442, 1303, 1164 
Ultra violet: A ~e::H nm (log E): 290 (3.52) 
With NaOAe: 290 
With AICh : 311 
IH and 13e NMR Data: Refer to table 2.8 (page 100) 
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2.5 Extractives from Drimia capitata 
Plants of the genus Drimia, (subfamily: Urgineoideae, family: Hyacinthaceae), are 
perennial, deciduous bulbous herbs, varying in size and sometimes forming clumps. 
The bulbs are oval in shape with loose scales that are reddish in colour4. There are 
approximately thirteen species in southern Africa, which enjoy a varied habitat, but 
they are most frequently found in open grasslands, amongst rocks or occasionally in 
marshy ground. Plants of the genus Drimia are used in traditional medicine and as 
protective charm mixtures. Drimia capitata has not previously been investigated 
chemically and no uses of this plant are reported in literature. 
Figure 2.27. Photograph of Drimia capitata (photographed by Dr. Neil Crouch). 
2.5.2 Results and Discussion 
The methanol extract of Drimia capitata (Jacq.) yielded a bufadienolide (compound 
VIU) and the glycoside of compound VITI (compound IX). Unfortunately no 












Figure 2.28. The structures of compounds VIII and IX. 
compound IX 
2.5.1.1 Structural Elucidation of Compound VIII 
5~-3~,16~-dihydroxybufa-20,22-dienolide 
(Spectra 8a-g, pages 287-293) 
o 
The first compound isolated from Drimia capitata was found to be a bufadienolide, 




Figure 2.29. The structure of compound VIII. 
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Compound VIII belongs to the class of compounds known as the bufadienolides. 
These compounds are often isolated with a sugar attached at C-3, however, this 
compound was isolated as the aglycone. 
The mass spectrum showed a parent ion peak at mlz 386, which was consistent with 
the molecular formula of C24H3404 (C24H3404 requires 386). A double bond 
equivalence of eight was deduced. 
The presence of the characteristic lactone ring of the bufadienolide was indicated in 
the IH NMR spectrum by three double doublet proton resonances at 8 7.59 (IH, 
J = 1.0, 2.5 Hz), 87.77 (IH, J = 2.6, 9.7 Hz) and 8 6.25 (IH, J = 1.0, 9.7 Hz), which 
are assigned to H-21, H-22 and H-23 respectively. The corresponding methine carbon 
resonances were observed in the I3C NMR spectrum at 8 152.3, 8 151.2 and 8 114.4, 
using the HSQC spectrum. The H-2l and H-23 proton resonances were seen to be 
coupled in the COSY spectrum with H-22. The fully substituted carbon resonance 
ascribed to C-24 was observed at 8 164.8 and showed correlations in the HMBC 
spectrum to H-2l, H-22 and H-23. 
In the HMBC spectrum the C-20 fully substituted carbon resonance at 8 118.8 showed 
correlations to H-17 (8 2.16, lH, d, J = 7.5 Hz), H-2l and H-23. The H-17 proton 
resonance was seen to be coupled in the COSY spectrum to H-16 (84.39, lH, m). The 
methine carbon resonance, due to C-17, was observed at 8 58.2 and showed 
correlations in the HMBC spectrum to H-15a (2.32, lH, m) and the three-proton 
singlet at 8 0.85 ascribed to 3H-18. The 3H-18 proton resonance, which, for 
biosynthetic reasons, is known to be in the ~ orientation, showed no correlation in the 
NOESY spectrum to H-17 thus confirming that H-17 is in the a orientation. The H-17 
proton resonance, however, showed correlations in the NOESY spectrum to H-16, 
H-21, H-22 and H-14 (8 1.05) indicating that the lactone ring and H-16 are also a in 
orientation. 
The IH NMR spectrum showed the presence of a second three-proton singlet signal at 
8 0.99, integrating to three protons, and this was assigned to 3H-19. This proton 
resonance was seen to be correlated in the NOESY spectrum to H-5 (8 1.76, lH, m), 
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H-S (8 1.47, 1H, m) and 2H-1 (8 1.27 and 8 1.44). Furthermore, as the 3H-19 proton 
resonance is in the ~ orientation this indicates that H-5 and H-S are also of the ~ 
orientation. The H-5 proton resonance was seen to be coupled in the COSY spectrum 
to 2H-4 (82.00 and 8 1.30), while H-9 (8 1.57, 1H, m) was seen to be coupled to H-S 
(8 1.47, 1H, m) and H-11a (8 1.43). The H-9 proton is in the a orientation on 
biosynthetic grounds, and, this was confirmed by the absence of correlations in the 
NOESY spectrum to 3H-1S, H-5 and H-S. The IH NMR spectrum showed a one-
proton multiplet resonance at 8 4.03, which was assigned to H-3 as it was seen to be 
coupled in the COSY spectrum to 2H-4. The H-3 proton resonance was assigned the 
usual a configuration as it showed no correlation in the NOESY spectrum to H-5~, 
however the NOESY spectrum did show correlations to the resonances at 8 1.45, 
82.00 and 8 1.96, assigned to H-2a, H-4a and H-6a respectively. The C-5 (8 37.9), 
C-S (8 41.4), C-9 (8 36.S) and C-1O (8 36.4) carbon resonances showed HMBC 
correlations to 3H-19. 
The presence of the hydroxy group at C-16 was indicated in the l3C NMR spectrum 
by a methine carbon resonance at 8 73.9 in the oxygenated carbon region of the 
spectrum. In the HMBC spectrum this C-16 methine carbon resonance showed 
correlations to H-17 and 2H-15 (8 1.29 and 8 2.32), while the C-13 methine carbon 
resonance at 8 45.0 showed a correlation to H-16, thus confirming that the hydroxy 
group was situated at C-16. In the COSY spectrum, the H-16 proton resonance was 
seen to be coupled to the 2H-15 proton resonances. 
This compound was identified as the novel bufadienolide, 5~-3~,16~-dihydroxybufa-
20,22-dienolide. The HMBC and NOESY correlations are shown in figures 2.30 and 
2.31 while all the NMR data and correlations are shown in table 2.9. 
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o 
4 H 6 
Figure 2.30. The HMBC (C -7 H) correlations for compound VIII. 
o 
Figure 2.31. The NOESY correlations for compound VIII. 
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Table 2.9. NMR data and correlations for compound VIII (CD30D) 
Carbon IHNMRdata 13C NMRdata COSY 
HMBC NOESY 
correlations 
Number (400 MHz) (100 MHz) correlations C7H 
correlations 
l a 1.27 (lH, m) H-1~, 2H-2 
H-1~, H-2a, 
31.0 (CH2) 3H-19 3H-19 
1~ 1.44 (lH, m) H-la H-la,3H-19 
2a l.4S (lH, m) 28.S (CH2) 
H-la, H-2~ H-1a, H-2~, H-3 
2(3 
-
1.S4 (lH, m) H-2a H-2a 




4a 2.00 (lH, m) 34.3 (CH2) 
H-3, H-4~, H-5 H-3 
4(3 
-
1.30 (lH, m) H-3, H-4a, H-S 3H-19 
5 1.76 (lH, m) 37.9 (CH) 2H-4 3H-19 H-8,3H-19 
6a 1.96 (lH, m) 27.6 (CH2) 
H-S, H-6~ H-3, H-6~, H-7 
6(3 H-6a,2H-7 
-
1.20 (lH, m) H-6a 
7 1.16 (lH, m) 27.8 (CH2) 2H-6, H-8 - H-8 
8 1.47 OH, m) 41.4 (CH) H-9, H-14, 2H-7 3H-19(w) H-S , H-19 
9 1.57 (lH, m) 36.8 (CH) H-8, H-lla 3H-19 -
10 - 36.4 (C) - 3H-19 -
11a 1.43 (lH, m) 21 .5 (CH2) 
H-9, H-11~ H-12a 
11~ 1.26 (lH, m) H-lla 
-
3H-18,3H-19 





12(3 1.50 (lH, m) H-12a H-1S~, 3H-18 
13 - 45.0 (C) H-8, H-1Sa, - -
H-16, H-17 
14 LOS (lH, m) S4.3 (CH) H-8,2H-15 H-15~, 3H-18 H-17 
15a 2.32 (lH, m) 
H-14, H-15~, 
H-1S~, H-16 
H-16 37.8 (CH2) H-14, H-1Sa, 
H-17 
15~ 1.29 (lH, m) 
H-16 H-12~, H-15a 
16 4.39 (1H, m) 73.9 (CH) 2H-15, H-17 H-1S~, H-17 H-15a, H-17 
2.16 (lH, d, H-12a, H-14, 
17 
1=7.5 Hz) 
58.2 (CH) H-16 H-1Sa,3H-18 H-16, H-21, 
H-22 
18 0.8S (3H, s) lS.2 (CH3) - H-14, H-17 H-12~, H-21, 
H-22 
19 0.99 (3H, s) 24.4 (CH3) - - 2H-1, 2H-4, H-S, H-8 
20 - 118.8 (C) - H-17, H-21, 
H-23 -
21 7.59 (lH, dd, 152.3 (CH) H-22 H-17, H-22 1=1.0, 2.5 Hz H-17,3H-18 
22 7.77 (lH, dd, 151.2 (CH) H-21, H-23 H-17, H-21 H-17,3H-18, 1=2.6,9.7 Hz) H-23 
23 6.25 (lH, dd, 114.4 (CH) H-22 1=1.0, 9.7 Hz) - H-22 
24 - 164.8 (C) - H-21, H-22, 
H-23 -
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2.5.1.2 Structural Elucidation of Compound IX 
5~-16~-hydroxybufa-20,22-dienolide 3~-O-~-D-galactoside 
(Spectra 9a-i, pages 294-302) 
The second compound isolated from Drimia capitata was identified as the novel 
bufadienolide glycoside, 5 ~-16~-hydroxybufa-20,22-dienolide 3 ~-O-~-D-galactoside. 
o 
4 H 6 
OH 
5~ -163 -hydroxybufa-20,22-dienolide 3 ~O-~ -D-galactoside 
Figure 2.32. The structure of compound IX. 
The mass spectrum of compound IX indicated a molar mass of 548 using Fast Atom 
Bombardment (FAB) mass spectrometry, which corresponded to a molecular formula 
of C30H440 9 (C30H4409 requires 548). A double bond equivalence of nine was 
deduced. 
The infra-red spectrum showed bands at 3395 cm-1 (O-H stretching), 2928 cm-1 (C-H 
stretching), 1702 cm-1 (C=O stretching), 1454 cm-1 (CH2/CH3 bending) and 1028 cm-1 
(C-O stretching). 
By comparison of the NMR data for compound IX with that of compound VIII, it was 
determined that the aglycone group of compound IX was identical to that of 
compound VIII. The presence of the sugar group was observed in the IH NMR 
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spectrum by the doublet one-proton resonance at 8 4.31(J = 7.9 Hz), assigned to the 
anomeric proton of the sugar, H-l'. This proton resonance showed coupling in the 
NOESY spectrum to H-3 (84.06, IH, m), thus confirming the sugar attachment at C-3 
(8 7S.S). In the COSY spectrum, the H-l' proton resonance was seen to be coupled to 
a one-proton multiplet resonance at 8 3.18 which was ascribed to H-2'. The 
corresponding C-l' methine carbon resonance, was observed in the l3C NMR 
spectrum at 8 102.6 and showed a correlation in the HMBC spectrum to H-2'. The 
COSY spectrum showed coupling between the H-2' proton resonance and H-l' and a 
one-proton multiplet resonance at 8 3.32, due to H-3'. In the HMBC spectrum, C-3' 
(8 78.2) showed a correlation with H-2'. In the COSY spectrum the H-3' proton 
resonance was seen to be coupled to H-2' and a one-proton multiplet resonance at 
8 3.26, assigned to H-4', which was, in turn, coupled to a one-proton multiplet 
resonance at 8 3.22, ascribed to H-S'. In the COSY spectrum, the H-3' proton 
resonance showed a correlation to H-4', which in turn showed a correlation to H-S'. 
In the HMBC spectrum the C-4' methine carbon resonance at 8 71.6, showed a 
correlation to H-3' and a two-proton multiplet resonance at 8 3.64 and 8 3.82. These 
proton resonances were assigned to H-6'A and H-6'B respectively and both the COSY 
and NOESY spectra showed correlations between the two H-6 resonances and H-5'. 
The methylene carbon resonance, C-6', was observed at 8 62.7 in the l3C NMR 
spectrum. 
In order to ascertain what the sugar group was, this compound was subjected to 
enzyme hydrolysis using 13-glucosidase at 37°C for one week. The resultant mixture 
was sent to Forestry and Forest Products, which has a high throughput sugar Gas 
Chromatography analysis system, run by Professor Andrew Spark, who identified the 
sugar as galactose by comparing it to a range of standards. The instrument used was a 
Perkin Elmer HPLC with Dionex Anion exchange column run with pure water. A post 
column pH adjustment to pH 14 (3S0mM NaOH) was performed and pulsed 
amperometric detection was used. 
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Compound IX was identified as the novel bufadienolide glycoside, 5~-16~­
hydroxybufa-20,22-dienolide 3~-O-~-D-galactoside. The NMR data and correlations 
for compound IX are shown in table 2.10. 




Number (400 MHz) 




1 l.4S (2H, m) 31.S (CH2) H-2 3H-19 H-2 
2 1.6S (2H, m) 27.7 (CH2) H-l, H-3 - H-1 
3 4.06 (lH, m) 7S .S (CH) H-2,2H-4 2H-ll, H-l' H-4a, H-6a, H-1' 
4a 1.S6 (lH, m) 31.0 (CH2) 
H-3, H-4~, H-S H-3, H-4a 
4P 1.S4 (lH, m) H-3, H-4a, H-S 
-
H-4~ 






6[3 l.4S (lH, m) H-6a H-6a 




7p 1.92 (lH, m) H-7a H-7a,3H-19 
8 1.46 (lH, m) 41.6 (CH) H-7a, H-9, H-14 3H-19 H-S, 3H-1S, 3H-19 
9 1.56 (lH, m) 36.S (CH) 
H-7a, H-S, H-lla, 
H-7a, H-12a, 3H-19 
H-12a,3H-19 
-
10 - 36.1 (C) - 3H-19, H-S, H-4~ -
11a 1.46 (lH, m) 
21 (CH2) 
H-9,2H-12 H-ll~, H-12a 
11[3 1.26 (lH, m) 2H-12 
-
H-lla,3H-19 
12a 1.12 (lH, m) 
39.3 (CH2) 
2H-ll, H-12~ H-lla 
12[3 1.S0 (lH, m) 2H-ll, H-12a 
H-17,3H-lS 
3H-lS,3H-19 
13 - 4S.0 (C) - 3H-1S, H-17, H-1Sx, 
H-16, H-S(w) 
-
14 1.06 (lH, m) S4.3 (CH) H-S,2H-1S 2H-lS, H-17, 3H-IS H-1Sa, H-17 
15a 2.33 (lH, m) 
37.S (CH2) 
H-14, H-1S~ H-14, H-1S~, H-16 
15[3 1.30 (lH, m) H-14, H-15a 
-
H-15a,3H-IS 
16 4.37 (lH, m) 73.9 (CH) H-17,2H-IS 2H-1S, H-17 H-1Sa, H-17 
17 
2.16 (lH, d, 1= 7.5 
SS.2 (CH) H-16 H-15a, H-21 H-14, H-16, H-21, Hz) H-22 
18 O.SS (3H, s) IS.2 (CH3) - H-17 
H-S, H-12~, H-lS~, 
H-21, H-22 
19 0.9S (3H, s) 24.2 (CH3) - -
H-4~, H-S, H-7~, 
H-llS, H-12S 
20 - l1S.S (C) - H-17, H-21, H-23 -
21 
7.59 (lH, dd, 
152.2 (CH) 1=2.S, 1.0 Hz) H-22 H-17, H-22 H-17, H-1S 
22 
7.77 (lH, dd, 
151.2 (CH) 1=2.5,9.7 Hz) H-21, H-23 H-17, H-21 H-17, H-1S, H-23 
23 6.25 (lH, dd, 114.4 (CH) H-22 1=1.0,9.7 Hz) - H-22 
24 - 164 (C) - H-21, H-22, H-23 -
l' 4.3 1 (lH, d, 102.6 (CH) H-2' H-3, H-2', H-3', H-4', 1=7.9Hz) H-2' H-S' 
2' 3.1S (lH, m) 7S.1 (CH) H-1', H-3' H-1' H-l' 
3' 3.32 (lH, m) 7S.2 (CH) H-2', H-4' H-2' H-l ', H-4' 
4' 3.26 (lH, m) 71.6 (CH) H-3', H-S' H-3',2H-6' H-l', H-3' 
5' 3.22 (lH, m) 77.S (CH) H-4',2H-6' H-l', H-4', H-6'A H-1',2H-6' 
6'A 3.64 (lH, m) H-S', H-6'B H-5', H-6'B 
6'B 3.S2 (lH, m) 
62.7 (CH2) -H-5', H-6'A H-S ', H-6'A 
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2.5.2 Experimental 
Drimia capitata bulbs were collected from Stutterheim by R. McMaster and a voucher 
specimen (SN) was retained at the Natal Herbarium. The dried plant material (873 g) 
was chopped and extracted with dichloromethane and methanol at room temperature 
for 48 hours using continuous agitation. The excess solvents were removed using a 
rotor evaporator and yielded the dichloromethane (6.47 g) and methanol (61.31 g) 
extracts. 
Isolation of compounds VIII and IX 
The dichloromethane and methanol extracts were separated using column 
chromatography (3 cm in diameter) and silica gel (Merck 9385) as the stationary 
phase. 
The mobile phase used for the dichloromethane extract was a dichloromethane : 
methanol step gradient [100% dichloromethane (fractions 1-10), 1 % methanol in 
dichloromethane (fractions 11-20), 2% methanol in dichloromethane (fractions 21-
30), 5% methanol in dichloromethane (fractions 31-40) 10% methanol in 
dichloromethane (fractions 41-50)]. Fraction sizes of 100 cm3 were collected in each 
step. Elution with 5% methanol in dichloromethane afforded compound VIII, which 
was purified on a pasteur pipette column using the same solvent system. 
The methanol extract was separated using a dichloromethane : methanol step gradient 
[100% dichloromethane (fractions 1-30), 1 % methanol in dichloromethane (fractions 
31-50), 2% methanol in dichloromethane (fractions (51-90), 3% methanol in 
dichloromethane (fractions 91-106), 5% methanol in dichloromethane (fractions 107-
130), 7% methanol in dichloromethane (fractions 131-200), 10% methanol in 
dichloromethane (fractions 201-220), 20% methanol in dichloromethane (fractions 
221-249), 100% methanol (fractions 250-260)] as the mobile phase. In each step, 100 
cm-3 fractions were collected. Compound IX eluted from the column using a 5% 
methanol in dichloromethane solvent system and was purified on a column (2 cm in 
diameter) using 1 % methanol in dichloromethane as the mobile phase. 
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2.5.2.1 Physical Data for Compound VIII 
Name: 5 ~-3~, 16~-dihydroxybufa-20,22-dienolide 
Physical appearance: white amorphous 
Yield: 12.2 mg 
Mass: [M+] at mlz 386, C24H3404 requires 386 
Optical Rotation: [a]D = +16.7° (c = 0.006 g/100 cm3; MeOH), 
IH and 13e NMR Data: Refer to table 2.9 (page 108) 
2.5.2.2 Physical Data for Compound IX 
Name: 5~-16~-hydroxybufa-20,22-dienolide 3~-O-~-D-galactoside 
Physical appearance: cream powdered substance 
Yield: 55.5 mg 
Mass: [M+] at mlz 548 FAB, C30H440 9 requires 548 
Infra-red: v ~:;I cm-1 : 3395,2928, 1702, 1454, 1028 
Optical Rotation: [a]D = +66.4° (C = 0.226 g/100 cm3; CHCl)) 
IH and 13e NMR Data: Refer to table 2.10 (page 111) 
113 
2.6 References 
1) Speta, F., 1998. In: Kubitzki, K. (Ed.). The families and genera of vascular 
plants III. Flowering plants. Monocotyledons. Liliaceae (except Orchidaceae), 
Springer, Berlin, 261-285. 
2) Meyer, N.L. and Williams, R, 1997. In: Meyer, N.L., Mossmer, M., Smith, G.P. 
(Eds.). Taxonomic literature of southern African plants, National Botanical 
Institute, Pretoria, 128-130. 
3) http://tolweb.org/tree?group=Hyacinthaceae&contgroup=Asperagales 
4) Leistner, O.A, 2000. Seed plants of southern Africa: families and genera, 
Strelitzia 10, National Botanical Institute, Pretoria, 610. 
5) Hutchings, A, 1996. Zulu medicinal plants, An inventory. University of Natal 
Press, Pietermaritzburg, 38-44. 
6) Jessop, J.P., 1970. Journal of South African Botany 36, 233. 
7) Neuwinger, H.D., 2000. African traditional medicine: A dictionary of plant use 
and applications, Medpharm GmbH Scientific Publishers, Germany, 301. 
8) Hutchings, A and Terblanche, S.E., 1989. Observations on the use of some 
known and suspected toxic Liliiflorae in Zulu and Xhosa medicine, South 
African Medical Journal 75, 62-69. 
9) Watt, J.M. and Breyer-Brandwijk, M.G., 1962. The medicinal and poisonous 
plants of southern and eastern Africa. 2nd Edition. E. & S. Livingston Ltd., 
Edinburgh,715. 
10) Pohl, T., Koorbanally, c., Crouch, N.R and Mulholland, D.A, 2001. Secondary 
metabolites of Scilla plumbea, Ledebouria cooperi and Ledebouria ovatifolia 
(Hyacinthaceae). Biochemical Systematics and Ecology 29,857-860. 
11) Pohl, T.S., 2002. PhD Thesis, University of Natal, Durban, South Africa, 147-
152. 
12) Ziegler, Rand Tamm, C., 1976. Isolation and structure of eucosterol and 16~­
hydroxy-eucosterol, two novel spirocyclic nortriterpenes and of a new 24-nor-
5a-chola-8,16-diene-23-oic acid from bulbs of several Eucomis species. 
Helvetica Chimica Acta 59, 1997-2011. 
13) Parrilli, M., Lanzetta, R, Adinolfi, M. and Mangoni, L., 1980. Glycosides from 
Muscari comosum. Tetrahedron 36, 3591-3596. 
114 
14) Pillay, B., 2003. MSc Thesis, University of Natal, Durban, South Africa, 56-122. 
15) Moodley, N., 2002. MSc Thesis, University of Natal, Durban, South Africa, 
62-65 . 
16) Adinolfi, M. , Barone, G. , Belardini, M. , Lanzetta, R , Laonigro, G. and Parrilli, 
M., 1985. Homoisoflavanones from Muscari comosum bulbs. Phytochemistry 
24, 2423-2426. 
17) Bellamy, LJ., 1954. The infra-red spectra of complex molecules. Methuen and 
Co. Ltd, London, 133-145. 
18) Pohl, T.S., Crouch, N.R and Mulholland, D.A., 2000. Southern African 
Hyacinthaceae: Chemistry, bioactivity and ethnobotany. Current Organic 
Chemistry 4, 1287-1324. 
19) Heller, W. and Tamm, c., 1981. Homoisoflavanones and biologically related 
compounds, Fortschritte der Chemie Organischer Naturstoffe 40, 105-152. 
20) Adinolfi, M., Lanzetta, M., Laonigro, G. and Parrilli, M. , 1986. IH and BC 
Chemical shift assignments of homoisoflavanones. Magnetic resonance in 
chemistry 24, 663-666. 
21) Adinolfi, M., Barone, G., Belardini, M., Lanzetta, R, Laonigro, G. and Parrilli, 
M. , 1984. 3-Benzyl-4-chromanones from Muscari comosum. Phytochemistry 23, 
2091-2093. 
22) Kirkiacharian, B.S., Gomis, M. , Tongo, H.G., Mahuteau, J. and Brion, J.D., 
1984. The J3C NMR spectra of homoisoflavonoids. Organic Magnetic 
Resonance 22,106-108. 
23) Bohler, D. and Tamm, c., 1967. The Homo-isoflavanones, a new class of 
natural product. Isolation and structure of eucomin and eucomol. Tetrahedron 
Letters 36, 3479-3483. 
24) Zhu, Y., Yan, K. and Tu, G., 1987. Two homoisoflavanones from Ophiopogon 
japonicus. Phytochemistry 26, 2873-2874. 
25) Gonzalez, G., Leon, F., Sanchez-Pinto, L., Padron, J.1. and Bermejo, J. 2000. 
Phenolic compounds of Dragon ' s Blood from Dracaena draco. Journal of 
Natural Products 63, 1297-1299. 
26) Krenn, L. and Kopp, B., 1998. Bufadienolides from animal and plant sources. 
Phytochemistry 48, 1-29. 
115 
CHAPTER 3 
Extractives from the Papaveraceae 
3.1 Introduction to the Papaveraceae 
Plants belonging to the family Papaveraceae may be annual, biennial or perennial 
herbs having hairs or spines1. They usually contain white, yellow or orange sticky 
latex in all parts of the plant except the seeds. There are approximately twenty-three 
genera with about two hundred and forty species distributed mainly in the temperate 
regions of the northern hemisphere and extending into central and South America. In 
southern Africa there are four genera, three of which are exotic, and about eight 
species, only one of which, Papaver aculeatum, is indigenous1. Many species of 
Poppy (Papaver) are cultivated as ornamentals and a few species have become locally 
established. 
Plants belonging to the family Papaveraceae are a rich source of opium, which is used 
medicinally, and in the illegal production of heroin. The latex of some species is used 
in the treatment of warts, for eye disorders and as a dye source for colouring feathers2. 
3.2 Extractives from Papaver aculeatum 
Plants of the genus Papaver are annual, biennial or perennial herbs with the green 
parts having hairs or bristles, or spines in the case of P. aculeatum. 
Figure 3.1 . Photograph of Papaver aculeatum (photographed by Dr. Neil Crouch). 
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The sap of P. aculeatum is milky or coloured. There are approximately eighty species 
of Papaver widespread in the northern hemisphere. This project was initiated by 
Professor P. Tetenyi of the Institute of Research into Medicinal Plants in Budapest, 
Hungary who communicated that the South African species was considered primitive 
amongst the Papavers and could contain simple alkaloid precursors. 
3.2.1 Results and Discussion 
The methanol extract of the leaves of Papaver aculeatum Thunb. yielded an alkaloid, 
N-acetylanonaine (compound X). 
3.2.1.1 Structural Elucidation of Compound X 
(+ )-N-acetylanonaine 
(Spectra lOa-n, pages 303-316) 
The only compound to be isolated from Papaver aculeatum was identified as the 
alkaloid, (+ )-N-acetylanonaine. (-)-N-acetylanonaine has been previously isolated 








(+ )-N -acetylanonaine 
Figure 3.2. The structure of compound X. 
The proposed biosynthesis of compound X is shown in scheme 3.1. This involves the 
combination of two molecules of tyrosine, one forming dopamine and the other 
forming 4-hydroxyphenylacetaldehyde. These two molecules then undergo a 
117 
Mannich-type reaction to form the trihydroxy alkaloid norcoc1aurine, formed 
sterospecifically as the (S)-enantiomer5. The next step in the biosynthesis is the 
formation of a dienone, which forms via oxidative artha-para coupling to the phenol 
group. Mter reduction of the carbonyl group, a rearrangement occurs, restoring the 
aromatic ring and expelling the hydroxy group5. Many biosynthetic pathways of 
alkaloids feature this type of rearrangement, and it occurs because keto-enol 
tautomerism is not possible for rearomatisation when coupling involves positions 
already substituted5. The final step in the biosynthesis is the acetylation of anonaine to 
form (+ )-N-acetylanonaine. The formation of (-)-N-acetylanonaine occurs via the 
same biosynthetic route, however, the change in configuration from the (S)-
enantiomer to the (R)-enantiomer is achieved by an oxidation-reduction process and 
the formation of an intermediate, (R)-coc1aurine. 
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~
CO'H -CO,/ ~ I NH~ ~ I NH, I NH 
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HO ~ H" 0 CO H reaction 
.. _......... ' CHO - "'" 
L-tyrosme transamination ,:7' -r ~ ~ H # • ~ -00 I 
HoD HOA) (S)-norcoclaurine 
~ 
<71P' I NCOCH, <WP' I NH ~CH~O: I NH CH~~O: I . NH oXidativeCH~:g?0P' I NH 
't H ~ 'IH"- " H ~ IH ~upling 'I H 
-::p" acetylation -7" -?" I ':::::::: 
~ I ~ I W H # # H # 






H+ H .# 
(-)-anonaine 
(+ )-anonaine 





















The high resolution mass spectrum indicated a molar mass of 307.11974 g mor
I
, 
which corresponded to a molecular formula of CI9H17N03 (CI9H17N03 requires 
307.12084). A double bond equivalence of twelve was deduced. 
The infra-red spectrum showed a broad band at 3444 cm-I due to the O-H stretching 
vibrations and a peak at 2921 cm-I due to the asymmetric C-H stretching. The sharp 
peak at 1648 cm-I was due to the presence of a carbonyl group. The CH2 and CH3 
bending vibrations were observed at 1223 cm-I and 1055 cm-I. 
The IH NMR spectrum showed two non-equivalent proton resonances for the non-
equivalent protons of the methylene ' dioxy group at 8 6.08 and 8 5.97. A singlet 
proton resonance at 8 6.65 was assigned to H-3. The C-1 and C-2 fully substituted 
carbon resonances at 8 144.2 and 8 148.1 both showed coupling in the HMBC 
spectrum to the methylene dioxy group protons and H-3. The IH NMR spectrum 
showed a double doublet at 8 8.10 (J = 7.9 Hz), which was seen to be coupled in the 
COSY spectrum to three superimposed proton resonances between 8 7.23 and 8 7.35. 
The IH NMR spectrum indicated the presence of a three-proton acetate methyl group 
proton resonance at 8 2.22. The l3C NMR spectrum indicated a further methine 
carbon resonance at 8 52.2 (C-6a) and three methylene carbon resonances at 8 43.3 
(C-5), 8 34.5 (C-7) and 8 31.4 (C-4). The COSY spectrum showed coupling between 
protons of two of the methylene carbons, C-5 (H-5a and H-5B, 8 3.27 and 8 4.11) and 
C-4 (H-4, 8 2.81) and coupling between the methine proton (H-6a, 8 5.04, dd, J = 4.5 
Hz and 14.0 Hz) and the third methylene group protons (2H-7, 8 3.07 and 8 2.84). 
Use of 1-D NOE spectra and the NOESY spectrum enabled the assignment of the 
relative stereochemistry of the aliphatic protons. It was initially assumed that H-6a 
was B as in the 1iterature3, and the other protons were assigned relative to this. 
However, when the optical rotation was determined, it became clear that compound X 
was the en anti orner of the known compound and H-6 was actually a. The [a]o value 
obtained for compound X was + 410° while the [a]o value3 for (-)-N-acetylanonaine 




















Figure 3.3. The structures of (-)-N-acetylanonaine and (-)-N-acetylasimilobine3 
The H-6a proton showed a correlation in the NOESY spectrum to the one H-7 proton 
resonance at 8 3.07 indicating this proton to be H-7a and the other proton of the 
methylene group co-occurred with the 2H-4 resonance at 8 2.84 to be H-7~. 
Irradiation of H-3 showed positive correlations in the NOESY spectrum with both the 
superimposed H-4 protons, thus they were not distinguished as a or ~. 
Irradiation of the H-5 resonance at 8 4.11 showed no correlation in the NOESY 
spectrum with H-6a (which is a in orientation), indicating it must have the ~ 
stereochemistry. This resonance showed a correlation with H-5a (8 3.27), 2H-4 and 
the acetate methyl group proton resonance. Irradiation of H-ll only gave a NOE 
correlation with the superimposed aromatic proton resonances. 
There was great difficulty in obtaining literature NMR data for comparison purposes 
as Hufford et ai. 3 only gives selected IH NMR data and the literature reference4 only 
refers to the NMR data for the isolated (-)-N-acetylanonaine being compared to an 
authentic sample. 
Compound X was identified as the alkaloid, (+ )-N-acetylanonaine. The NMR data and 
correlations are shown in table 3.1. 
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Table 3.1. NMR data and correlations for compound X (CD30D) and literature 
data for (-)-N-acetylanonaine (CDCh)3 
13CNMR 
IH NMR literature 
IHNMR HMBC data for 
Carbon 
data 
data COSY correlations 
NOESY (-)-N-
Number (100 MHz) correlations C-7H 
correlations I .) 
(400 MHz) acety anoname 
1 - 144.2 (C)t - H-3,OCH2O - -
2 - 148.1 (C)t - H-3,OCH2O - -
3 6.6S (lH, s) 108.S (CH) - - 2H-4 6.87 (lH, s) 
3a - 128.1 (C) - - -
4 2.81 (2H, m) 31.4 (CH2) 2H-S H-3 
H-3, H-Sa, ± 
H-SI3 
Sa 3.27 (lH, m) 2H-4, H-SI3 
2H-4, H-SI3, 
43.3 (CH2) COCfu COCfu 
5[3 4.11 (lH, m) 2H-4, H-Sa 2H-4, H-Sa 
± 
S.04 (lH, dd, 
6a 1=4.S Hz and S2.2 (CH) H-7a, H-713 H-7a, H-713 H-7a, COCfu 
± 
14.0 Hz) 





7a 3.07 (lH, m) H-6a, H-713 
H-6a, H-713 
34.S (CH2) - COCH) 
7[3 2.84 (lH, m) H-6a, H-7a H-7a ± 
7a - 137.0 (Cl - H-7a, H-713, - -
H-11, X 
8 7.30 (lH, X) 128.8 (CH)T X * X 7.37 (lH, m) 
9 7.30 (lH, X) 128.9 (CH) X * X 7.37 (lH, m) 
10 7.30 (lH, X) 129.6 (CH)T X * X 7.37 (lH, m) 
11 
8.10 (lH, dd, 
128.4 (CH) X X 8.18 (1H, dd) 1=7.9 Hz) 
11a - 131.9 (C)* - H-713, X - -
12 - 127.9 (C) - H-11 - -
6.08 and S.97 
6.20 and 6.08 (lH, OCH2O (1H each, d, 102.3 (CH2) - - -
1=1.0 Hz) each, d, 1=1.8 Hz) 
COCH] - 169.1 (C) - COCl{l - -
COCH) 2.22 (3H, s) 22.3 (CH) - - H-Sa, H-7a 2.23 (3H, s) 
x = three superimposed aromatic resonances 
t.:!: values may be interchangeable, * cannot be assigned due to superimposed peaks 
± IH NMR data not available in literature3 
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3.2.2 Experimental 
Papaver aculeatum was collected from Hella Hella by Dr. Neil Crouch and a voucher 
specimen (N. Crouch 848) was retained at the Natal Herbarium. The dried plant 
material was divided up into seeds, capsules and leaves/stems, and each was extracted 
with methanol at room temperature for 48 hours using continuous agitation. The 
excess solvent was removed using a rotor evaporator, which afforded the seed 
methanol extract (5.01 g), the capsule methanol extract (11.33 g) and the leaves/stem 
methanol extract (188.52 g). The three extracts were run on a GC-Mass Spectrometer 
to ascertain the components of the extracts. From this data, the three extracts were 
considered to be similar and thus due to the greater quantity of the leaves/stem extract, 
this extract was subjected to column chromatography in order to separate the 
compounds. 
Isolation of compound X 
All compounds were separated on a crude column (3 cm in diameter) using silica gel 
(Merck 9385) as the stationary phase and a mobile phase of a dichloromethane : 
methanol gradient step [100% dichloromethane (fractions 1-30), 1% methanol in 
dichloromethane (fractions 31-50), 2% methanol in dichloromethane (fractions 51-
60), 5% methanol in dichloromethane (fractions 61-90), 10% methanol in 
dichloromethane (fractions 91-110),10 dichloromethane : 2 methanol (fractions 111-
130), 10 dichloromethane : 3 methanol (fractions 131-150) 100% methanol (fraction 
151-160)]. In each step a fraction size of 40 cm3 was collected. Compound X was 
eluted from the crude column using a 1 % methanol in dichloromethane solvent 
system and was purified on a column (1 cm in diameter) using the same solvent. 
Two other compounds were isolated from this extract, however they were isolated in 
such a small yield that there was too little material to purify further, hence they were 
not investigated further. 
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3.2.2.1 Physical Data for Compound X 
Name: (+ )-N-acetylanonaine 
Synonyms: 6-acetyl-l,2-methylenedioxynoraporphine 
Physical appearance: cream needles 
Yield: 14.4 mg 
Melting Point: 220-222°C, Literature = 229-230°C3 for (-)-N-acetylanonaine 
Mass: HRMS [M+] at mlz 307.11974, C19H17N03 requires 307.12084 
EIMS:mlz: 307,248,236,235,206, 178, 165, 149,72,57,43 
Infra-red: V NaCI cm-1 : 3444,2921,2383,2288,1648,1419,1223,1055,935 
max 
Optical Rotation: [a]D = + 410.7° (c = 0.028 g/100 cm3;MeOH), 
Literature [a] ~ = -356° (c = 0.49; CHCh)3 for (-)-N-acetylanonaine 
IH and 13e NMR Data: Refer to table 3.1 (page 121) 
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CHAPTER 4 
Extractives from the Asteraceae 
4.1 Introduction to the Asteraceae (Compositae) 
Plants belonging to the family Asteraceae may be annual, biennial or perennial herbs, 
shrubs or trees. These plants are rarely aquatic and are sometimes succulent, typically 
having resin ducts or latex canals1. There are approximately one thousand five 
hundred and thirty-five genera containing about twenty-five thousand species. These 
plants usually prefer a cosmopolitan habitat and are absent only from Antarctica
1
• In 
southern Africa alone, there are two hundred and forty-six genera and two thousand 
three hundred and five species. 
4.1.1 Introduction to Alkamides (Isobutylamides) 
The alkamides comprise a group of closely related fatty acid amides with 
characteristic olefinic and acetylenic patterns2• Purely olefinic derivatives occur in the 
Piperaceae, Aristolochiaceae and Rutaceae, while the Asteraceae tribes Heliantheae 
and Anthemideae additionally contain a great number of acetylenic amides2. Some 
olefinic isobutylamides have been found to possess insecticidal activit/ and to be 
effective as molluscicides and cercaricides (cercariae are the haploid forms of 
schistosomes which penetrate the skin of humans and cause disease) and thus are 
important for the use against bilharzia3. Alkamides have been reported to have a 
pungent taste and produce local anaesthesia of the mucous membranes accompanied 
by profuse salivation2• Thus plants that contain these compounds have been used 
medicinally since ancient times as sialogogues, antitussives and analgesics2• 
4.2 Extractives from Spilanthes mauritiana 
The genus Spilanthes belongs to the Heliantheae tribe and plants are annual herbs 
found mainly rooting near rocks in damp places. There are six species, with two 
species, including S. mauritiana (Pers.) DC., being indigenous to southern Africa1• 
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Figure 4.1. Photograph of Spilanthes mauritiana.(photographed by Dr. Neil Crouch). 
In South Africa, the African plant Spilanthes mauritiana, of the family Asteraceae, is 
used medicinally by the Zulus as an oral local analgesic for the relief oftoothache
4
. 
This is achieved by applying the moistened, powdered leaves to hollow teeth in order 
to relieve the pain4. Plants of this species are given the name isisinini by the Zulus, 
which is derived from the Zulu noun for gums (insini) . The first recorded use in 
southern Africa was by Woods in 1897, who, because of its peculiar pungent taste, 
noted its name as the 'electric' plant. 
The Xhosa use the flowers for treating toothache and pyorrhoea 4, while the Chagga 
use the roots for toothache and sore throats, and unspecified parts of the plants are 
used as fever, articular rheumatism and snakebite remedies6 . The Tsonga rub the 
leaves of this plant on mouth ulcers as an analgesic7. Other medicinal usage of S. 
mauritiana includes healing broken limbs, stomachache, diarrhoea, bladder 
complaints and headaches. The leaves stimulate the flow of saliva and numb the 
mouth. Antiscorbutic, diuretic and digestive stimulant properties have also been 
reported6 . 
Previous chemical investigations of Spilanthes mauritiana have yielded volatile oils, 
while an acid amide, spilanthol (affinin, N-isobutyl-deca-2,6,8-trienamide), a sterol 
and a nonreducing polysaccharide have been isolated from the flowers4. Spilanthol 
acts as a strong local analgesic and has a distinctive hay-like odour. It has also been 
attributed with larvicidal and other insecticidal properties. Whole plant extracts have 
been reported to have extensive activities, including antifungal, antibacterial, 
antiprotozoal, antiviral and anthelmintic effects8. 
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Jondiko et al. 9 isolated a potent mosquito larvicide, N-isobutyl-2E,4E,8E,lOZ-
dodeca-2,4,8,1O-tetraenamide from the methanol extract of the fresh aerial parts of 
Spilanthes mauritiana. This compound gave 100% mortality against 3
rd 
instar larvae 
of Aedes aegypti9 at 5-10 mg/cm3. This compound was not isolated in my chemical 
investigation of this plant, however, some related compounds were isolated. 
4.2.1 Results and Discussion 
This plant was initially the project of postdoctoral student Dr. J.J. Nair who 
investigated this plant in an attempt to isolate the compounds responsible for the 
numbing action of the plant. Dr. Nair isolated two compounds but he left the 
department before these compounds could be identified. I was given Dr Nair's work 
to complete and to determine the structures of the compounds that he had isolated. Dr 
Nair managed to run some 2-D spectra before leaving, however, even though his 
compounds were stored in a freezer, they still decomposed. These isobutylamide 
compounds are highly unstablelO and several efforts to re-isolate this type of 
compound proved unsuccessful as they rapidly decomposed. Thus, the spectral data 
used in elucidating the structures of these compounds were taken from Dr Nair who 
managed to run only incomplete sets of spectra for analysis. 
Two alkamides, one known, spilanthol (compound XI), previously isolated from the 
flowers of the plant, and one novel (compound XII) were isolated from the hexane 







~ 2' 9# 8 
~ ~ 2' 7 6 4 6 4 
4' 4' 
compound XI compound XII 
Figure 4.2. The structures of compounds XI and XII. 
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4.2.1.1 Structural Elucidation of Compound XI 
N-(2'-methylpropyl)-deca-2E,6Z,8E-trienamide (Spilanthol) 
(Spectra l1a-e, pages 317-321) 
The first compound isolated from this plant was a pale yellow viscous oil identified 
as the known isobutyl amide, N-(2'-methylpropyl)-deca-2E,6Z,8E-trienamide, 
commonly known as spilanthol. This compound has been isolated previously from 
the flowers of Spilanthes mauritiana6, and the roots of Heliopsis longipes3 and 
Spilanthes oleraceae11 • 
1 a 





N -(2' -methylpropyl)-deca-2E ,6Z,8E -trienamide 
Figure 4.3. The structure of compound XI. 
Due to these alkamides being so unstable, they decompose almost immediately after 
isolation. Thus only the i H, l3C, COSY and HETCOR spectra were available to 
elucidate this structure. 
The l3C NMR spectrum showed the presence of fourteen carbon resonances. The 
fully substituted carbon signal at 8 168.8 indicated the presence of a carbonyl group. 
The COSY spectrum showed coupling between the proton resonance due to H-2' 
(8 1.81, tqq, IH) and 2H-l' (83.09) as well as to the 3H-3' /3H-4' six-proton doublet 
resonance at 8 0.95. The COSY spectrum showed coupling between the proton peak 
at 85.95 (d, H-2) and H-3 (86.80, dt), which, in tum, was coupled to 2H-4 (8 2.32, 
m). The proton signal attributed to 2H-4 was seen to be coupled in the COSY 
spectrum to 2H-5 (8 2.32, m); 2H-5 was seen to be coupled to H-6 (8 5.28, dt). The 


















in turn, seen to be coupled to H-8 (8 6.32, brdd); H-8 was seen to be coupled to H-9 
(85.71, dq) and this proton resonance was coupled to 3H-1O (8 1.78, brd). 
The coupling constants could not be obtained from the IH NMR spectrum, as the line 
list for the spectrum had not been stored. Thus, in order to determine whether 
compound XI was the trans-cis-trans isomer or the all trans isomer, the spectrum was 
enlarged using a photocopier and the coupling constants calculated manually. A 
coupling constant of 11 Hz for J6,7 and approximately 16 Hz for h,3 and J8 ,9 indicated 
that this isolated compound is N-(2'-methylpropyl)-deca-2E,6Z,8E-trienamide. The 
IH NMR data for compound XI was compared to that of literature lO and the data 
correlated well. 
Compound XI was found to be the known alkamide identified as spilanthol. Table 4.1 
shows the NMR data for compound XI including the IH NMR literature data
10 
and 
l3C NMR literature data 11 for spilanthol. 
Table 4.1. NMR data and correlations for compound XI (CD30D) and literature 
data for spilanthollO,l1 (CDCl)) 
iHNMRdata 13C NMRdata COSY correlations IH NMR literature lYC NMR literature 
(300 MHz) (75 MHz) data for spilanthol
lO data for spilantholll 
(250 MHz) (15.1 Hz) 
- 168.8 (C) - - 166.3 
5.95 (lH, d) 125.2 (CH) H-3 5.83 (IH, dt, 124.5 
i-15Hz, l.5Hz) 
6.80 (IH, dt) 144.7 (CH) H-2,2H-4 6.82 OH, dt, 143.4 
i-15Hz, 6.5Hz) 
2.32 OH, m) 33.2 (CH2) H-3,2H-5 2.28 OH, m) 32.2 
2.32 OH, m) 27.5 (CH2) 2H-4, H-6 2.28 (lH, m) 26.5 
5.28 (lH, dt) 128.5 (CH) 2H-5, H-7 5.26 OH, dt, 127.8 
i-11Hz, 7Hz) 
5.98 (lH, dd) 130.7 (CH) H-6, H-8 5.97 (IH, dd, 129.6 
J-11Hz,l1Hz) 
6.32 (lH, brdd) 128.0 (CH) H-7, H-9 6.29 (lH, brdd, 126.9 
J 11Hz, 15Hz) 
5.71 (lH, dq) 130.6 (CH) H-8,3H-1O 5.70 (lH, dq, 130.0 
J-15Hz, 7Hz) 
1.78 (3H, brd) 18.3 (CH) H-9 1.78 (3H, brd, 18.3 
J 7Hz) 
3.09 (2H, dd) 48.0 (CH2) H-2' 3.14 (2H, dd, J=7Hz, 47.0 
6.5Hz) 
1.81 (lH, tqq) 29.7 (CH) 2H-l', 3H-3', 3H-4' 1.80 (lH, tqq, 28.7 
J 6.5Hz, 7Hz, 7Hz) 
0.95 (3H, d) 20.5 (CH) H-2' 0.93 (3H, d, J 7Hz) 20.2 
0.95 (3H, d) 20.5 (CH) H-2' 0.93 (3H, d, J 7Hz) 20.2 
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4.2.1.2 Structural Elucidation of Compound XII 
N-(2'-methylpropyl)-nona-2E,4E-dien-8-ynamide 
(Spectra 12a-e, pages 322-326) 
The second compound to be isolated from Spilanthes mauritiana was identified as the 
novel compound, N-(2 '-methylpropyl)-nona-2E,4E-dien-8-ynamide. 
o 
H 4' 
'Y3' N 2' H 
N -(2' -methylpropyl)-nona-2E,4E -dien-8-ynamide 
Figure 4.4. The structure of compound XII. 
The IH NMR spectrum showed the presence of a doublet resonance, integrating to 
two protons, at «5 3.10 (1 = 6.8 Hz), which was due to 2H-l '. This resonance was 
shifted downfield due to the deshielding effect of the nitrogen atom. This resonance 
was seen to be coupled in the COSY spectrum to the proton resonance at «5 1.87, 
which was assigned to H-2'. The H-2' proton resonance was, in tum, seen to be 
coupled in the COSY spectrum to two three-proton doublets superimposed at «5 0.96 
(1=6.8 Hz), which were ascribed to 3H-3' and 3H-4'. The corresponding carbon 
resonance were observed at «5 20.5 (C-3' and C-4). 
The doublet resonance at «56.02 (J = 15.1 Hz) was assigned to H-2 and was seen to be 
coupled in the COSY spectrum to a double doublet proton resonance at «5 7.15 (lH, 
J = 1O.7Hz and 15.1 Hz), which was due to H-3. The large coupling constant 
indicated the presence of a trans double bond between C-2 and C-3. The H-3 proton 
resonance was also seen to be coupled in the COSY spectrum to a proton resonance 
at «5 6.30 (H-4, dd, J = 10.7, 15.3 Hz), which, in tum, was seen to be coupled in the 
COSY spectrum to H-5 (86.16). The coupling constant of 15.3 Hz for H-4 indicated 
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a trans double bond between C-4 and C-S. The COSY spectrum showed coupling of 
the H-S proton with the two-proton resonance at 8 2.43, assigned to H-6. The H-7 
proton resonance was observed at 8 2.43 and was seen to be coupled in the COSY 
spectrum to H-6. 
In the \3C NMR spectrum, the fully substituted carbon resonance at 8 169.4 indicated 
the presence of a carbonyl group and hence was assigned to C-1. The downfield 
shifted carbon resonances at 8 124.2 (C-2), 8 141.S (C-3), 8 131.2 (C-4) and 8 140.6 
(C-S) indicated the presence of double bonds between C-2 and C-3 as well as 
between C-4 and C-S. The presence of the triple bond between C-S and C-9 was 
confirmed by the fully substituted carbon resonance at 8 77.S (C-S) and the methine 
carbon resonance at 8 66.S (C_9)12. The one-proton singlet resonance at 8 2.S1 in the 
IH NMR spectrum was assigned to H-9. 
This compound was found to be the novel alkamide, N-(2'-methylpropyl)-nona-
2E,4E-dien-S-ynamide. The NMR data for compound XII are shown in table 4.2. 
Table 4.2. NMR data and correlations for compound XII (CD30D) 
Carbon IH NMR data 13CNMRdata COSY 
Number (300 MHz) (75 MHz) correlations 
1 - 169.4 (C) -
2 6.02 OH, d, J-15.1 Hz) 124.2 (CH) H-3 
3 7.15 (lH, dd, J=10.7, 15.1 Hz) 141.5 (CH) H-2, H-4 
4 6.30 OH, dd, J=1O.7, 15.3 Hz) 131.2 (CH) H-3, H-5 
5 6.16(lH, m) 140.6 (CH) H-4, H-6 
6 2.43 (2H, m) 32.4 (CH2)+ H-5, H-7 
7 2.43 (2H, m) 19.3 (CH2) + H-6 
8 - 77.5 (C) -
9 2.51 OH, s) 66.8 (CH) -
l' 3.10 (2H, d, J .... 6.8 Hz) 48.1 (CH2) H-2' 
2' 1.87 (IH, m) 29.8 (CH) H-l', H-3', H-4' 
3' 0.96 (3H, d, J-6.8 Hz) 20.5 (CH3) H-2' 
4' 0.96 (3H, d, J .... 6.8 Hz) 20.5 (CH3) H-2' 
± Values are uncertain due to insufficient spectra 
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4.2.2 Experimental 
Cultivated material of Spilanthes mauritiana (611 g) was obtained from Silverglen 
Medicinal Plant Nursery for Dr. Nair by Dr. Neil Crouch and a voucher specimen 
(N. Crouch 788) was retained at the Natal Herbarium. The dried leaves were 
extracted using hexane for 48 hours at room temperature using continuous agitation. 
The hexane extract (5.10 g) resulted from the removal of excess solvent using a rotor 
evaporator. Column chromatography using silica gel (Merck 9385) was used to 
separate the compounds. Compound XI eluted from the column using a 20% ethyl 
acetate in 80% hexane solvent system, while compound XII eluted using 30% ethyl 
acetate in 70% hexane solvent system as the mobile phase. Dr. Nair who initially 
isolated these two isobuylamides recorded the data reported here. 
4.2.2.1 Physical Data for Compound XI 
Name: N-(2'-methylpropyl)-deca-2E,6Z,8E-trienamide 
Synonyms: spilanthol, affinin, N-isobutyl-deca-2E,6Z,8E-trienamide 
Physical appearance: pale yellow viscous oil 
Yield: 5 mg before decomposition 
Melting Point: No sample, Literature = 23°C13 
Mass: No sample 
Infra-red: No sample 
IH and 13e NMR Data: Refer to table 4.1 (page 128) 
4.2.2.2 Physical Data for Compound XII 
Name: N-(2'-methylpropyl)-nona-2E,4E-dien-8-ynamide 
Yield: 4 mg before decomposition 
Melting Point: No sample 
Mass: No sample 
Infra-red: No sample 
IH and 13e NMR Data: Refer to table 4.2 (page 130) 
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CHAPTERS 
Extractives from the Gentianaceae 
5.1 Introduction to the Gentianaceae 
Plants of the family Gehtianaceae may be annual, biennial or perennial herbs, which 
may be erect or straggling. The plants are rarely shrubs or trees
l
. There are 
approximately eighty-nine genera containing one thousand two hundred species. 
These plants are mostly found in temperate and subtropical regions. In southern 
Africa alone, nine genera and seventy species exist l . 
5.2 Extractives from Tachiadenus longijlorus 
The Madagascan plant, Tachiadenus longiflorus Griseb. belongs to the family 
Gentianaceae. This family is a diverse lineage of over one thousand five hundred 
angiosperm species, including many tropical and temperate trees, shrubs and herbs 
with a wide range of floral types and colours2• Plants belonging to the family 
Gentianaceae have many economical uses such as providing dyes and flavourings. 
Many species accumulate bitter iridoid substances, which are used medicinally. The 
plants are often used as cultivated ornaments3• A basic iridoid structure, as well as that 





Figure 5.1. The structures of a basic iridoid and longiflorone4. 
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Figure 5.2. Photograph of Tachiadenus longiflorus 
(photograph provided by Dr M. Randrianarivelojosia). 
A decoction of the aerial parts of T. longiflorus is drunk: to relieve stomach pains and 
dyspepsia, while a leaf decoction is drunk: as a purgative or to alleviate gall bladder 
ailments5. 
5.2.1 Results and Discussion 
The hexane extract of Tachiadenus longiflorus Griseb. yielded oleanolic acid 
(compound XIll) in large quantities, while the dichloromethane extract yielded two 
coumarins, scopoletin (compound XIV) and scoparone (compound XV). An iridoid 








compound XV compound XVI 
Figure 5.3. The structures of compounds XIII - XVI. 
5.2.1.1 Structural Elucidation of Compound XIII 
3~-hydroxy-12-oleanen-28-oic acid 
(Spectra 13a-n, pages 327-340) 
H 
o 
The first compound to be isolated from Tachiadenus longijlorus was a green-brown 
precipitate, which crystallised out of the hexane extraction in large quantities 
(approximately 2.5% of the hexane extract). This compound was identified as 
3~-hydroxy-12-oleanen-28-oic acid, commonly known as oleanolic acid6 (compound 
XIII). Oleanolic acid (Figure 5.3) has been reported to show antiulcer properties, anti-
inflammatory activity and is an inhibitor of type 1 allergic reactions7• It occurs as 
glycosides in mistletoe, cloves (Syzygium aromaticum), sugar beet (Beta vulgaris) and 




Figure 5.4. The structure of compound XIII. 
The mass spectrum showed the presence of a parent ion peak at mlz 456.3578, which 
was consistent with the molecular formula of C30H4S03 (C30H4S03 requires 456.3603). 
A double bond equivalence of seven was deduced. 
The infra-red spectrum showed absorption bands at 3412 cm-1 (O-H stretching), 2923 
cm-1 and 2869 cm-1 (asymmetric and symmetric C-H stretchings) and 1692 cm-1 (C=O 
stretching). 
The 1 H NMR spectrum showed the presence of seven singlet proton resonances at 
8 0.73, 8 0.75, 8 0.88, 8 0.89, 8 0.90, 8 0.96 and 8 1.11, each integrating to three 
protons. These singlet proton resonances were ascribed to 3H-26, 3H-24, 3H-29, 
3H-25, 3H-30, 3H-23 and 3H-27 respectively by comparison of compound XIII to the 
literature data6 for oleanolic acid and these were confirmed using the HMBC spectra. 
The triplet proton resonance at 8 5.25, integrating to one proton, indicated the 
presence of a double bond. This proton resonance, ascribed to H-12, was seen to be 
coupled in the COSY spectrum to the proton resonance at 8 1.84 (2H, m), which was 
due to H -11. The corresponding carbon resonances, obtained from the HSQC 
spectrum, were observed at 8 122.6 (C-12, CH) and 8 23.4 (C-11, CH2). In the HMBC 
spectrum the methine carbon resonance due to C-12 showed a correlation to a one-
proton resonance at 8 2.80, which was assigned to H-18. The proton resonance 
ascribed to H-18 was seen to be coupled in the COSY spectrum with 2H-19 (8 1.15 
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and 8 1.S8), while C-18 (8 41.0) showed a correlation in the HMBC spectrum to 
2H-16 (8 1.S9 and 8 1.92). 
The proton resonance at 8 3.20 (lH, m) indicated the presence of a 3~-equatorial 
hydroxy group (W1l2 = 16 Hz). The proton resonance ascribed to H-3 was seen to be 
coupled in the COSY spectrum to a proton resonance at 8 1.S6 (2H), which was due 
to 2H-2. The methine carbon resonance at 8 79.1, assigned to C-3, showed 
correlations in the HMBC spectrum to 2H-1 (8 0.92 and 8 1.S8), 3H-23 and 3H-24. 
The H-S proton resonance did not show a correlation in the NOESY spectrum to 
3H-2S, which biosynthetically is ~ in orientation, thus indicating that H-S is a in 
orientation; and since H-Sa is correlated in the NOESY spectrum to H-3, we can 
conclude that H-3 is also a in orientation. 
The l3C NMR spectrum showed the presence of a fully substituted carbon resonance 
at 8 183.S, which indicated, in conjunction with the IR spectrum, the presence of a 
carboxylic acid group. This carbon resonance was positioned at C-17 (8 46.S, C) as it 
showed correlations in the HMBC spectrum to 2H-16, H-18 and 2H-22 (8 1.S4 and 
8 1.72, each 1H). The two carbon resonances at 8 143.6 (C-13, C) and 8 122.6 (C-12, 
CH), confirmed the presence of the /:1 12 double bond. 
The molecular formula of C30H4S02 indicated seven double bond equivalents. 
However, it was deduced that one alkene double bond and one carboxylic acid group 
were present, thus indicating the presence of five ring systems. The presence of six 
quaternary carbon resonances and one methyl group converted to a carboxylic acid 
group, in the l3C NMR spectrum, suggested an oleanane-type compound. The olefinic 
carbon resonances at 8 122.6 (CH) and 8 143.6 (C), were characteristic of the /:112 
double bond in olean-12-eness. The olean-12-ene structure of compound XIII was 
further suggested by the presence of a peak at m/z 248 ([C16H2402t), in the mass 
spectrum, due to a reverse Diels Alder fragmentation (Scheme S.l). The l3C NMR 
data of compound XIII was compared to the literature data6 of oleanolic acid, and the 










Scheme 5.1 The MS fragmentation pattern for compound XIII. 
Compound XIII was oxidised using Jones' reagent, to yield white crystals, identified 
as oleanonic acid (Figure 5.5). The secondary alcohol at C-3 was oxidised to a ketone 
group. The NMR data and correlations for compound XIII and the literature l3C NMR 
data for oleanolic acid are reported in table 5.1. The l3C NMR data for oleanolic acid, 










































Table 5.1. NMR data and correlations for compound XIll (CDCh) and literature 
data for oleanolic acid6 (CDCh) 
HMBC 
13CNMR 
lH NMR data 13CNMRdata COSY NOESY literature data 
(400 MHz) (100 MHz) correlations 
correlations correlations for oleanolic acid
6 
C~H (50.1 MHz) 
0.92 (lH, m) 
38.4 (CH2) H-2 3H-25 
H-l~, H-5 38.5 
1.58 (!H, m) H-la 
1.56 (2H, m) 27.1 (CH2) 2H-l, H-3 2H-l H-3 27.4 
3.20 (lH, m) 79.1 (CH) H-2 2H-l, 3H-23, 3H-24 H-2, H-5, 3H-23 78.7 
- 38.7 (C) - 3H-23, 3H-24 - 38.7 
1.69 (lH, d, J=9 .5 
Hz) 
55.2 (CH) 2H-6 
3H-23, 3H-24, 
3H-25 
H-la, H-3, H-6a 55.2 
1.30 (lH, m) 
18.3 (CH2) H-5,2H-7 
H-6a 
18.3 
1.51 (lH, m) 
-
H-5, H-6~ 
1.26 (lH, m) 
32.6 (CH2) 2H-6 H-6(w),3H-26 
H-7a 
32.6 
1.38 (lH, m) H-7~, 3H-27 
- 39.2 (C) -
H-6, H-ll, 3H-26, 39.3 
3H-27 
-
1.52 (lH, m) 47.6 (CH) H-ll H-5, H-ll, 3H-25 H-ll 47.6 
- 37.1 (C) -
H-2, H-6, H-ll, 37.0 
3H-25 
-
1.84 (2H, m) 23.4 (CH2) H-9, H-12 3H-26(w) 
H-9, H-12, 3H-25, 
23.1 
3H-26 




- 143.6 (C) -
H-ll , 2H-15, H-18, 143.4 
2H-19 
-
- 41.6 (C) - H-9, 3H-26, 3H-27 - 41.6 
1.05 (lH, m) 
27.7 (CH2) 2H-16 2H-16(w),3H-27 
H-15~ 
1.68 (lH, m) H-15a,3H-26 
27.7 
1.59 (lH, m) 
22.9 (CH2) 2H-15 H-18 
H-16B 
23.4 
1.92 (lH, m) H-I6A 
- 46.5 (C) - 2H-16, H-22 - 46.6 
2.80 (IH, m) 41.0 (CH) 2H-19 
H-12,2H-16, H-12, H-19~, 
41.3 
H-19(w),3H-29(w) 3H-30 
1.15 (lH, m) 
3H-30,2H-19(w), H-12, H-18, 
45.9 (CH2) H-18 H-21(w), H-22, 3H- H-19a 45.8 
1.58 (lH, m) 29 H-19~ 
- 30.7 (C) - H-19(w), H-21(w), 30.6 H-22,3H-29 -
1.29 (lH, m) 
33.8 (CH2) 
H-19(w), H-22(w), H-21~, 3H-29 





1.72 (lH, m) 
H-21~, H-22~, 
32.4 (CH2) 2H-21 2H-21(w) 3H-29 32.3 
1.54 (lH, m) H-22a, 3H-30 
0.96 (3H, s) 28.1 (CH3) - 3H-24 H-3,3H-24 28.1 
0.75 (3H, s) 15.6 (CH3) - H-6(w), 3H-23 3H-23 15.6 
0.89 (3H, s) 15.3 (CH3) - 3H-26(w) H-ll,3H-26 15.3 
0.73 (3H, s) 17.1 (CH3) - 3H-25(w) H-15~, 3H-25 16.8 
1.11 (3H, s) 25.9 (CH3) - H-7(w) H-7a 26.0 
- 183.5 (C) - 2H-16, H-18, 2H-22 - 181.0 
0.88 (3H, s) 33.1 (CH3) -
2H-19,2H-21, 
H-21a, H-22a 33.1 3H-30 
0.90 (3H, s) 23.6 (CH3) - 2H-19(w),3H-29 H-22~ 23.6 
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oleanonic acid 
Figure 5.5. The structure of oleanonic acid. 
Table 5.2. A comparison of l3C NMR data for oleanolic acid (CDCh) and 
oleanonic acid (CDCh) 
l3C NMR data for 
13C NMR data for 
Carbon Number 
oleanolic acid (100 MHz) oleanonic acid (100 
MHz) 
1 38.4 (CH2) 39.2 (CH2) 
2 27.1 (CH2) 34.1 (CH2) 
3 79.1 (CH) 217.8 (C) 
4 38.7 (C) 47.4 (C) 
5 55.2 (CH) 55.3 (CH) 
6 18.3 (CH2) 19.5 (CH2) 
7 32.6 (CH2) 32.1 (CH2) 
8 39.2 (C) 39.1 (C) 
9 47.6 (CH) 46.8 (CH) 
10 37.1 (C) 36.8 (C) 
11 23.4 (CH2) 22.9 (CH2) 
12 122.6 (CH) 122.4 (CH) 
13 143.6 (C) 143.6 (C) 
14 41.6 (C) 41.7 (C) 
15 27.7 (CH2) 27.6 (CH2) 
16 22.9 (CH2) 23.5 (CH2) 
17 46.5 (C) 46.5 (C) 
18 41.0 (CH) 41.1 (CH) 
19 45.9 (CH2) 45 .8 (CH2) 
20 30.7 (C) 30.6 (C) 
21 33.8 (CH2) 33.8 (CH2) 
22 32.4 (CH2) 32.4 (CH2) 
23 28.1 (CH3) 26.4 (CH3) 
24 15.6 (CH3) 21.4 (CH3) 
25 15.3 (CH3) 15.0 (CH3) 
26 17.1 (CH3) 16.9 (CH3) 
27 25.9 (CH3) 25.8 (CH3) 
28 183.5 (C) 183.4 (C) 
29 33.1 (CH3) 33.0 (CH3) 
30 23.6 (CH3) 23.5 (CH3) 
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5.2.1.2 Structural Elucidation of Compound XIV 
7-hydroxy-6-methoxy-2H-l-benzopyran-2-one (Scopoletin) 
(Spectra 14a-h, pages 341-348) 
The second compound to be isolated from Tachiadenus longiflorus was a crystalline 
material identified as 7-hydroxy-6-methoxy-2H-l-benzopyran-2-one, commonly 
known as scopoletin9 (compound XIV). This compound could not be detected on a 
thin layer chromatographic plate using anisaldehyde spray reagent, instead it 
fluoresced with a bright blue spot under ultra violet (UV) light at 366 nm. It is 
possible to make assignments of the structural class from the colour of the 
fluorescence. Characteristically 7-alkoxycoumarins show a purple fluorescence while 
7-hydroxycoumarins and 5,7-dioxygenated coumarins fluoresce with a blue colourlO. 
Scopoletin has been reported to be used as an antispasmodic agent7• It occurs widely 
in the plant world including the root of Gelsemium sempervirens, Atropa belladonna 
and Fabiana imbricata to name just a few. The structure of compound XIV is shown 





Figure 5.6. The structure of compound XIV. 
Mass spectrometry showed a molecular ion peak at mlz 192, which indicated a 
molecular formula of ClOHS04 (CIOHs04 requires 192). Characteristic peaks were 
observed at mlz 177 [M+ - 15], mlz 149 [M+ - 15 - 18] and mlz 121. A double bond 
equivalence of seven was deduced. 
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The infra-red spectrum showed an intense band at 3338 cm-I due to the O-H 
stretching vibration. Less intense bands at 2914 cm-I and 2845 cm-I were due to the 
asymmetric and symmetric C-H stretching respectively. The carbonyl stretching 
vibration of the a,p-unsaturated lactone was shown as a strong sharp band at 1716 
cm-I. The bands at 1297 cm-I and 1139 cm-I were due to the CH2 and CH3 bending 
vibrations. 
In the IH NMR spectrum the two one-proton doublet signals at 86.25 and 8 7.58 were 
ascribed to the H-3 and H-4 protons respectively. They appear as doublets as they 
belong to an isolated spin system and are split by each other. The coupling constant of 
9.3 Hz is indicative of cis coupling (this was also confirmed by a correlation in the 
NOESY spectrum between H-3 and H-4). Both the H-3 and H-4 proton resonances 
showed coupling in the HMBC spectrum with the signal due to C-2 (8 161.5). The 
two resonances at 8 6.83 and 8 6.90, each integrating to one proton, were assigned to 
the H-5 and H-8 protons respectively. An expanded spectrum showed that these 
signals are doublets and the coupling constant of 0.4 Hz indicates para coupling to 
one another. The singlet proton resonance at 8 3.93, integrating to three protons was 
due to the three equivalent protons of the methoxy group at C-6, which was seen to 
correlate in the HMBC spectrum to the resonance ascribed to C-6. The hydoxy group 
proton signal was observed as a broad singlet at 8 6.10 (lH). 
The l3C NMR spectrum showed the presence of ten carbon resonances. The HSQC 
spectrum was used to assign the proton resonances. In the HMBC spectrum the 
carbon resonance ascribed to C-8a showed a correlation with the signal assigned to 
H-5 and that of H-4, while the C-4a carbon peak showed correlations in the HMBC 
spectrum with H-3 and H-8. The resonance at 8 56.4 was due to the methoxy group 
carbon while the methine signals at 8 113.4, 8 143.3, 8 107.4 and 8 103.2 were 
ascribed to C-3, C-4, C-5 and C-8 respectively using the HSQC spectrum. The fully 
substituted signal at 8 161.5 was shifted far downfield and was due to the carbonyl 
group. Four other fully substituted carbon signals were observed at 8 111.5 (C-4a), 
8 144.0 (C-6), 8 149.7 (C-7) and 8 150.2 (C-8a). 
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In the COSY spectrum, coupling is evident between the H-3 and H-4 protons and also 
between the three equivalent protons of the methoxy group and H-5. The NOESY 
spectrum showed coupling of the H-4 proton resonance with that of H-3 and H-5, 
while a correlation was evident in the NOESY spectrum between H-5 and the 
methoxy group proton resonance at C-6. 
A literature search indicated that this compound was scopoletin. Compound XIV, at a 
concentration of 10 Ilg!cm3, showed a 7.5% inhibition of prostglandin synthesis using 
the microsomal cell screen and a 4.5% inhibition using the Cox-2 screen (page 72). 
The NMR data for compound XIV and the literature data9 for scopoletin are given in 
Table 5.3. The C-4a, C-5 and C-Sa literature values for scopoletin do not agree with 
the l3C NMR data for compound XIV. This problem has arisen previously with other 
students in the research group whose l3C NMR data also did not match that of the 
quoted literature values for this compund, thus an attempted synthesis of scopoletin 
was performed to conf!rm the structure. This synthesis (reported later in this chapter) 
proved unsuccessful, although the related coumarins, aesculetin, scoparone and 
isoscopoletin were synthesised and NMR data acquired for these compounds were 
used for comparison purposes. The NMR data for compound XIV is tabulated in table 
5.3, while the HMBC and NOESY correlations for this compound are shown in 
figures 5.7 and 5.S respectively. 
Figure 5.7. The HMBC (C ~ H) correlations for compound XIV. 
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~o 
Figure 5.8. The NOESY correlations for compound XIV. 
Table 5.3. NMR data and correlations for compound XIV (CDCh) and literature 
data for scopoletin (CDCh) 9 
lHNMR 13CNMR HMBC 
-f3
CNMR 
Carbon COSY NOESY literature data for 
Number 
data data correlations 
correlations 
correlations scopoletin9 
(400 MHz) 100 MHz) C~H (62.9 MHz) 
2 - 161.5 (C) - H-3, H-4 - 160.3 (C) 
3 
6.25 (lH, d, 




7.58 (lH, d, 
143.3 (CH) H-3 H-5 H-3, H-5 143.4 (CH) 
1=9.3 Hz) 
4a - 111.5 (C) - H-3, H-8 - 114.4 (C) 
5 
6.83 (1H, d, 
107.4 (CH) OCH3 at C-6 H-4 
H-4, OCH3 at 113.9 (CH) 
1=0.4 Hz) C-6 
6 - 144.0 (C) - H-5, H-8, 143.3 (C) 
OCH~ atC-6 
-
7 - 149.7 (C) - H-5 - 149.8 (C) 
8 
6.90 (lH, d, 
103.2 (CH) 104.2 (CH) 1=0.4Hz) 
- - -
8a - 150.2 (C) - H-4, H-5, H-8 - 147.2 (C) 
OCH3 at 3.93 (3H, s) 56.4 (CH3) H-5 H-5 C-6 - 56.3 (CH3) 
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5.2.1.3 Structural Elucidation of Compound XV 
6,7-dimethoxy-2H-l-benzopyran-2-one (Scoparone) 
(Spectra 15a-h, pages 349-356) 
The third compound isolated from this species was identified as the known coumarin, 
6,7-dimethoxy-2H-l-benzopyran-2-one, commonly known as scoparone9 (compound 
XV). It was isolated as a crystalline material from the dichloromethane extract. 
Compound XV (Figure 5.8) was also not detected using anisaldehyde spray reagent 
on a thin layer chromatographic plate and rather fluoresced under ultra violet light of 
366 nm, as a bright purple spot. Scoparone has been previously isolated from several 
citrus oils and is also found in Artemisia scoparia and Zanthoxylum setosum. This 





Figure 5.9. The structure of compound XV. 
The mass spectrum indicated a molar mass of 206 g mor l , which corresponded to a 
molecular formula of CllHlO0 4 (CllHlO0 4 requires 206). A double bond equivalence 
of seven was deduced. 
The infra-red spectrum showed peaks at 2914 cm- l and 2849 cm- l which were due to 
the C-H asymmetric and symmetric stretching respectively. The C=O stretching was 
observed at 1717 em-I, while the C=C stretching was seen at 1616 em-I. The bands at 
1380 em-I, 1279 cm-
l 
and 1138 cm- l indicated the CH2 and CH3 bending vibrations, 
while the C-O stretching vibration was observed at 10 14 em-I. 
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The IH NMR spectrum of compound XV showed a pair of doublets at 8 6.26 and 
8 7.60, both integrating to one proton, which corresponded to H-3 and H-4 
respectively. These two protons are cis to each other as shown by a coupling constant 
of 9.3 Hz. The COSY spectrum showed coupling between H-3 and H-4. The methine 
carbon signal at 8 113.5 was assigned to C-3 while the methine carbon signal at 
8 143.3 was assigned to C-4. The H-3 and H-4 proton resonances showed correlations 
in the NOESY spectrum, which confirmed the cis orientation. The C-3 resonance 
showed no correlations in the HMBC spectrum while that of C-4 showed a correlation 
in the HMBC spectrum with H-5. The HMBC spectrum also showed a correlation 
between the C-5 resonance and H-4. 
In the IH NMR spectrum, two one-proton doublet peaks are observed at 8 6.83 (J = 
0.4 Hz) and 8 6.82 (J = 0.4 Hz). These resonances are due to the H-5 and H-8 protons 
respectively, which are para coupled to one another. The methine carbon resonances 
for C-5 and C-8 were observed at 8 107.9 (C-5) and 8 100.0 (C-8). The final two 
singlet peaks, which appeared in the 1 H NMR spectrum both integrated to three 
protons and were found to be methoxy group protons. The carbon resonances were 
observed at 8 3.90 (OCH3 at C-6) and 8 3.93 (OCH3 at C-7). The carbon signals for 
the methoxy groups occur at 8 56.3 (OCH3 at C-6) and 8 56.4 (OCH3 at C-7). In the 
NOESY spectrum the H-5 proton resonance showed a correlation with H-4 and the 
methoxy protons of the methoxy group at C-6, while the H-8 proton signal showed a 
correlation in the NOESY spectrum with the proton resonance at 8 3.93 (3H, s, OCH3 
at C-7). The fully substituted carbon resonance due to C-7 showed HMBC 
correlations with H-5 and the methyl protons of the methoxy group at C-7, while the 
fully substituted carbon resonance due to C-6 showed correlations in the HMBC 
spectrum with H-8 and the methyl protons of the methoxy group at C-6. Thus 
confirming the attachment of the two methoxy groups at C-6 and C-7. 
The fully substituted carbon signals ascribed to C-2, C-4a, C-6, C-7 and C-8a were 
observed at 8 161.4, 8 111.4, 8 146.3, 8 152.8 and 8 150.0 respectively. The carbon 
signal assigned to C-2 showed a correlation in the HMBC spectrum with the H-3 and 
H-4 proton signals. In the HMBC spectrum correlations were also seen between C-4a 
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and the four proton resonances due to H-3, H-5, H-8 and H-4(w). The H-4 and H-8 
proton peaks showed a correlation in the HMBC spectrum with C-8a. 
From this data and by comparison with literature data9, compound XV was found to 
be the known coumarin, scoparone. This compound, at a concentration of 10 Ilg/cm3, 
showed a 4.5% inhibition of prostaglandin synthesis using the microsomal cell screen 
(page 72). 
The NMR data for compound XV and scoparone is shown in Table 5.4, while the 
HMBC and NOESY correlations are illustrated in figures 5.10 and 5.11 respectively. 
The l3C NMR data for compound XV did not correlate well with that of literature9, 
and hence the attempted synthesis of scoparone was also performed so as to obtain 
NMR data that could be correctly assigned. This synthesis, which will also be 
discussed later in this chapter, proved successful, thereby proving that the assignments 
for compound XV were correct. 
Figure 5.10. The HMBC (C -7 H) correlations for compound XV. 
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Figure 5.11. The NOESY correlations for compound XV. 
Table 5.4. NMR data and correlations for compound XV (CDCh) and literature 
data for scoparone9 (CDCh) 
IHNMR 13CNMR HMBC 
13CNMR 
Carbon COSY NOESY literature data 
Number 
data data correlations 
correlations 
correlations for scoparone9 
(400 MHz) (100 MHz) C-7H (62.9 MHz) 
2 - 161.4 (C) - H-3, H-4 - 160.2 (C) 
3 
6.26 (lH, ct, 
113.5 (CH) H-4 H-4 114.9 (CH) 
J=9 .3 Hz) 
-
4 
7.60 (lH, ct, 
143.3 (CH) H-3 H-5 H-3, H-5 143.5 (CH) 
J=9.3 Hz) 
4a - 111.4 (C) - H-3, H-4, H-5, 114.9 (C) H-8 -
5 
6.83 (lH, ct, 
107.9 (CH) H-4 
H-4, OCH) at 
113.6 (CH) 
J=O.4Hz) C-6 
6 - 146.3 (C) - H-8, OCH) at C- 148.8 (C) 
6 
-
7 - 152.8 (C) - H-5, OCH) at C- 149.4 (C) 
7 -
8 
6.82 (lH, ct, 
100.0 (CH) OCH3 atC-7 104.5 (CH) J=Oo4Hz) - -
8a - 150.0 (C) - H-4, H-5, H-8 - 147.5 (C) 
OCH3 at 3.90 (3H, s) 56.3 (CH) H-5, OCH) at 56.3 (CH) C-6 - - C-7 
OCH3 at 3.93 (3H, s) 5604 (CH) H-8, OCH) at - - 55.2 (CH) C-7 C-6 
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5.2.1.4 Structural Elucidation of Compound XVI 
Angelone 
(Spectra 16a-h, pages 357-364) 
Figure 5.12. The structure of compound XVI*. 
The fourth compound isolated from Tachiadenus longiflorus provided difficulties in 
determining the structure, as we were unable to determine the structure based purely 
on the NMR data. As this compound was isolated from a member of the Gentianaceae 
family, it was thought that the compound could be an iridoid. Iridoids have the 
following basic skeleton: 
The methyl group at C-lO is often oxidatively lost and iridoids with the basic structure 
shown below are formed. 
a 
From the COSY spectrum it was evident that the ring II structure was present, with 
protons for two methylene groups at 8 4.50 (H-9, t, J = 6.0 Hz) and 8 3.19 (H-8, t, 
J = 6.0 Hz) seen to be coupled together in the COSY NMR spectrum. In the HMBC 
spectrum a correlation was observed between C-7 (160.8) and H-9. The IH NMR 
• Numbering of sidechain does not fit in with IUPAC rules due to there being an extra carbon atom. 
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spectrum showed a singlet at 8 8.12 (H-1, 1H) and a methyl group three-proton 
resonance at 82.50 (H-6, 3H, s). 
The high resolution mass spectrum indicated a molecular mass of 180.04220 g mor
l
, 
which corresponded to a molecular formula of C9HS04 (C9HS04 requires 180.04226). 
A double bond equivalence of six was deduced. The mass spectrum appeared to 
indicate the presence of a methyl ketone with peaks at mlz 165 [M - CH3] and mlz 137 
[M - CH3 - CO]. 
The infra-red spectrum showed peaks at 2916 cm- l and 2845 cm- l which were due to 
the C-H asymmetric and symmetric stretching respectively. The peak at 1746 cm-
I 
is 
indicative of a saturated six-ring lactone, while the peak at 1686 cm- l indicates the 
presence of an a,~-unsaturated ketone carbonyl group. The C=C stretching was 
observed at 1610 cm- I . The bands at 1408 cm- l , 1248 cm- l and 1082 cm- l indicated the 
CH2 and CH3 bending vibrations, while the C-O stretching vibration was observed at 
1019 cm- l . 
The lack of further correlations in the COSY and NOESY spectra made it difficult to 
suggest a structure. Hence this compound was sent to Professor Jean-Marc Nuzillard 
at the Universite de Reims, France, who ran the NMR data through the LSD (Logic 
for Structure Determination) Programll . The LSD program produces planar structures 
according to 2D NMR correlation data and sub-structural information provided by the 
user. This program was used to elucidate a possible structure for compound XVI and 
the most likely structure suggested by the program, was that shown in figure 5.13. 
Figure 5.13. The structure of compound XVI as given by the LSD program*. 
• The numbering system used here was according to the decending order of carbon data and not 
according to the IUP AC numbering system. 
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Then after being given the proposed structure from the LSD analysis, we were able to 
tentatively confirm this structure using lIMBC and NOESY correlations. The 
structure also agreed with the methyl ketone group suggested by the mass spectrum. 
In the lIMBC spectrum C-5 (0 188.4) showed correlations with the 3H-6 resonance 
and the 2H-8 resonance, while C-7 (0 160.8) showed a correlation in the lIMBC 
spectrum with 2H-9. The C-1 (0 148.2) methine carbon resonance was seen to be 
correlated weakly to H-8 in the lIMBC spectrum (J4 correlation), while the C-4 
(0 147.4) carbon resonance showed correlations in the lIMBC spectrum with H-1, 
3H-6, 2H-8 and weakly with the 2H-9 resonances. 
o 
Figure 5.14. The lIMBC (C ~ H) correlations for compound XVI. 
(J3 in black, J2 and J4 in red) 
The fully substituted C-3 carbon resonance at 0 128.3 showed correlations to 2H-9 
and 2H-8 in the lIMBC spectrum, while C-2 (0 117.6) was correlated to H-1 and 
2H-8. In the COSY spectrum, the 2H-9 resonance was seen to be coupled to the 2H-8 
resonance and a correlation in the NOESY spectrum was also evident between these 
two resonances. The corresponding C-9 methylene carbon resonance at 068.5 showed 
an lIMBC correlation to the 2H-8. The 3H-6 singlet proton resonance showed a weak 
correlation to the 2H-8 resonance in the NOESY spectrum. In the NOESY spectrum, 
the 2H-8 proton resonance was seen to be correlated to the 2H-9 and weakly to the 
3H-6 resonance, while the corresponding methylene carbon resonance at 0 21.3, 
showed a correlation in the lIMBC spectrum with H-9. However, biosynthetically the 
formation of this compound is difficult to explain. 
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The sample was sent to Dr. Peter Sandor at the Varian Applications Laboratory in 
Darmstadt, Germany, for the acquisition of an INADEQUATE spectrum to try and 
prove the structure but insufficient material was available for the experiment. 
We have requested more plant material to be collected by Dr. M. 
Randrianarivelojosia, however, we were informed that this is the wrong time of year 
for collecting this plant and so this compound will be investigated further at a later 
stage. 
The HMBC correlations and the NOESY correlations for compound XVI are given in 
figure 5.14 and figure 5.15 respectively and the NMR data and correlations are 
tabulated in table 5.5. 
o 
H 
Figure 5.15. The NOESY correlations for compound XVI. 
Table 5.5. NMR data and correlations for compound XVI (CDCh) 
-13
CNMR 
Carbon IH NMR data data COSY HMBC correlations NOESY 
Number (400 MHz) (100 MHz) correlations C7H correlations 
1 8.12 OH, s) 148.2 (CH) - 2H-8(w) -
2 - 117.6 (C) - H-l,2H-8 -
3 - 128.3 (C) - 2H-9,2H-8 -
4 - 147.4 (C) -
H-l, 2H-9(w), 3H-6, 
2H-8 -
5 - 188.4 (C) - 3H-6,2H-8 -
6 2.50 (3H, s) 26.8 (CH1) - - 2H-8(w) 
7 - 160.8 (C) - 2H-9 -
8 3.19 (2H, t, J 6.0 Hz) 21.3 (CH2) 2H-9 2H-9 2H-9,6H-6(w) 
9 4.50 (2H, t, J-6.0 Hz) 68.5 (CH2) 2H-8 2H-8 2H-8 
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5.2.2 Experimental 
The stem and bark of Tachiadenus long ijlo rus, was collected from Feverive, 
Madagascar and identified by Dr Milijaona Randrianarivelojosia. A voucher specimen 
was retained at the University of Antananarivo, Madagascar (09-99 MJ/DUL). The 
milled stem and bark (755 g) were collectively extracted using soxhlet extraction for 
approximately 24 hours using hexane, dichloromethane, ethyl acetate and methanol 
respectively. The excess solvent was removed using a rotor evaporator, which 
afforded the hexane (70 g), dichloromethane (54 g), ethyl acetate (27 g) and methanol 
(92 g) crude extracts. NMR analysis of the crude methanol extract indicated that only 
sugars were present and hence was not examined further. 
Isolation of compounds XIII - XV 
The hexane, dichloromethane and ethyl acetate extracts were subjected to column 
chromatography using silica gel (Merck 9385) on a column (3 cm in diameter) in 
order to separate the compounds. 
Compound XIII was the predominant compound in this plant and precipitated out of 
the hexane extract in large quantities. Column chromatography run on the hexane 
extract yielded only more compound XIII and large quantities of fatty acids. 
The mobile phase used for the dichloromethane extract was a dichloromethane : 
methanol step gradient [100% dichloromethane (fractions 1-40), 5% methanol in 
dichloromethane (fractions 41-80), 10% methanol in dichloromethane (fractions 81-
120), 100 methanol (fractions 121-130)]. Compounds XIV and XV were eluted using 
5% methanol in dichloromethane and were purified on a column (2 cm in diameter) 
using a 100% dichloromethane solvent system. 
The mobile phase used for the ethyl acetate extract was a dichloromethane : methanol 
gradient step [100% dichloromethane (fractions 1-40), 1% methanol in 
dichloromethane (fractions 41-80), 2% methanol in dichloromethane (fractions 81-
120), 5% methanol in dichloromethane (fractions 121-140), 10% methanol in 
dichloromethane (fractions 141-160), 100% methanol (fractions 161-170). 
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Compound XVI was eluted using a 1 % methanol in dichloromethane solvent system 
and was purified on a Pasteur pipette column using 100% dichloromethane. 
Jones' oxidation of compound XIII 
Compound XIII (0.10 g) was dissolved in acetone (10 cm3) and the solution was 
stirred at room temperature in a flat-bottomed flask. The Jones' reagent was prepared 
as follows: concentrated H2S04 (23 cm
3) was diluted with water to a volume of 
100 cm3 and chromic trioxide (26.74 g) was dissolved in this solution. The Jones' 
reagent (0.1 cm3) was then added slowly to the solution in the flat-bottomed flask and 
was allowed to stir for 5 hours. The solution was diluted with water and then washed 
with bicarbonate solution (5 cm3). The product was extracted into dichloromethane 
(2 x 5 cm3) and the solvent was removed using a rotor evaporator. 
5.2.2.1 Physical Data for Compound XIII 
Name: 3~-hydroxy-12-oleanen-28-oic acid 
Synonyms: oleanolic acid, oleanol 
Physical appearance: yellow-green crystalline precipitate 
Yield: 39 g 
Melting Point: 307-309°C, Literature = 306-308°C7 
Mass: [Mt at mlz 456.3578, C30~803, requires 456.3603 
Infra-red: v ~~l cm-I: 3412,2923,2852, 1692 
Optical rotation: [a]D = +53.6° (c = 0.14 g/100 cm3; CHCh), 
Literature [a]D = + 79.5° (CHC13)7 
IH and l3e NMR Data: Refer to table 5.1 (page 139) 
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5.2.2.2 Physical Data for Compound XIV 
Name: 7 -hydroxy-6-methoxy-2H-l-benzopyran-2-one 
Synonyms: scopoletin, 7-hydroxy-6-methoxycoumarin, aesculetin 6-methyl ether 
Physical appearance: cream coloured needles 
Yield: 3.6 mg 
Melting Point: 196-198°C, Literature = 204°C9 
Mass: [M+] at mlz 192, C lOHs0 4 requires 192 
EIMS:mlz: 192,177, 149,121 
Infra-red: v ~~[ cm-1 : 3338,2914,2845, 1716, 1297, 1139 
IH and 13e NMR Data: Refer to table 5.3 (page 144) 
5.2.2.3 Physical Data for Compound XV 
Name: 6,7 -dimethoxy -2H -1-benzopyran-2-one 
Synonyms: scoparone, 6,7 -dimethoxycoumarin, scoparin 
Physical appearance: cream coloured needles 
Yield: 9.4 mg 
Melting Point: 141-143°C, Literature = 147°C9 
Mass: [M+] at mlz 206, CllHlO04 requires 206 
Infra-red: v ~~[ cm-1 : 2914,2849, 1717, 1616, 1380, 1279, 1138, 1014 
IH and 13e NMR Data: Refer to table 5.4 (page 148) 
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5.2.2.4 Physical Data for Compound XVI 
Name: angel one 
Physical appearance: light brown crystals 
Yield: 7 mg 
Melting Point: insufficient sample 
Mass: HRMS [M+] at mlz 180.04220, C9HS0 4 requires 180.04226 
ElMS: mlz (reI. int.) : 180 (100.00), 165 (51.77), 152 (24.10), 150 (18.91), 135 
(22.28), 124 (16.44), 122 (55.29), 109 (21.17), 94 (4.67), 79 (24.68), 71 
(5.33),51 (19.83), 43 (64.09) 
Infra-red: v ~:;I cm-1 :3349,2916, 2845, 1746, 1686, 1610, 1544, 1408, 
1248, 1082, 1019 
IH and 13e NMR Data: Refer to table 5.5 (page 152) 
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5.3 The Synthesis of Coumarins 
The synthesis of coumarins, specifically scopoletin and scoparone, was attempted in 
order to confirm the NMR data obtained for compounds XIV and XV. The NMR data 
for these compounds did not correlate well with the relevant literature values9 and so 
it was decided to synthesise these compounds so as to confirm the NMR assignments 
of compounds XIV and XV. 
5.3.1 Introduction 
A reaction by which coumanns may be synthesised is known as the Pechmann 
condensation and involves condensation of phenols with either malic acid or 
~-ketonic esters in the presence of Lewis acid catalysts 12. 
U CH3UOEt 
H2SO4 I + • 









Scheme 5.2. The two types of Pechmann condensation reactions12. 
The product of the Pechmann reaction depends on the nature of the phenol, the nature 
of the ~-ketonic ester and the condensing agent used12• 
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5.3.2 The Synthesis of Aesculetin 
The synthesis of aesculetin is the first step in the synthesis of scoparone, thus this 
compound had to be synthesised initially. In the synthesis of aesculetin, the three 
acetate groups of the starting material 1,2,4-triacetoxybenzene are cleaved off under 
the acidic conditions to give hydroxyquinol. Next, condensation of malic acid with the 
phenol occurs, which takes place in three stages. Firstly, the malic acid is converted 
into malonaldehydic acid and formic acid, which is further decomposed into water 
and carbon monoxidel2 . In the second stage, reaction of the aldehyde with the phenol 
yields an unstable addition product. Two molecules of water are released in the third 
step resulting in the formation of the coumarin derivative 12. This reaction is made 
possible as malonaldehydic acid contains a ~-carbonyl group, which resembles the 
acetoacetic ester in its reaction with a phenol to yield a coumarin 12. 
HO 
o OH 0 
II I II 




1- H,o. -CO 
~Q 0 
'--Jj II 
H-C- CHT C- OH 
HO co malonaldehydic 
acid 1,2,4-triacetoxy benzene 
HOJ / H 
HOY0 ..... ""_HO~~: 









Scheme 5.3. The proposed mechanism of the Pechmann condensationl 2. 
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5.3.2.1 Structural Elucidation of Compound XVII 
6,7-Dihydroxy-2H-l-benzopyran-2-one (Aesculetin) 
(Spectra 17a-h, pages 365-372) 




Figure 5.16. The structure of compound XVII. 
The mass spectrum indicated a molar mass of 178 g mOrl which indicated a 
molecular formula of C9H604 (C9H604 requires 178) and a double bond equivalence 
of seven. 
The infra-red spectrum showed bands at 3262 cm-l (O-H stretching), 1680 cm-l (C=O 
stretching), 1569 cm-l (C=C stretching), 1394 cm-l, 1293 cm-l and 1149cm-l (CH2 and 
CH3 bending). 
The IH NMR spectrum showed the presence of a pair of doublet resonances at 8 7.77 
(lH, J = 9.3 Hz) and 8 6.17 (1H, J = 9.3 Hz), which were assigned to H-4 and H-3 
respectively. These two pairs of doublets were seen to be coupled to each other in the 
COSY and NOESY spectrums. 
The downfield fully substituted carbon resonance at 8 164.3 in the l3C NMR spectrum 
indicated the presence of a carbonyl group and was assigned to C-2 due to this 
resonance being correlated to H-3 and H-4 in the HMBC spectrum. The fully 
substituted carbon signal at 8 112.8 was due to H-4a as it was seen to be correlated to 
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H-3 and H-S (8 6.74, 1H, d, J = 0.4 Hz) in the HMBC spectrum. The remaining 
doublet proton resonance at 8 6.93 (J = 0.4 Hz), integrating to one proton, was 
assigned to H-5 as it was seen to be correlated to H-4 in the NOESY spectrum and 
showed a correlation in the HMBC spectrum to C-4 (8 146.1) 
The two fully substituted carbon resonances in the l3C NMR spectrum observed at 
8 144.6 and 8 152.0 were due to C-6 and C-7 respectively based on a comparison of 
l3C NMR data for these carbon atoms in scopoletin, scoparone and isoscopoletin. 
Also, stronger HMBC correlations were observed between C-6 and H-S as well as 
between C-7 and H-5, while slightly weaker correlations in the HMBC spectrum were 
observed between C-6 and H-5 as well as between C-7 and H-S. The remaining fully 
substituted carbon resonance at 8 150.5 was ascribed to H-Sa and showed correlations 
in the HMBC spectrum to H-4, H-5 and H-S. Compound XVII, at a concentration of 
10 )lg/cm3, showed a 27.7% inhibition of prostaglandin synthesis using the 
microsomal cell screen and a 2.3% inhibition using the Cox-2 screen (page 72). 
The NMR data and correlations for aesculetin and the literature data9 for aesculetin 
are tabulated in table 5.6. 
Table 5.6. NMR data and correlations for compound XVII (CD30D) and 







Number (400 MHz) 
data 
correlations 
correlations data for 




2 - 164.3 (C) - H-3, H-4 - 160.4 
3 
6.17 (IH, d, 





7.77 (1H, d, 
146.1 (CH) H-3 H-5 H-3, H-5 
143.5 
J=9.3 Hz) 
4a - 112.8 (C) - H-3, H-8 - 112.4 
5 
6.93 (lH, d, 




6 - 144.6 (C) - H-5, H-8 - 142.7 
7 - 152.0 (C) - H-5, H-8 - 150.2 
8 
6.74 (lH, d, 
103.6 (CH) 104.4 
J=O.4Hz) - - -
8a - 150.5 (C) - H-4, H-5, H-8 - 148.1 
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5.3.3 The Synthesis of Scoparone 
The methylation of aesculetin to form scoparone involves reacting one mole of 
aesculetin with two moles of iodomethane with an excess of potassium carbonate in 
acetone and refiuxing overnightl 3. The potassium carbonate renders the solution basic, 
thereby abstracting the protons from the hydroxy groups of aesculetin. This creates 
nucleophilic sites on aesculetin, which bind to the electron deficient carbon atom of 
iodomethane. Subsequently, the iodide group from iodomethane is released and 
complexes with the excess potassium ions to form potassium iodide. This proposed 












Scheme 5.4. The proposed mechanism for the methylation of aesculetin to form 
scoparone l 3. 
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5.3.3.1 Structural Elucidation of Compound XVIII 
6,7-dimethoxy-2H-l-benzopyran-2-one (Scoparone) 
(Spectra 18a-f, pages 373-378) 





Figure 5.17. The structure of compound XVIII. 
The NMR spectral data for this compound was identical to the isolated scoparone 
(compound XV) and so will not be discussed again in detail. Table 5.7 lists all the 
NMR data and correlations for this compound. The NMR data for compound XVIII 
did not correlate well with literature9, however it did correlate very well with the 
NMR data for scoparone (compound XV) isolated from Tachiadenus longijlorus. 











(100 MHz) (C7H) 
2 - 161.4 (C) - H-3, H-4 -
3 6.26 (lH, d, 1=9.3 Hz) 113.5 (CH) H-4 - H-4 
4 7.59 (lH, d, 1=9.2 Hz) 143.3 (CH) H-3 H-5 H-3, H-5 
4a - 111.4 (C) - H-3, H-8 -
5 6.83 (lH, s) 107.9 (CH) OCH3 at C-6 H-4 
H-4, OCH3 at 
C-6 
6 - 146.3 (C) - H-8, OCH3 at C-6 -
7 - 152.8 (C) - C-7, OCH3 at C-7 -
8 6.81 (lH, s) 100.0 (CH) OCHl at C-7 - OCHl at C-7 
8a - 150.0 (C) - H-4, H-5 -
OCH3 at 3.92 (3H, s) 56.3 (CH3) H-5 C-6 - -
OCH3 at 3.89 (3H, s) 56.3 (CH3) H-8 C-7 - -
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5.3.4 The Synthesis of Isoscopoletin 
The methylation reaction was repeated in the same way as that for scoparone13, 
however, a mono-methoxy compound was required and thus only one mole of 
iodomethane was reacted with one mole of aesculetin. However a large amount of 
scoparone was still formed, thus separation of the compounds by column 
chromatography was necessary. One of the compounds isolated from this reaction was 
isoscopoletin. This reaction was initially performed so as to obtain scopoletin, as we 
wanted to check the NMR data of compound XIV, however, scopoletin was not 











Kl+ + Kl 
HO 0 0 
scopoletin isoscopoletin 
Scheme 5.5. The proposed formation of scopoletin and isoscopoletin13. 
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5.3.4.1 Structural Elucidation of Compound XIX 
6-Hydroxy -7 -methoxy -2H -1-benzopyran-2-one (Isoscopoletin) 
(Spectra 19a-h, pages 379-386) 






Figure 5.18. The structure of compound XIX. 
The mass spectrum of compound XIX indicated a molecular mass of 192 g mor l , 
which indicated a molecular formula of C lOHg04 (CIOHg04 requires 192). A double 
bond equivalence of seven was deduced. 
The infra-red spectrum showed a broad band at 3415 cm-I due to the O-H stretching 
vibration. The carbonyl stretching vibrations of the a,B-unsaturated lactone was 
shown as a sharp peak at 1695 em-I. The peaks at 1301 cm-I and 1149 cm-I were due 
to the CH2 and CH3 bending vibrations. 
The IH NMR spectrum showed the presence of a pair of doublets at 8 7.58 (lH, 
J = 9.4 Hz) and 8 6.26 (lH, J = 9.4 Hz), which were assigned to H-4 and H-3 
respectively. The corresponding methine carbons, identified from the HSQC 
spectrum, were observed at 8 143.4 (C-4) and 8 113.9 (C-3). This region of the l3C 
NMR spectrum indicates the presence of a double bond. The H-4 and H-3 doublet 
proton resonances were seen to be coupled to each other in the COSY spectrum. 
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The l3C NMR spectrum showed a fully substituted carbon resonance at 8 161.5 
indicating the presence of a carbonyl group. This carbon resonance was ascribed to 
C-2 as it showed correlations in the HMBC spectrum to both H-3 and H-4. The 
doublet proton resonance at 8 6.95 (J = 0.4 Hz), integrating to one proton, was 
assigned to H-5 as it showed correlations in both the HMBC and NOESY spectra to 
H-4. The resonance at 8 6.S1 (lH, d, J=O.4 Hz) was therefore assigned to H-S. The 
doublet proton resonance due to H-4 was seen to be correlated in the NOESY 
spectrum to H-3, H-5 and H-S (8 6.S1, IH, d, J = 0.4 Hz). 
The IH NMR spectrum showed the presence of one methoxy group at 8 3.95 (3H, s), 
which could be positioned at C-6 or C-7. The NOESY spectrum showed a correlation 
between this methoxy group and H-S, thus positioning the methoxy group at C-7 
(8 150.1, C). This was further proved by the HMBC spectrum, which showed 
correlations between C-7 and the methoxy at C-7, as well as to H-5 and H-S. A 
hydroxy group was placed at the remaining, C-6 (8 142.7, C), position. Compound 
XIX, at a concentration of 10 J,.tg/cm3, showed a 21.6% inhibition of prostaglandin 
synthesis using the microsomal cell screen (page 72). 
The literature melting point of scopoletin (204°C) is very similar to that of 
isoscopoletin (207.5 - 209°C) and thus the formation of isoscopoletin could not be 
confirmed based on the recorded melting point of compound XIX. The NMR data 
and correlations for compound XIX and the literature data9 for isoscopoletin are given 
in table 5.S. 
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Table 5.8. NMR data and correlations for compound XIX (CDCh) and 








data correlations data for data 
correlations correlations Number 
(400 MHz) (100 MHz) (C-7H) . I f 9 ISOSCOpo e lD 
(62.9 MHz) 
2 - 161.5 (C) - H-3, H-4 - 160.3 
6.26 (IH, ct, 
113.9 (CH) H-4 H-4 
113.2 
3 -J=9.4 Hz) 
7.58 (JH, ct, 
143.4 (CH) H-3 H-5 
H-3, H-5 , 143.3 
4 
J=9.4 Hz) H-8 
4a - 112.2JCl - H-3, H-8 - 113.2 
6.95 (JH, ct, 





6 - 142.7 (C) - H-8 - 144.5 
7 150.1 (C) 
H-5, H-8, 150.3 
- -
OCH3 at C-7 
-
8 
6.81 (lH, ct, 
99.3 (CH) 
H-4, OCH3 at 104.2 
J=O.4Hz) - - C-7 
8a - 149.2 (C) - H-4 - 149.4 
OCH3 at C-7 3.95 (3H, s) 56.4 (CH3) - - H-8 55.4 
5.3.5 A Comparison of the 13C NMR Data of Selected Coumarins 
A table comparing the carbon NMR data of these synthetic and naturally occurring 
compounds could be compiled (Table 5.9). From this data it is evident that whether 
the coumarins have two hydroxy groups or two methoxy groups, or even one methoxy 
and one hydroxy group attached at C-6 and C-7, the carbon values of the coumarins 
are very similar. 
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Table 5.9. 13C NMR data for compound XVII (CD30D), compound XVIII 
(CDCh), compound XIV (CDCh) and compound XIX (CDCh) 
BC NMR data for 13C NMR data for l3C NMR data for IJC NMRdata 
synthesised synthesised naturally occurring for synthesised 
Carbon Number aesculetin, scoparone, scopoletin, isoscopoletin, 
compound XVII compound XVIII compound XIV compound XIX 
(lOOMHz) (100 MHz) (100 MHz) (100 MHz) 
2 164.3 (C) 161.4 (C) 161.5 (C) 161.5 (C) 
3 112.5 (CH) 113.5 (CH) 113.4 (CH) 113.9 (CH) 
4 146.1 (CH) 143.3 (CH) 143.3 (CH) 143.4 (CH) 
4a 112.8 (C) 111.4 (C) 111.5 (C) 112.2 (C) 
5 113.0 (CH) 107.9 (CH) 107.4 (CH) 111.0 (CH) 
6 144.6 (C) 146.3 (C) 144.0 (C) 142.7 (C) 
7 152.0 (C) 152.8 (C) 149.7 (C) 150.1 (C) 
8 103.6 (CH) 100.0 (CH) 103.2 (CH) 99.3 (CH) 
8a 150.5 (C) 150.0 (C) 150.2 (C) 149.2 (C) 
OCH3 at C-6 - 56.3 (CH3) 56.4 (CH3) -
OCH3 at C-7 - 56.3 (CH3) - 56.4 (CH3) 
5.3.6 Conclusion 
The purpose of synthesising scopoletin and scoparone was so that we could prove that 
the IH and l3C NMR data of these two coumarins isolated from Tachiadenus 
longiflorus were accurate and the data in the literature were incorrect. 
Unfortunately, scopoletin was not synthesised so the NMR data of naturally occurring 
scopoletin could not be compared to that of synthesised scopoletin. However, the IH 
and l3C NMR data of the synthesised scoparone, was identical to that of the naturally 
occurring scoparone which confirmed that our NMR data was correct. It can therefore 
be concluded that the NMR data obtained from the naturally occurring coumarins, 
scopoletin and scoparone were correct, thus confirming that the literature data for 
these compounds were inaccurate. 
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5.3.7 Experimental 
Synthesis of aesculetin 
1,2,4-Triacetoxybenzene (20.0 g, 79.4 mmol) and (+)-malic acid (11.7 g, 83.3 mmol) 
were powdered in a mortar. The mixture was added to concentrated sulphuric acid 
(32 cm3) in one addition in a large beaker. The mixture was stirred for five minutes 
using a mechanical stirrer and then heated on a steam bath (100°C) with continuous 
stirring for one hour. Heating and stirring were continued for a further ninety minutes, 
after which the mixture was left to cool, poured onto crushed ice (250 g) and then left 
in the refrigerator for forty-eight hours. The brown precipitate formed was filtered, 
washed with copious amounts of water, and dried to provide aesculetin (8.32 g, 
59 %). 
Synthesis of scoparone 
Aesculetin (1.0 g, 5.6 mmol), potassium carbonate (3.88 g, 28.1 mmol) and 
iodomethane (1.4 cm3, 22.5 mmol) were refluxed for twenty-four hours in acetone 
(25 cm\ The mixture was filtered, and the acetone solution was concentrated in 
vacuo to give pure scoparone (949.6 mg, 82%). 
Synthesis of isoscopoletin 
Aesculetin (1.0 g, 5.6 mmol), potassium carbonate (3.01 g, 30.4 mmol) and 
iodomethane (0.30 cm3, 4.8 mmol) were refluxed for twenty-four hours in acetone (25 
cm
3
). The mixture was filtered, and the acetone solution was concentrated in vacuo to 
give a mixture of coumarins. The mixture was separated using column 
chromatography (Merck 9385) and a 100% dichloromethane solvent system. A large 
portion of the extract consisted of unreacted aesculetin as well as a large amount of 
the dimethoxy product, scoparone. Scoparone eluted first off the column, while pure 
isoscopoletin was collected in subsequent fractions (10 mg, 1.0 %). 
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5.3.7.1 Physical data for compound XVII 
Name: aesculetin 
Synonyms: 6,7 -dihydroxy-2H-l-benzopyran-2-one 
Physical appearance: dark brown crystals 
Melting point: 260-264°C, Literature = 268-270°C9 
Yield: 8.32 g 
Mass: [M+] at mlz 178, C9H604 requires 178 
Infra-red: v NaCl cm-l : 3262, 1680, 1569, 1394, 1293, 1149 
max 
IH and Be NMR Data: Refer to table 5.6 (page 160) 
5.3.7.2 Physical data for compound XVIII 
Name: scoparone 
Synonyms: 6,7 -dimethoxy-2H-l-benzopyran-2-one 
Physical appearance: yellow crystals 
Melting point: 141-143°C, Literature = 147°C9 
Yield: 949.6 mg 
IH and Be NMR Data: Refer to table 5.7 (page 162) 
5.3.7.3 Physical data for compound XIX 
Name: isoscopoletin 
Synonyms: 6-hydroxy-7 -methoxy-2H-l-benzopyran-2-one 
Physical appearance: pale yellow substance 
Melting point: insufficient sample, Literature = 207.5-209°C9 
Yield: 10 mg 
Mass: [M+] at mlz 192, C lOH804 requires 192 
EIMS:mlz: 192, 177, 149, 121 
Infra-red: v ~~I cm- l : 3415, 1695, 1633, 1571, 1526, 1447, 1385, 1301 , 1149 
1 13 Hand e NMR Data: Refer to table 5.8 (page 166) 
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The Attempted Synthesis of (E)-1-(4'-hydroxyphenyl)-3-(S"-
hydroxy -3" ,4" -dimethoxyphenyl)-1,4-pentadiene 
6.1 Introduction 
Although the norligan that was isolated from Ledebouria ovatifolia was found to 
be (2)-1-( 4'-hydroxyphenyl)-3-(5"-hydroxy-3 ",4"-dimethoxyphenyl)-1 ,4-pentadiene, 
it was initially thought that compound I was isolated as the trans isomer due to 
confusion in the literature discussed below. However, only after completing the 
synthesis of compound XXIII, was it determined that compound I was the cis isomer, 
based on NMR correlations and the coupling constant (J = 11.7 Hz) of H-l and H-2. 
There is confusion in the literature regarding cis/trans isomers of norlignans and the 
structure of the known norlignan, hinokiresinol (Figure 6.1), has presented researchers 




Figure 6.1. The structure of hinokiresinol. 
In 1965 Hirose et al. 1, who isolated hinokiresinol from the wood of Chamaecyparis 
obtuse, concluded that the ~1 .2 double bond was trans based on an infra-red 
absorption at 967 cm-
1 
and no chemical shifts or coupling constants for H-l and H-2 
were given. In 1967, Enzell et al. 2 assumed the trans stereochemistry, based on the 
work of Hirose et aI., to be correct and investigated the absolute stereochemistry at 
C-3 through a series of chemical transformations. 
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In 1967, Beracierta and Whiting3 identified their synthetic (±)-dimethylether product 
as trans, based on a It ,2 coupling constant of 12 Hz and an infra-red absorption of 967 
cm-1. They also commented that the value of 12 Hz was at the "low end of the range", 
lower than the value of 16 Hz found in the trans intermediate and higher than the 
value of 9 Hz found in the cis intermediate. 
In 1988, Ameer et al. 4 synthesised both the cis and trans isomers and obtained J 1,2 
coupling constants of 11.3 Hz and 15.9 Hz respectively. This indicated that the 
compound hinokiresinol reported previously in the literature to have a trans 
configuration, actually had the cis configuration. In 1996, Tsui and Browns isolated 
(+ )-nyasol from Asparagus cochinchinensis, and from the NOESY spectrum, they 
showed that their compound had the cis stereochemistry and reported a It ,2 coupling 
constant of 11.2 Hz. Thus the attempted synthesis in this chapter is of the trans isomer 
and not of the isolated cis isomer. 
The starting material for the norlignan, (E)-I-(4'-hydroxyphenyl)-3-(5"-hydroxy-
3" ,4"-dimethoxypheny I )-1,4-pentadiene i.e. 5 -hydroxy -3 ,4-dimethoxy -benzaldehyde 
was not readily available, and due to time constraints, the derivative 3,4-dimethoxy-
benzaldehyde, which was available, was used instead. It was thought that the 
synthesis could be performed using the latter starting material to see if the reaction 
was successful, and if it was, then the starting material could be obtained to make the 
required substituted benzaldehyde. Thus the synthesis of the norlignan (E)-1-( 4'-
hydroxyphenyl)-3-(3",4"-dimethoxy)prop-2-en-1-one was attempted based on the 
procedure reported by Muraoka and co-workers6• Scheme 6.1 shows the proposed 
overall reaction for what product should have been formed, while scheme 6.2 shows 
the proposed overall reaction for the product actually formed in the reaction. 
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HC 1 __ P
OH 
3 ~ 50%KOH 
MeOH 












Scheme 6.1. The proposed overall reaction for the expected product6. 
HC 1 __ P
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3 ~ 50%KOH 
MeOH 


















The key synthetic intermediate in the formation of the norlignan is the chalcone, (E)-
1-(4'-hydroxyphenyl)-3-(3",4"-dimethoxyphenyl)prop-2-en-1-one, which was 
prepared according to the reported method of Martin et al. 
7
• 
6.1.1 Chalcone Synthesis 
Chalcones can be synthesised using various methods, but the simplest involves the 
Claisen-Schmidt condensation. This approach involves reacting equimolar quantities 
of acetophenone with benzaldehyde in the presence of potassium hydroxide resulting 
in the formation of an a,~-unsaturated ketone (Scheme 6.3). Substituted chalcones 





Scheme 6.3. Chalcone formation by the Claisen-Schmidt condensation. 
The base catalysed formation of chalcones8-10 and their derivatives9, 10 was subjected 
to kinetic studies, and two mechanisms have been proposed for the reaction of 
benzaldehyde and acetophenone in the presence of a base catalyst. The first 
mechanism involves base abstraction of a proton from the methyl group of 
acetophenone, which creates a nuc1eophile, and attacks the electrophilic carbon atom 
of benzaldehyde to form the first intermediate (i), which then accepts a proton from 
water to form the second intermediate (ii). The latter undergoes dehydration to form 





o H 0 /~ t 




Scheme 6.4. Mechanism one of chalcone formation8. 
The second proposed mechanism involves the ethoxide anion, which acts as a 
nucleophile and attacks the electrophilic carbon atom of benzaldehyde, forming the 
first intermediate (i). The nucleophilic acetophenone then attacks the electrophilic 
centre in intermediate (i). The negative oxygen ion simultaneously accepts a proton 
from the solution to form the second intermediate (ii), which then undergoes 





rI ~~ ~ 
GyC~yV 
o O~ 
intermediate (i) f intermediate (ii) 
H+ 
o 
Scheme 6.5. Mechanism two of chalcone formation8. 
The alkali concentration in the Claisen-Schmidt reaction usually ranges between 10 
and 60%. The reaction can be carried out at 50°C for twelve to fifteen hours or at 
room temperature for five to seven days7. However, under these conditions, the 
Cannizzaro reaction also takes place, thus decreasing the yield of the desired 
chalcone. The Cannizzaro reaction occurs when an aldehyde with no a-hydrogen 
atom reacts with the concentrated aqueous alkali, which results in half the aldehyde 
being converted to a carboxylic acid, and the other half to an alcohol. 
A variety of condensing agents other than aqueous alkali have also been used to form 
chalcones. These include alkali metal alkoxides lJ •12, magnesium tert-butoxide13, 
hydrogen chloridel4• 15, aluminium chloridel6 and boron trifluoride l6. 
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6.1.2 Synthesis of (E)-1-(4'-hydroxyphenyl)-3-(3",4"-dimethoxy-
phenyl)prop-2-en-1-one 
The synthesis of the (E)-4'-hydroxy-3",4"-dimethoxy-cha1cone was attempted using 
the Claisen-Schmidt condensation reaction and proved successful (Scheme 6.6). The 
product was obtained in 56% yield. 
+ H,C (Y0H • 






3,4-dimethoxy-benzaldehyde 4-hydroxy-acetophenone (E)-l-( 4' -hydroxyphenyl)-3-(3",4"-dimethoxyphenyl) 
prop-2-en-l-one 
Scheme 6.6. The formation of (E)-1-(4'-hydroxyphenyl)-3-(3",4"-dimethoxyphenyl)-
prop-2-en-l-one. 
6.1.2.1 Confirmation of the Structure of Compound XX 
(E)-1-( 4' -hydroxyphenyl)-3-(3",4" -dimethoxyphenyl)prop-2-en-1-one 
(Spectra 20a-h, pages 387-394) 
(E)-l-( 4' -hydroxyphenyl)-3-(3",4" -dimethoxyphenyl) 
prop-2-en-l-one 
Figure 6.2. The structure of compound XX. 
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The high resolution mass spectrum showed a parent ion peak at mlz 284.10485, which 
was consistent with the molecular formula of C17H1604 (C17HI604 requires 
284.10486). A double bond equivalence of ten was deduced. 
The infra-red spectrum showed a broad band at 3273 cm- l due to the O-H stretching 
of the hydroxy group. The sharp peak at 1608 cm- l was assigned to the C=O 
stretching vibrations, while the peak at 1517 cm- l was due to the C=C stretchings. The 
CH2 and CH3 bending vibrations were observed at 1442 cm-
l
, 1271 cm- l and 
1159 cm- l , while the C-O stretching was seen at 1025 cm- l . 
The IH NMR spectrum showed the presence of a pair of doublets at 8 7.37 and 8 7.31, 
both integrating to one proton and having a coupling constant of 15.6 Hz, which were 
ascribed to H-2 and H-3 respectively. In the COSY spectrum, coupling can be seen 
between these two proton signals. The NOESY spectrum also shows coupling of H-2 
with the proton resonances assigned to H-2' /6' (87.93, 1H, J = 8.2 Hz), H-2" (87.12, 
1H, d, J = 2.0 Hz) and H-6" (8 7.19, 1H, dd, J=2.0, 8.2 Hz), while H-3 showed a 
correlation in the NOESY spectrum to H-2, H-2" and H-6". 
The fully substituted carbon resonance at 8 189.5 (C-1) indicated that a carbonyl 
group was positioned at C-1, and this carbon resonance showed correlations in the 
HMBC spectrum to H-2, H-3 and H-2'/6'. In the HMBC spectrum the fully substituted 
carbon resonance due to C-4' (8 151.4) showed correlations to H-2'/6' and H-3'/5' 
(86.88, 1H, J = 8.2 Hz). 
The two methoxy groups at C-3" (8 149.4) and C-4" (8 151.4) were observed in the 
IH NMR spectrum as two singlets, each integrating to three protons, at 83.91 (OCH3 
at C-3") and 8 3.89 (OCH3 at C-4"). The methine carbon ascribed to C-6" (8 123.2) 
showed correlations in the HMBC spectrum to H-3 and H-2", while H-6" was seen to 
be coupled in the NOESY spectrum to H-2, H-3 and H-5". The fully substituted 
carbon resonance assigned to C-4" showed correlations in the HMBC spectrum with 
H-2", H-5", H-6" and the protons of the methoxy group attached at C-4". In the l3C 
NMR spectrum the resonances assigned to the carbons of the methoxy groups at C-3" 
and at C-4" were observed at 8 56.2. 
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From the NMR data this synthesised compound was confirmed to be the chalcone, 
(£)-1-(4 '-hydroxyphenyl)-3-(3 ",4"-dimethoxyphenyl)prop-2-en-1-one. Compound 
XX, at a concentration of 10 Ilg/cm3, showed a 22.8% inhibition of prostaglandin 
synthesis using the microsomal cell screen (page 72). 
The NMR data and correlations for this compound are listed in table 6.1, while the 
HMBC and NOESY correlations are shown in figure 6.3 and figure 6.4 respectively. 
Figure 6.3. The HMBC (C -7 H) correlations for compound XX. 
Figure 6.4. The NOESY correlations for compound XX. 
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Table 6.1. NMR data and correlations for compound XX (CDCh) 
Carbon IHNMRdata 




(100 MHz) correlations 
Number (400 MHz) correlations 
C~H 
correlations 
1 - 189.5 (C) - H-2, H-3, H-2'/6' -
7.37 (1H, d, J=15.6 Hz) 120.1 (CH) H-3 
H-3, H-2' /6', 
2 - H-2", H-6" 
7.71 (lH, d, J=15 .6 Hz) 144.4 (CH) H-2 H-2", H-6" 
H-2, H-2", 
3 H-6" 
l' - l30.6 (C) - H-3'/5' -
2' 7.93 (lH, d, J-8.2 Hz) l31.3 (CH) H-3'/5' H-2'/6' H-2, H-3'/5' 
3' 6.88 (1H, d, J=8.2 Hz) 115.6 (CH) H-2'/6' H-3'/5' H-2'/6' 
4' - 161.6 (C) - H-2'/6', H-3'/5' -
5' 6.88 (lH, d, J-8.2 Hz) 115.6 (CH) H-2'/6' H-3'/5' H-2'/6' 
6' 7.93 (lH, d, J=8.2 Hz) l31.3 (CH) H-3'/5' H-2'/6' H-2, H-3'/5' 
1" - 128.3 (C) - H-2, H-3(w), H-5" -
2" 7.12 (lH, d, J=2.0 Hz) 110.3 (CH) H-3, H-6" 
H-2, H-3, 
-
OCH3 at C-3" 
3" 149.4 (C) 
H-2", H-5", -- - OCH3 at C-3" 
4" 151.4(C) 
H-2", H-5", H-6", 
-- - OCH3 at C-4" 
5" 6.86 (lH, d, J=8.2 Hz) 111.3 (CH) H-6" H-6" , -
OCH3 at C-4" 
6" 7.l9 (lH, dd, J=2.0, 8.2 123.2 (CH) H-5" H-3, H-2" H-2, H-3, H-5" Hz) 
OCH3 at 3.91 (3H, s) 56.2 (CH3) - - H-2" C-3' 
OCH3 at 3.89 (3H, s) 56.2 (CH3) - - H-5" C-4' 
6.1.3 Synthesis of 1-(4'-hydroxyphenyl)-3-(3",4" -dimethoxyphenyl)-
pent-4-en-l-one 
Firstly the Grignard reagent, vinylmagnesium bromide, had to be synthesised 
according to the method reported in Vogel 17 • Once synthesised, the Grignard reagent 
was reacted with the chalcone in the presence of cuprous iodide to give the adduct 1-














Scheme 6.7. The proposed attachment of the Grignard reagent to the chalcone. 
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In this reaction step, a Michael-type addition reaction is favoured and hence the vinyl 
group attacks C-3 instead of the carbonyl group carbon. 
6.1.3.1 Confirmation of the Structure of Compound XXI 
1-(4' -hydroxyphenyl)-3-(3",4" -dimethoxyphenyl)pent-4-en-1-one 
(Spectra 21a-g, pages 395-401) 




1-(4' -hydroxyphenyl)-3-(3",4" -dimethoxyphenyl)pent-4-en-l-one 
Figure 6.5. The structure of compound XXI. 
The high resolution mass spectrum showed a parent ion peak at mlz 312.13615, which 
was consistent with the molecular formula of C19H2004 (C19H2004 requires 
312.13616). A double bond equivalence of ten was deduced. 
In the IH NMR spectrum, the H-2'/6' proton resonance was observed at 8 7.83 (2H, d, 
J = 8.4 Hz) and this showed a correlation in the NOESY spectrum to a triplet proton 
resonance at 8 3.32 (2H) in the NOESY spectrum. This resonance was assigned to 
2H-2 as it was seen in the COSY spectrum to be coupled to a proton resonance at 
8 4.03, ascribed to H-3. The 2H-2 proton resonance showed correlations in the 
NOESY spectrum to H-3, H-2'/6', H-2" (86.74), H-6" (86.76) and a vinyl methylene 
proton resonance at 8 5.04 (H-5A, dd, J = 1.5, 10.0 Hz) and 8 5.00 (H-5B, dd, J = 1.5, 
16.8 Hz), assigned to 2H-5. 
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The COSy spectrum showed coupling between the 2H-5 proton resonance and a 
resonance at 8 6.00, ascribed to H-4, which was, in tum, seen to be coupled in the 
COSY spectrum to H-3. In the HMBC spectrum the C-2 methylene carbon resonance 
at 8 43.6 showed correlations to H-3 and H-4, while the C-3 methine carbon 
resonance at 8 44.5 showed coupling in the HMBC spectrum with 2H-2, H-4, 2H-5, 
H-2" and 2H-6". 
The IH NMR spectrum showed the presence of two singlet proton resonances at 
83.78 (3H) and 8 3.79 (3H), which were assigned to the methoxy groups at C-3" and 
C-4" respectively. The carbonyl group at C-1 was indicated by the fully substituted 
carbon resonance at 8 198.5 (C-1) and showed correlations in the HMBC spectrum to 
2H-2, H-3 and H-2' 16'. 
This synthesised compound was confirmed to be the novel vinyl ketone, 1-(4'-
hydroxyphenyl)-3-(3",4"-dimethoxyphenyl)pent-4-en-1-one. The NMR correlations 
are tabulated in table 6.2, while the HMBC and NOESY correlations are shown in 
figure 6.6 and figure 6.7 respectively. 
Figure 6.6. The HMBC (C -7 H) correlations for compound XXI. 
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Figure 6.7. The NOESY correlations for compound XXI 
Table 6.2. NMR data and correlations for compound XXI (CDCh) 
iHNMRdata l3c NMRdata COSY HMBC 
Carbon Number correlations NOESY correlations (400 MHz) (100 MHz) correlations C~H 
1 - 198.5 (C) - 2H-2, H-3, H-2'/6' -
2 3.32 (2H, m) 43.6 (CH2) H-3 H-3, H-4 
H-3, 2H-S, H-2'/6', 
H-2", H-6" 
3 4.03 (IH, m) 44.S (CH) 2H-2, H-4 
2H-2, H-4, 2H-S, 2H-2, 2H-S, H-4, 
H-2", H-6" H-2'/6', H-2", H-6" 
4 6.00 (IH, dt) 140.6 (CH) H-3,2H-S 2H-2, H-3, 2H-S 
2H-2, H-3, 2H-S, 
H-2", H-6" 
5A 
S.04 (lH,dd, H-4 
2H-2, H-3, H-4, H-2", 
J=1.S, 1O.0Hz) 114.4 (CH2) H-3 
H-6" 
5B 
S.OO (lH,dd, H-4 
2H-2, H-3, H-4, H-2", 
J=1.S, 16.8Hz) H-6" 
l' - 129.2 (C) - H-3'/S' -
2' 7.83 (IH, d, 130.8 (CH) H-3'/S' H-2'/6' 2H-2, H-3' /S' 
J=8.4 Hz) 
3' 
6.86 (lH, d, 11S.4 (CH) H-2'/6' H-3'/S' H-2' /6', OH at C-4' 
J=8.4 Hz) 
4' - 161.4 (C) - H-2'/ 6', H-3'/S' -
5' 6.86 (lH, d, l1S.4 (CH) H-2'/6' H-3 ' /S' H-2'/6', OH at C-4' 
J=8.4 Hz) 
6' 7.83 (lH, d, 130.8 (CH) H-3'/S' H-2'/6' 2H-2, H-3'/S' J=8.4 Hz) 
I" - 13S.6 (C) -
2H-2, H-3, H-4, 
H-S 
-
2" 6.74 (lH,)* 111.1 (CH) - H-3, H-6" OCH3 at C-3" 
3" - 148.6 (C)t - H-S", OCH3 atC-3" -




5" 6.76 (lH,) § 111.3 (CH) H-6" - OCH, at C-4", H-6" 
6" 6.76 (lH)* 119.4 (CH) H-S" H-3, H-2" H-S" 
OCH3 at C-3" 3.78 (3H, s) SS.7 (CH3)+ - - H-2" 
OCH3 at C-4" 3.79 (3H, s) SS .6 (CHi - - H-S" 
OHat C-4' 8.28 (brs) - - - H-3'/S' 
t,+ values may be mterchangeable 
§ superimposed resonances (J could not be determined) 
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6.1.4 Attempted Synthesis of 1-(4'-hydroxyphenyl)-3-(3",4"-
dimethoxyphenyl)pent-4-en-1-o1 
According to Muraoka and co-workers6, the reduction of the l,4-adduct with sodium 
borohydride (Scheme 6.8) should yield a diastereoisomeric mixture of the vinyl 
alcohol, 1-( 4'-hydroxyphenyl)-3-(3 ",4"-dimethoxyphenyl)pent-4-en-1-ol. 
OCH3 OCH3 
H3CO OH H3CO OH 
o OH 
1-( 4'hydroxyphenyl)-3-(3",4" -dimethoxyphenyl) 
pent-4-en-1-one 
1-( 4'hydroxyphenyl)-3-(3" ,4" -di methoxyphenyl) 
pent-4-en-1-ol 
Scheme 6.8. The proposed reduction of the l,4-adduct. 
This synthesis proved successful, however, only IH NMR and l3e NMR spectra were 
obtained as this stage and indicated a mixture of isomers that were not separated and 
were used as the starting material for the next synthetic step. 
6.1.4.1 Confirmation of the Structure of Compound XXII 
1-(4'-hydroxyphenyl)-3-(3",4" -dimethoxyphenyl)pent-4-en-1-o1 
(Spectra 22a-b, pages 402-403) 
This compound (Figure 6.8) was isolated in a 23 .3% yield as a brown oil. 
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OH 
1-( 4' -hydroxyphenyl) -3-(3",4" -dimethoxyphenyl )pent-4-en-l-01 
Figure 6.8. The structure of compound XXII. 
Due to this being a mixture of isomers, only the IH and I3C NMR spectra were run. 
The I3C NMR spectrum showed traces of the vinyl ketone, which have been marked 
in the spectrum. The presence of the hydroxy group at C-l was confirmed by the 
methine carbon signal at 8 79.0 in the I3C NMR spectrum. In the IH NMR spectrum, a 
multiplet occurred at approximately 8 1.9, shifted from 8 3.32 in the IH NMR 
spectrum for compound XXI, and was assigned to 2H-2. This indicated that C-l was 
no longer fully substituted, indicating the formation of the alcohol. 
6.1.5 Attempted Synthesis of 1-(4'-hydroxyphenyl)-3-(3",4"-
dimethoxyphenyl)-1,4-pentadiene 
The acid catalysed dehydration of the vinyl alcohol should have yielded the required 











1-(4' -hydroxyphenyl)-3-(3" ,4" -di methoxyphenyl) 
-1,4-pentadiene 
Scheme 6.9. The proposed formation of the noriignan. 
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However, the dehydration of the hydroxy group to form a double bond between C-1 
and C-2, using 7% H2S04, was not successful and rather the compound cyclised to 
form the novel indene-type compound (E)-3-vinyl-1-( 4'-hydroxyphenyl)-3",4"-
dimethoxyindene (Scheme 6.10). This occurred via a nucleophilic attack on the 















Scheme 6.10. The proposed formation of (E)-3-vinyl-1-(4'-hydroxyphenyl)-3",4"-
dimethoxyindene. 
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6.1.5.1 Structural Elucidation of Compound XXIII 
(E)-3-vinyl-1-( 4' -hydroxyphenyl)-3",4" -dimethoxyindene 





Figure 6.9. The structure of compound XXIII. 
The mass spectrum showed a parent ion peak at mlz 296, which was consistent with 
the molecular formula of C19H2003 (C19H2003 requires 296). A double bond 
equivalence of ten was deduced. 
The IH NMR spectrum showed the presence of a pair of doublets at 8 6.95 (2H, 
J = 8.6 Hz) and 8 6.73 (2H, J = 8.6 Hz) which are ascribed to the H-2' /6' and 
H-3'/5' protons respectively. These two proton resonances are seen to be coupled to 
one another in the COSY spectrum. The H-3'/5' proton signal showed a correlation in 
the NOESY spectrum to H-2'/6', while the C-3'/5' methine carbon resonance at 
8 115.3 was correlated to H-2' /6' in the HMBC spectrum. In the HMBC spectrum the 
C-2' /6' methine carbon resonance at 8 128.8 showed a correlation to a one-proton 
superimposed resonance at 8 4.31 which was assigned to H-l. The corresponding 
carbon resonance at 8 49.0 (C-l) was correlated in the HMBC spectrum to 2H-2 
(8 2.24 and 8 2.36) and a one-proton singlet proton resonance at 8 6.53 which was 
assigned to H-5". This H-5" proton resonance also showed a correlation in the 
NOESY spectrum to H-l. 
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The H-2" proton resonance showed a correlation in the NOESY spectrum to a one-
proton resonance at 8 3.85 which was ascribed to H-3 as it also showed a correlation 
in the NOESY spectrum to H-2A and 2H-5 (8 5.06 and 8 5.03) and was seen to be 
coupled in the COSY spectrum to 2H-2. Due to the fact that no correlation could be 
seen in the NOESY spectrum between H-l and H-3, the relative stereochemistry 
could be determined, and these protons were observed to be trans to one another. In 
the HMBC spectrum the C-3 methine carbon resonance at 8 48.3 showed a correlation 
to H-2", 2H-2 and a two-proton resonance at 8 5.05 which was due to the vinyl 
methylene protons, 2H-5. In the COSY spectrum the 2H-5 proton resonance was seen 
to be coupled with a one-proton multiplet at 85.86, which was assigned to H-4 as the 
corresponding methine carbon resonance at 8 141.3 showed correlations in the HMBC 
spectrum to 2H-2 and H-3. The C-5 methylene carbon resonance at 8 114.4 also 
showed a correlation in the HMBC spectrum to H-3. 
In the IH NMR spectrum two singlet proton resonances, both ascribed to three 
protons, were observed at 83.86 and 8 3.75 and were assigned to the methoxy group 
attached to C-3" and the methoxy group attached to C-4" respectively. In the 
NOESY spectrum the methoxy group at C-3" showed a correlation to H-2", while 
the methoxy group at C-4" showed a correlation to H-5". The C-3" fully substituted 
carbon resonance was thus assigned to the resonance at 8 148.6 as it was correlated in 
the HMBC spectrum to the methoxy group at C-3" proton resonance, similarly, the 
C-4" fully substituted carbon resonance was due to the resonance at 8 148.5. Four 
additional fully substituted carbon resonance were observed in the l3C NMR spectrum 
at 8 154.0, 138.0, 137.4 and 129.4 and were ascribed to C-4', C-1', C-6" and C-1" 
respectively. 
This compound was found to be the novel indene-type compound identified as 
(E)-3-vinyl-l-(4'-hydroxyphenyl)-3",4"-dimethoxyindene. The NMR data for 
compound XXIII is tabulated in table 6.3 and the HMBC and NOESY correlations 
(both showing the relative stereochemistry) are shown in figure 6.10 and figure 6.11 
respectively. 
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Figure 6.10. The HMBC (C -7 H) correlations for compound XXIII. 
H 
Figure 6.11. The NOESY correlations for compound XXIII. 
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Table 6.3. NMR data and correlations for compound XXIII (CDCh) 




Carbon Number data correlations 
correlations correlations (400 MHz) (100 MHz) C-7H 
4.31 (lH, dd, 49.0 (CH) 2H-2 
2H-2, H-2' /6', 2H-2, H-2' /6' , 
1 J-5 .5, 8.1Hz) H-5" H-5 " 
H-l, H-2B, H-l, H-2B, 
2A 2.24 (IH, m) H-3 H-3, H-2'/6' 
43.8 (CH2) H-1, H-2A, 
H-l(w) 
2B 2.36 (lH, m) H-3 
H-1, H-2A 
48.3 (CH) 2H-2 
2H-2, H-4(w), H-2A,2H-5, 
3 3.85 (lH, m) 2H-5, H-2" H-2" 
4 5.86 (lH, m) 141.3 (CH) 2H-5 2H-2, H-3 2H-5 
SA 
5.06 (lH, dd, H-4 H-3. H-4 
J=1.8, 17.2Hz) 114.4 (CH2) H-3 
5B 
5.03 (IH,dd, H-4 H-3, H-4 
J-1O.6Hz) 
l' - 138.0 (C) - H-1, 2H-2, H-3'/5' -
6.95 (2H, d, J 
128.8 (CH) H-3 ' /5 ' H-1, H-2' /6' 
H-1, H-2A, 
2' -8.6 Hz) H-3 ' /5 ', H-5" 
3' 
6.73 (2H, d, 
115.3 (CH) H-2'/6' H-2' /6', H-3' /5' H-2'/6' 
J-8.6 Hz) 
4' - 154.0 (C) - H-2'/6', H-3'/S'(w) -
5' 
6.73 (2H, d, 
115.3 (CH) H-2'/6' H-2' /6' , H-3' /S' H-2'/6' 
J=8.6 Hz) 
6' 6.95 (2H, d, J 128.8 (CH) H-3'/S' H-1, H-2'/6' H-1, H-2A, 
=8.6 Hz) H-3'/S', H-5" 
I" - 129.4 (C) - H-l -
2" 6.71 (lH, s) 107.3 (CH) H-3, - -
OCH3 at C-3" 
3" 148.6 (C) 
H-2", -- - OCH3 at C-3" 
4" 148.5 (C) 
H-5", -- - OCH3 at C-4" 
5" 6.53 (lH, s) 107.9 (CH) H-1, H-2'/6', - - OCH3 at C-4" 
6" 137.4(C) H-5", -- - OCH3 at C-4"(w) 
OCH3 at C-3' 3.86 (3H, s) 56.0 (CH3) - - H-2" 
OCH3 at C-4' 3.75 (3H, s) 56.0 (CH3) - - H-5" 
6.1.6 Experimental 
Synthesis of 1-(4 '-hydroxyphenyl)-3-(3 ",4 "-dimethoxyphenyl)prop-2-en-1-one 
Potassium hydroxide pellets (90 g) were dissolved in water (90 em3) in a round-
bottomed flask. The 4'-hydroxyaeetophenone (20 g in 220 em3 methanol; 0.1469 
moles) was added to the flask followed by the 3,4-dimethoxybenzaldehyde (24.41g in 
220 cm
3 
methanol; 0.1469 moles) and the flask was stoppered. The contents of the 
flask were left to stir for 5 days. The solution turned from yellow to orange in colour. 
The resultant solution was diluted with 500 cm3 of deionised water and then acidified 
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with 500 cm3 of 4M hydrochloric acid. The reaction solution was then extracted with 
dichloromethane (5 x 500 cm3 portions). The chalcone (23.3 g, 56%) crystallised out 
as bright yellow crystals from the dichloromethane extract. 
Formation of the Grignard reagent 
A dry three-necked round bottom flask, under nitrogen, was equipped with a magnetic 
stirrer bar, a dry-ice condenser and an addition funnel. Magnesium (1.5 g, 0.06 mol) 
was placed inside the flask with 13 m1 dry tetrahydrofuran (THF). In the addition 
funnel was placed vinyl bromide (3.8 cm3, 54.5 mmol) in dry THF (37 cm3). 
Approximately 2 cm3 of this solution was added to the flask, with very rapid stirring, 
to initiate the reaction. After initiation, the remaining vinyl bromide solution was 
added slowly to maintain steady reflux. Once all the magnesium had been consumed 
the reaction flask was allowed to cool. 
Synthesis of (+)-1-(4 '-hydroxyphenyl)-3-(3 ",4 "-dimethoxyphenyl)pent-4-en-l-one 
Under nitrogen, a solution of vinylmagnesium bromide in tetrahydrofuran (THF, 
50 cm3, 54.5 mmol) was added to a suspension of cuprous iodide (520 mg, 2.7 mmol) 
in THF (50 cm3) at oce, and the mixture was stirred at oce for 15 minutes. To the 
mixture was added a solution of the chalcone (7.3 g, 24.3 mmol) in THF (20 cm3) at 
room temperature for 24 hours. The reaction was quenched by the addition of 10% 
hydrochloric acid to the mixture, which was then extracted with diethyl ether. The 
extract was washed successively with aqueous sodium hydrogen carbonate and brine 
and then evaporated to give a red amorphous substance, identified by NMR as the 
vinyl ketone (1478 mg, 20%). 
Synthesis of 1-(4 '-hydroxyphenyl)-3-(3 ",4 "-dimethoxyphenyl)pent-4-en-l-01 
A mixture of the vinyl ketone (1421 mg, 4.5 mmol), sodium borohydride (0.33 g, 
30.9 mmol) and ethanol (20 cm3) was stirred at room temperature for three days and 
then concentrated using a rotor evaporator. The residue was diluted with 50 cm3 brine, 
acidified with 10% hydrochloric acid solution and extracted with benzene. The 
extract was washed successively with aqueous sodium hydrogen carbonate and brine 
and then evaporated to give a brown oil (1316.7 mg, 93%). This is a diastereoisomeric 
mixture of the vinyl alcohol 
191 
Synthesis of (E)-3-vinyl-l-( 4 '-hydroxyphenyl)-3 ",4 "-dimethoxyindene 
A mixture of the vinyl alcohol (1284.5 mg, 4.3 mmol), 7% hydrochloric acid (20 cm3) 
and methanol (33 cm3) was refluxed for 24 hours using steam. Once cool, the reaction 
mixture was poured into aqueous sodium hydrogen carbonate and extracted with 
chloroform. The extract was washed with brine and evaporated to give a brown oil 
(532 mg). This was subjected to column chromatography (2 cm3 in diameter) using 
100% dichloromethane as the mobile phase and silica gel (Merck 9385) as the 
stationary phase to yield the final product (149 mg, 11.7%). 
6.1.6.1 Physical data for Compound XX 
Name: (£)-1-( 4'-hydroxyphenyl)-3-(3 ",4"-dimethoxyphenyl)prop-2-en-1-one 
Physical appearance: yellow crystals 
Melting point: 84-86°C 
Yield: 56% 
Mass: HRMS [M+] at mlz 284.10485, C17H1604 requires 284.10486 
EIMS: mlz: 284, 269, 253, 241, 226, 210, 191, 181, 163, 147, 138, 121, 105, 
93,77,65 
Infra-red: V~:;l cm-1 : 3273,1608,1517,1442,1271,1159,1025 
IH and 13e NMR Data: Refer to table 6.1 (page 180) 
6.1.6.2 Physical data for Compound XXI 
Name: 1-( 4'-hydroxyphenyl)-3-(3",4 "-dimethoxyphenyl)pent-4-en-l-one 
Physical appearance: red amorphous 
Yield: 20% 
Mass: HRMS [M+] at mlz 312.13615, C19H2004 requires 312.13616 
EIMS:mlz: 312,284,253,229,191,177,146,121,93,77,65,51 
Optical Rotation: [a]D = +0.11° (c = 1.932 g/100 cm3; CHCh) 
IH and 13e NMR Data: Refer to table 6.2 (page 183) 
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6.1.6.3 Physical data for Compound XXIII 
Name: (E)-3-vinyl-1-( 4'-hydroxyphenyl)-3 ",4"-dimethoxyindene 
Physical appearance: brown amorphous 
Yield: 11.7% 
Mass: [M+] at mlz 296, C19H2003 requires 296 
IH and 13C NMR Data: Refer to table 6.3 (page 190) 
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This thesis involved the chemical investigation of seven African medicinal plants as 
well as the synthesis, or partial synthesis, of certain isolated compounds. 
The first plant family investigated in this work was the Hyacinthaceae, and in this 
chemical investigation, four plants were investigated, namely Ledebouria ovatifolia, 
Eucomis pole-evansii, Lachenalia rubida and Drimia capitata. A diverse range of 
compounds were isolated from this plant family including a norlignan, 
homoisoflavonoids, nortriterpenoids and bufadienolides. 
Ledebouria ovatifolia yielded a novel norlignan, (-)-(2)-1-( 4'-hydroxyphenyl)-3-(5"-
hydroxy-3",4"-dimethoxyphenyl)-1,4-pentadiene (compound I) and two 
nortriterpenoids, (23S)-17a,23-epoxy-3~,29-dihydroxy-27 -norlanost-8-ene-15,24-
dione (compound II) and (23S)-17a,23-epoxy-3~,28,29-trihydroxy-27-norlanost-8-
en-24-one (compound III). This was the first time that a norlignan had been isolated 
from the Hyacinthaceae family. Ledebouria ovatifolia had previously been worked on 
by Pohl et al. who isolated 4,4'-dihydroxy-2',6'-dimethoxychalcone and 5,7-
dihydroxy-3-( 4'-hydroxybenzyl)-4-chromanone1• Further investigations of this plant 
have also yielded the novel chalcone, ovatifolin2. This plant was chemically 
investigated for a second time as the plant in this study was the Highveld form which 
was collected from the Blyde Nature Reserve, while the first investigation was 
performed on Ledebouria ovatifolia that was purchased from the Warwick Triangle 
market in Durban, Kwazulu-Natal. This confirmed that the environment that a plant 





5' .# 3' 
4' HO 
OH 
compound I compound IT 
o 





Eucomis pole-evansii yielded a 3-benzyl-4-chromanone type homoisoflavonoid, 
(-)-5, 7 -dihydroxy-3-( 4 '-hydroxybenzyl)-8-methoxy-4-chromanone (compound IV) 
and a novel 3-benzylidene-4-chromanone type homoisoflavonoid, (E)-5,6,7-
trihydroxy-3-( 4'-hydroxybenzylidene )-8-methoxy-4-chromanone (compound V). 
OH 0 H OH 0 H 
compound IV compound V 
Lachenalia rubida yielded a 3-benzyl-4-chromanone type homoisoflavanone, (-)-5-
hydroxy-3-(4'-hydroxybenzyl)-7-methoxy-4-chromanone (compound VI) and a novel 
3-benzyl-4-chromone type homoisoflavone, 5-hydroxy-3-( 4'-hydroxybenzyl)-7-
methoxychromone (compound VII). Compound VI has been reported by Adinolfi et 
al.3, however, it was not clear from the paper whether this compound was isolated as a 
natural compound or if it resulted from a methylation reaction. Compound VII is an 
unusual type of homoisoflavonoid that has not been widely isolated. 
H H H H 
compound VI compound VIT 
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Drimia capitata yielded a novel bufadienolide 5~-3~,16~-dihydroxybufa-20,22-
dienolide (compound VIII) and the novel glycoside of compound VIII, 5~-16~­
hydroxybufa-20,22-dienolide 3~-O-~-D-galactoside (compound IX). The identity of 
the sugar group was unsure, thus a hydrolysis of compound IX with ~-glucosidase 
was performed in order to cleave off the sugar from the aglycone. The sugar was 
identified as galactose. 
o o 
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The fifth plant to be investigated was Papaver aculeatum of the family, Papaveraceae. 
This project was initiated by Professor P. Tetenyi of the Institute of Research into 
Medicinal Plants in Budapest, Hungary who communicated that the South African 
species was considered primitive amongst the Papavers and could contain simple 
alkaloid precursors. This plant yielded an alkaloid, (+ )-N-acetylanonaine (compound 
X). 
compound X 
The Asteraceae was the third plant family to undergo chemical investigation and 
Spilanthes mauritiana, yielded one known isobutyl amide, N-(2'-methylpropyl)-deca-
2E,6Z,8E-trienamide (compound XI) and a novel isobutyl amide, N-(2'-
methylpropyl)-nona-2E,4E-dien-8-ynamide (compound XII). This work was initially 
the project of postdoctoral student Dr. J.1. Nair who investigated this plant in an 
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attempt to isolate the compounds responsible for the numbing action of the plant. Dr. 
Nair isolated these two compounds but he left the department before they could be 
identified. Dr Nair managed to run some 2-D spectra before leaving, however, even 
though his compounds were stored in a freezer, they still decomposed. These 
isobutylamide compounds are highly unstable4 and several efforts to re-isolate this 
type of compound proved unsuccessful as they rapidly decomposed. 
0 0 
~3' ~3' 
1 ~ 2' 94 8 6 N 2' 7 4 H H 
4' 
4' 
compound XI compound XII 
The seventh and final plant investigated was Tachiadenua longiflorus from the 
family, Gentianaceae. This plant yielded a wide variety of compounds including an 
oleane triterpenoid, oleanolic acid (compound XIII), which precipitated out of the 
hot hexane extract in a large quantity. Other compounds isolated included two 
coumarins, scopoletin (compound XIV) and scoparone (compound XV), as well as 
an iridoid derivative, angelone (compound XVI). 
H H 
compound XIII compound XIV 
H H 
compound XV compound XVI 
198 
The isolation of the two coumarins prompted their syntheses, as the NMR data for 
these compounds did not correlate well with literature. The synthesis of aesculetin 
(compound XVII) and scoparone (compound XVIII) proved successful, however 
scopoletin was unable to be synthesised. However, isoscopoletin (compound XIX) 
was successfully synthesised, but in a low yield. 
H H H H H H 
HO 
HO 
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The isolation of the norlignan from Ledebouria ovatifolia prompted its attempted 
synthesis. However, due to confusion in the literature, it was initially thought that 
compound I was of the trans orientation and thus the synthesis was performed 
according to the method of Muraoka and co-workers5. The starting material, 5-
hydroxy-3,4-dimethoxy-benzaldehyde, was not readily available, and due to time 
constraints, the derivative 3,4-dimethoxy-benzaldehyde, which was readily available 
was used instead. It was presumed that if the reaction was successful with this starting 
material, then compound I could be synthesized using the same procedure, with the 
appropriate starting material. The initial step in the reaction resulted in the formation 
of the chalcone, (£)-1-( 4'-hydroxyphenyl)-3-(3 ",4"-dimethoxyphenyl)prop-2-en-l-one 
(compound XX). The formation of the appropriate Grignard reagent was required and 
this was reacted with the chalcone to yield the vinyl ketone, (+)-1-( 4'-hydroxyphenyl)-
3-(3",4"-dimethoxyphenyl)pent-4-en-l-one (compound XXI). Reduction of the 
ketone to form the vinyl alcohol, 1-(4'-hydroxyphenyl)-3-(3",4"-
dimethoxyphenyl)pent-4-en-l-01 (compound XXII) resulted in a mixture of isomers 
which were then dehydrated to give the final product, (£)-3-vinyl-l-(4'-
hydroxyphenyl)-3",4"-dimethoxyindene (compound XXIII). Thus the formation of 
the norlignan was unsuccessful. However, the synthesis of the indene-type compound 
was interesting and this work will be investigated further by a student in the research 
group. 
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I-D and 2-D NMR spectroscopy were used to elucidate all the structures isolated in 
this work, while mass spectrometry, infra-red analysis and ultra-violet spectroscopy 
were used to confirm the structures. Seven novel compounds resulted from the sixteen 
natural products isolated. Compounds I, IV, V, XIV, XVII, XVIII, XIX and XX were 
screened for biological activity and these provided promising results (Table 7.1). The 
anti-inflammatory activity given is measured as a percentage inhibition of 
prostaglandin synthesis using indomethacin as a positive control. 






COX-l screen COX-2 screen 
cellscreen 
I 72.7 42.2 23.4 -
IV 28.2 - 2.5 -
V 29.7 - - MIe 0.98 rnM 
XIV 7.5 - 4.5 -
XVII 27.7 - 2.3 -
XVIII 4.5 - - -
XIX 21.6 - - -
XX 22.8 - - -
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In earlier times, all drugs and medicinal agents were derived from natural products in 
higher plants. Today many drugs are synthesised to compete with the growing 
demand for medicinal agents. However, the study of natural products has its 
advantages over synthetic drugs as it primarily leads to compounds having new 
structural features and novel biological activities6. Higher plants serve as an important 
source of new drugs and novel compounds isolated from them are extremely useful as 
lead structures for synthetic modification and optimisation of bioactivitl. The future 
of higher plants as sources of medicinal compounds for use in investigation, 
prevention and treatment of diseases is very promising6. 
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Spectrum 19: NOESY spectrum of compound I 
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Spectrum Ih: Mass spectrum of compound I 
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Spectrum Ii: Infra-red spectrum of compound I 
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cmc'I::l.lomc / 43 in coc13 
p r obe;5mmAS W 
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Spectrum 2b: 13c NMR spectrunl of compound II (CDCh) (100 MHz) 
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Spectrum 2c: ADEPT spectrum of compound II 
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Spectrum 2d: HSQC spectrum of compound II 
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HBmc43a.lomc/43 in cdc13 
Gradient HMBC expt . 
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Pulse Sequence: ghmqc_da 
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Gradient NOE SY e~ p t . 
mix =lsec 
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Pulse Se qu ence: noe sy_da 
~ 





-~----a 1. 0---1 @ L ~o . f7 @ ~ ~ .-0 0 . ! 
- ,, -- - 0 Mo, I @ 
1. 5---1 9 €> I S 
("} @ 
0 0~ t 
~ '!Xl) @l lilI 
2.0---1 0 0 . g 
m ~ o I 0 0 
2 . 51 
0 0 @J ~o 
U .., ~ m <II> ~ .... '" 
o · 
3. O~ 
I\) c7 I.:l CJ @ 00 
3 . 5--1 
/ 4.0-j 
.  c:f a ~ ~ 
4.5-1 0 
D ~ (@ @ 
4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 o . 5 
Fl (ppm) 
Spectrum 2g: NOESY spectrum of compound II 
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c l omc 40a. l omc/3 0- 40 /acety l i n c dc 13 
p r o b e~5mmAS\ol 
Pul se Seq ue nce: s2p u l 
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dlomc40a.lomc/30-40/acetyl jn cdc 13 
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HQlomc~Oa.lomc/30-~O/acetyl in cdcl3 
Gradient HSQC expt. 
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Spectrum 2n: COSY spectrulD of acetylated compound II 




n l omc~oa.lomc/30-~O/acetYl in cdcl3 
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Spectrum 20: HMBC spectrum of acetylated compound II 
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NUlomc4ua.lomc/30-40 /ace tyl In cdc13 
NOESY expt. 
mix=lse c 
probe =S mmAS\oI 
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h1za70.1za70 In c dc1 3 
probe=5mmASW 
Pulse Sequence: s2pul 
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HQl za7 0 . 1za 7 0 in c dc'3 
Gradient HSQC eM pt. 
with mult .editing 
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cylza70,lza70 in c d c 13 
lH Cosy-90 
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1 -'--- 1 1 1 1 
3. 0 2.5 2 .0 1. 5 1.0 0. 5 3.5 
Fl (ppm) 




HBlza70.lza70 in cdc 13 
Gra di ent HMBC expt. 
probe=5mmASW 
Pulse Seque nce: ghmq c_da 




























1 "lIf iilil 
120 100 
Fl (ppm) 



























NOl za7 0 , l za7 0 in c dc l 3 
Gradient NOESY eNpt , 
mix=lsec 
probe=5mmASW 
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Spectrum 3g: NOESY spectrum of compound III 
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probe=3 mm iO 
Pu l se Sequence: s2pul 
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HQepmc14 .e pmc4/14 in cdc13 
Gradient HSQC expt. 
with mult.editing 
probe=3mmID 
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Spectrum 4c: HSQC spectrum of compound IV 
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cyepmc14 . epmc4 / 14 in cdc13 
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HBepmc14.epmc4/14 in cdcl3 
Gradient HMBC expt . 
opt imi zed for 7 Hz coupling 
probe~3mmID 
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Spectrum 4e: HMBC spectrum of compound IV 
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NOepm c14.e pmc4 / 14 in cdc13 
NOE SY expt . 
mix =lsec 
probe=3mmID 
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Spectrum 4g: Mass spectrum of compound IV 
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Spectrum 4i: Infra-red spectrum of compound IV 
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Spectrum 4j: IH NMR spectrum of acetylated compound IV (CDCh) (400 MHz) 





CemCHl.epmc 9/17-18- 1n crlc13 
probe=5mmAS\oI 
Pulse Sequence: s2pul 
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demc18 , epmc 9/ 17-18 in cdc13 
probe =5mmASW 
Pulse Sequence: dept 
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Spectrum 41: ADEPT spectrum of acetylated compound IV 
HQemc1B.epm c 9/17-1B in cdc13 
Gradient HSQC expt. 
with mult.editing 
probe=5mmASW 
Pulse Sequence: ghsqc_da 
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cyemc18.epmc 9/17-18 in cdc13 
lH Cosy-90 
probe=5mmASW 
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Spectrum Sb: l3C NMR spectrum of compound V (CDCh) (100 MHz) 
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Spectrum 5d: COSY spectrum of compound V 
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Spectrum Sf: NOESY spectrum of compound V 
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Spectrum Sg: Mass spectrum of compound V 
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dlr79.lrmc7/9 i n cdcl3 
probe=5mmASW 
Pulse Sequence: dept 




Spectrum 6c: ADEPT spectrum of compound VI 
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HBlr79 . lrmc7/9 in cdcl3 
Gradient HMBC eNpt. 
optimized for 7Hz coupling 
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Pulse Sequence: ghmqc_da 
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Spectrum 6f: HMBC spectrum of compound VI 
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NOlr79 . lrmc7/9 in cdcl3 
NOESY expt . 
mix =lsec 
probe=5mmAS\oI 
Pulse Sequence: noesy_da L u J ~~ 
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Spectrum 6g: NOESY spectrum of compound VI 
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NOl r79. lrmc7/9 In cdcl3 
NOE SY ex pt . 
mi x= l sec 
probe=SmmASIoI 
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Spectrum 7c: HSQC spectrum of compound VII 
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optimized for 7 Hz coupling 
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Spectrum 7e: HMBC spectrum of compound VII 
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Gradient HSQC expt . 
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Spectrum 9d: HSQC spectrum of compound IX 
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with pr esat_h20 
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Spectrum 9f: HMBC spectrum of compound IX 
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Spectrum 9h: Mass spectrum of compound IX 
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Spectrum 9i: Infra-red spectrum of compound IX 
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Spectrum lOa: IH NMR spectrum of compound X (CD30D) (400 MHz) 
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HUpa c 4 . pa c/~ i n c d30d 
Gra die nt HSQC eM pt . 
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Spectrum lOd: HSQC spectrum of compound X 
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Spectrum 109: NOESY spectrum of compound X 
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Spectrum 13d: COSY spectrum of compound XIII 
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Pulse Seq ue nce: noesy_da 
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Spectrum 13f: NOESY spectrum of compound XIII 
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HQhxpto.hex-ppt/oxidation In cdc13 
Gradient HSQC expt. 
with mUlt.editing 
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HBhxpto.hex-ppt/oxtdation in cdcl3 
Gradient HMBC expt. 
optimized for 7 Hz coupling 
probe=SmmASW 
Pulse Seq uence: ghmqc_da 
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NOhxpto.hex-ppt/oxidation in cdc l 3 
NO ESY ex pt. 
mi x= l sec 
probe=5mmASW 
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Spectrum 13n: NOESY spectrum of oxidised compound XIII 
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prOlJe =::l mmID 
Pul se Sequence: s2 pul 
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HQmc36.lomc2/34-36 in cdcl3 
Gradient HSQC expt. 
with mult.edit i ng 
probe=3 mm ID 
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Spectrum 14c: HSQC spectrum of compound XIV 
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cymc3 6 . 1omc2 / 34-36 in c dc1 3 
lH Co s y-SO 
pr obe=3mmID 












HBmc36.lomc2/34-36 in cdc13 
Gradient HMBC expt. 
probe=3mmID 
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NOmc36.1omc 2/3 4-36 In cdc13 
Gradient NOESY ex pt . 
mix=lsec 
probe=3 mm ID 
Pulse Se qu e nce: noesy_ da 
,.J --.. 
J 
_u II ~ L 
-
F2 {J0 







..,. t:l • 





d IlJ '"' 
'" 0 
I I I I I ' I I I I 
7 . 5 7 . 0 6 . 5 6 . 0 5 . 5 5 . 0 4 .5 4.0 3.5 
Fl (ppm) 







Scan 1509 (12.945 min): TUMC2.D (-) 
149 1 ~2 
a I, 4,' fl· ,1iIII1.lIUj, .. ~·.ll P I II L L . 
m/z--> 0 ,1 " "" , , , , , I I 
50 100 150 200 250 300 350 400 450 500 550 




101 ~ ._-_._-... __ . __ .. --- _._-.---_._ ... _.".-.-... -~--... - ----.. --,---.. -.---.~ .. --
1
-----.·-.. ·-------------.,.-<-----.---
100 ~ ~ 
· 99 ! Ii I i 













~i ttance 93 






















I I t I I ' I I I I ,~ -r r I I I , I I I I I I I I I ' '-'T -, I I '--" , . 1 I , T'1 







L Wavenumbers (cm-1) .-"~ --''Y''- . ~~.r-~_~~~"~L~V=~"""'""""_.ID<~=~O_"~_"'~""'~'::";lo_~"'~~·.r..~~;:t.~-W':l'>C'''''~-~·~,.",c...~~ ...... _."._.,_ .... ~~ ... ~ ............ ...-=> ... ~,~w=.~ ..  




nmc'-~. lomc2/1B-19 in cdc 13 
probe=3mmID 
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cmc19.lomc2/18-19 in cdcl3 
probe=3mmID 




I I I I I I I f I I I I I I I I I I I I i I I I I I I I Iii iii i I 1,---,-- 1 
2 00 180 160 140 120 100 80 60 40 20 ppm 
Spectrum ISb: 13C NMR spectrum of compound XV (CDCI3) (100 MHz) 
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HQmc19.lomc2/18-19 in cdc13 
Gradient HSQC e~pt . 
probe;3mmID 
Pulse Seque nce: ghsqc_da 
F 2 -

































cymc19.lomc2/18-19 in cdc 13 
IH Cosy-90 
probe ~3mmIO 
Pul se Sequence: relayh 
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Spectrum 15d: COSY spectrum of compound XV 
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HBmc19.lomc2 / 18-19 in cdc13 
Gradient HMBC expt . 
probe=3mmID -
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NOmc19 . lomc2 /18 - 19 in cdcl3 
Gradient NOESY expt. 
mix =lsec 
probe=3mmID 
Pulse Sequence : noe sy_da 
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.'tTe~S"- 6) j n c rl c 13 
pr obe;3mmI 
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HQtle6.tle6(S-6) in cdcl3 
Grad i e nt HSQC expt. 
with mUlt .editing 
probe =3mmID 
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cytle6.tle6(S-6) in cdc13 
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Spectrum 16d: COSY spectrum of compound XVI 
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NUtleti . tle6(S-6) in cd c 13 
Gradient N O~SY expt . 
mix =lsec 
probe =3mmID 
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Spectrum 17b: l3C NMR spectrum of compound XVII (CD30D) (400 MHz) 
HQssx.ss/xtals in c d30d 
Gradient HSQC expt. 
with mult.editing 
probe a 5mmASW 
Pulse Sequence: gh s qc_da 
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cyssx.ss/xtals in cd30 d 
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HB SS X. SS/xtal s in c d30d 
Gradient HMBC expt . 
probe - SmmASW 
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NOs sx .s s/xta l s in cd30d 
NOE SY expt. 
mix =l sec 
probe=SmmASW 
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Spectrum 17g: Mass spectrum of compound XVII 
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cSSZ ;ss - 2- rn-c dc 13 
probe=SmmASW 
Pul se Sequence: S2 pul 
~ 
_._ ... illl_~ ... _~J~_ ....... _,_ ... ~ ___ .... 
I i I I i I I I i I I i I I , I ' , I f I I I I I i j Ii' I 1 I I I 1 
200 180 160 140 120 100 80 60 40 20 ppm 

























# . '. 
Il 
I I I 
140 130 120 110 100 90 80 70 60 50 
Fl (ppm) 





cyss2.ss_2 jn cdcl3 
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probe =S mmASW 
Pulse Se quence: relayh 
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HBsS2 . sS_2 in cdc13 
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Spectrum 18e: HMBC spectrum of compound XVIII 
, .. ~ j 1 .. L 
a-
0 




NOs s 2 .sS 2 in c dc1 3 
NOESY expt . 
mix ; lsec 
probe;5mmASW 
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Spectrum 19b: 13c NMR spectrum of compound XIX (CDCh) (100 MHz) 
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Spectrum 19c: HSQC spectrum of compound XIX 






cyss~.ss_~ in cdcl3 
lH Cosy-90 
probe= 5mmASW 
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HBss3.ss 3 In cdc l 3 
Gradient-H MBC expt . 
probe =5 mmASW 
Pulse Sequence : ghmqc_da 
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Spectrum 1ge: HMBC spectrum of compound XIX 
• 
e 




NO ss3.ss_3 i n cdcl3 
NOE SY expt. 
mix =lsec 
probe =5 mmASW 
Pul se Se quence : noesy_ rla 
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Scan 1503 (12.910 min): SS3.D (-) 
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Spectrum 199: Mass spectrum of compound XIX 
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sy n-rxn c 
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HQ s rc. s yn-rxn c in cdcl3 
Gradient HSQC expt. 
with mult. editi ng 
probe=5mmASW 
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Spectrum 20c: HSQC spectrum of compound XX 
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cys r c.syn-rxn c jn c dc l 3 
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probe-SmmASW 
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Spectrum 20e: HMBC spectrum of compound XX 




NO s r c.syn-rxn c I n c dc 13 
NOE SY expt . 
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p "o be =S mmASW 
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Spectrum 20f: NOESY spectrum of compound XX 
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02180803: Scan 73 (16 85 !J1jn) 
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IIVK e1: .V - l< e t o ne in c rl c13 
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f J ~ 
I I I I I I I I I I 
9 8 7 6 5 4 3 2 1 ppm 




CYKet . Y- Ketone I n cdc 13 
probe- SmmASW 
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HQket.V-keton e in cd c 13 
Gradient HSQC expt . 
with mult.editing 
probe-SmmASW 
Pulse Sequence: ghsqc_da 
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cyket.V-ketone in cdc13 
lH Cosy-90 
probe=5mmASW 
Pulse Sequence: relayh 
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Spectrum 21d: COSY spectrum of compound XXI 
HBK et .v -Keto ne in cdc l 3 
Gradient HMBC expt. 
probe ~5 mmASW 
Pul se Se quence: ghmqc_da 




NO ket.v-ketone in cdc13 
NO ESY expt . 
mix =lsec 
pr'obe=S mmASW 
Pulse Sequence: noesy_da 
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Spectrum 21f: NOESY spectrum of compound XXI 
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hvalc.v-alcohol in cdcl3 
probe =5 mmASW 
Pulse Sequence: s2pul 
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Pul s e Sequence: s2pul 
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Spectrum 22b: 13C NMR spectrum of compound XXII (CDCh) (100 MHz) 
pro be=SmmASW 
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Spectrum 23b: 13c NMR spectrum of compound XXIII (CDCI3) (100 MHz) 
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dnlp4 . nlpp / 4 in cdcl3 
probe=SmmASW 
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Spectrum 23c: ADEPT spectrum of compound XXIII 
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HQnlp4 . nlpp /4 in cdc 13 
Gradient HSQC expt. 
with mult.editing 
probe =5 mmASW 
Pu lse Sequence: gllsqc_da 
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cyn lp4 .n lpP /4 in cdc 13 
IH Cosy -90 
probe=SmmASW 
Pulse Seq uence: relayh _hu~ .. ~ __ ~~ Jl ~. 
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Gradient HM BC expt. 
probe= 5mmASW 
Pul se Se qu e nce: ghm qc_da 
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NOnlp4.nlpp/4 in cdcl3 
NO ESY e~pt. 
mix=lsec 
pro be-SmmASW 
Pul se Sequence: noesY_dft ~_~ _______  ~JL_~----,,~ 
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Fl (ppm) 
Spectrum 23g: NOESY spectrum of compound XXIII 
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